Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 291.8;Proximal tubular cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.4	21.5	14.5	27.4	10.7	17.6	31.4	17.8	12.1	12.1	12.9	11.5	33.8	5.9	31.1	19.4	23.5	13.2	8.3	27.3	10.8	13.4	13.4	4.0	13.5	14.3	13.2	10.8	20.1	19.7	20.9	11.9	5.2	18.1	17.9	13.4	12.9	24.0	29.9	66.0	9.0	23.4	23.1	39.2	43.4	5.7	6.6	12.4	29.1	22.6	11.4	37.3	10.1	26.8	32.4	24.9	11.8	10.1	18.5	17.5	30.5	6.6	12.2	5.4	11.3	11.4	44.4	12.0	35.1	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3	6.0	0.0	18.5	25.1	34.5	26.2	1.1	50.9	0.0	2.3	52.4	7.9	145.9	291.8	115.8	1.0	22.5	124.9	0.0	97.6	75.8	26.7	26.8	5.7	37.6	83.8	28.6	86.6	25.2	24.7	2.0	32.5	23.2	50.6	83.0	83.1	23.6	132.7	74.8	20.5	208.8	16.4	19.4	13.3	10.1	80.0	39.6	50.6	15.2	96.8	26.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000357-55009057	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	11.1	12.8	8.6	12.0	12.3	11.9	10.2	8.7	11.8	10.0	12.3	13.7	8.2	12.3	11.5	12.6	20.8	10.7	13.9	10.6	8.7	7.2	15.4	18.5	10.3	14.2	9.7	6.0	14.4	10.7	10.7	12.7	17.8	8.8	11.0	15.1	9.1	10.4	10.0	10.3	16.7	18.7	10.0	9.9	18.0	10.8	7.7	8.9	21.9	10.6	10.2	27.4	11.6	12.7	6.7	9.4	9.2	9.9	26.6	7.5	6.3	22.0	19.9	7.9	11.4	11.5	7.7	13.4	9.1	12.3	17.7	17.3	10.8	18.6	14.6	14.3	8.6	20.9	16.6	18.0	17.3	13.4	11.8	13.7	17.8	19.8	11.0	7.4	10.9	16.8	7.6	14.2	24.9	9.0	8.4	14.0	15.6	9.1	9.9	13.1	21.5	14.7	14.3	15.6	10.5	24.0	13.1	13.1	15.9	9.5	11.1	7.3	8.0	17.2	20.9	8.8	18.8	16.5	8.5	8.1	10.5	15.3	21.1	11.8	10.4	13.3	12.1	11.2	18.7	12.4	9.2	7.8	8.5	7.5	9.9	6.2	6.1	7.1	7.4	9.4	6.7	6.4	6.2	2.9	26.6	8.3	5.1	7.5	6.3	8.6	12.3	8.7	11.8	8.7	7.2	9.7	6.0	8.8	8.9	3.0	16.9	15.2	10.8	11.4	3.2	4.7	10.2	12.0	9.1	10.4	0.0	43.2	13.3	21.7	0.2	7.7	13.7	70.0	13.2	28.4	7.0	7.8	8.1	10.2	21.2	6.4	5.8	8.6	8.6	0.8	5.5	13.5	0.0	29.7	11.1	5.8	15.0	14.8	8.1	15.8	2.1	19.4	4.4	1.0	10.8	11.0	39.8	15.8	11.3	10.0
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;testis: 51.4"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 73.9;Erythroid cells: 116.8;Extravillous trophoblasts: 134.7;Spermatocytes: 133.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 14.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	2.3	1.5	0.4	14.1	0.7	20.8	5.3	0.7	0.6	1.9	4.8	0.3	0.2	4.6	0.9	1.4	13.4	0.4	2.2	2.4	0.5	0.4	1.3	2.2	2.4	9.7	0.6	0.2	0.9	0.8	0.0	0.4	6.1	0.5	0.9	5.2	0.2	2.1	0.2	0.6	3.5	4.7	2.4	0.7	6.3	3.2	51.4	0.3	61.6	0.5	14.4	11.7	2.0	3.2	2.5	0.8	0.5	0.0	2.2	14.0	3.0	32.0	30.0	27.1	29.3	1.7	2.8	10.0	24.7	13.9	35.3	23.2	24.5	12.7	33.1	10.1	14.3	26.7	17.1	27.4	15.8	30.9	11.1	38.0	21.8	17.7	28.8	0.2	20.9	16.4	0.9	1.1	19.5	14.5	5.1	24.9	25.0	27.3	28.0	27.1	18.6	44.6	20.0	20.1	22.7	52.8	23.3	44.0	25.5	8.3	11.9	33.5	23.1	18.9	21.5	16.8	13.8	28.4	19.9	9.3	42.7	37.9	18.4	35.1	20.3	16.3	38.2	15.6	8.8	37.1	0.0	0.0	0.0	0.7	0.0	0.2	2.5	4.3	2.8	0.8	0.3	0.0	0.4	0.5	2.2	0.0	0.3	14.0	3.0	0.4	0.7	0.7	0.6	0.5	0.4	0.6	0.2	0.5	0.3	0.0	30.7	18.5	1.0	7.2	0.5	2.0	5.1	4.0	17.0	0.0	0.0	17.0	0.0	1.2	73.9	0.6	1.8	116.8	0.0	134.7	7.2	0.9	9.2	1.6	43.1	0.0	2.9	11.1	11.1	29.8	2.8	11.5	1.7	0.0	3.4	0.4	0.4	3.4	0.7	0.0	0.5	6.5	1.0	133.1	40.7	5.6	16.0	7.5	15.2	4.0
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 64.7;Spermatogonia: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.7	25.6	14.1	11.2	2.3	5.2	13.8	18.6	8.0	15.6	14.9	15.5	12.3	36.4	3.4	7.1	18.5	18.3	19.1	10.4	26.2	16.6	14.0	17.1	20.1	13.4	0.5	30.5	14.9	1.4	1.7	23.5	7.5	4.0	8.1	17.0	25.8	15.6	14.7	10.5	25.5	10.1	7.7	10.6	6.8	17.6	29.7	14.9	5.8	15.3	9.7	10.4	14.3	4.7	7.0	10.0	12.6	14.1	5.2	14.0	11.4	18.1	19.3	7.3	17.8	28.0	11.3	18.1	14.6	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0	0.0	3.2	5.2	3.8	2.6	8.3	10.4	7.6	13.4	5.7	1.8	21.6	7.0	0.0	2.6	11.1	2.9	1.0	0.0	1.0	17.5	2.9	2.4	8.1	16.1	8.6	11.1	0.0	5.5	4.0	5.2	2.3	5.3	0.0	3.6	3.7	2.8	1.6	3.1	1.4	0.8	21.1	6.5	1.4	64.7	61.1	1.9	3.3	2.5	3.5	2.5
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993700-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.8	3.2	10.8	12.6	13.7	4.7	6.8	13.4	16.0	3.8	16.8	8.8	2.4	22.5	2.9	3.0	10.7	5.0	9.8	3.0	11.0	10.8	8.3	7.5	3.4	14.2	10.9	10.3	2.2	11.2	9.8	4.0	2.6	10.5	3.8	17.8	4.7	4.1	3.1	2.0	8.0	21.8	3.3	12.6	7.3	9.0	2.6	7.7	11.1	5.4	4.5	17.8	3.6	4.3	2.4	5.7	9.5	2.5	1.5	1.2	0.7	9.4	12.5	4.6	4.3	4.0	2.1	5.0	6.7	1.5	4.0	1.9	7.9	6.5	38.1	7.9	1.7	2.8	11.7	10.8	6.0	3.9	7.0	5.9	17.5	5.6	7.1	0.7	25.4	22.0	0.9	3.5	4.7	2.6	1.9	1.7	13.9	6.0	2.2	4.2	10.1	13.0	11.4	2.5	10.3	4.9	8.3	7.7	8.3	6.2	14.5	6.2	4.0	8.2	9.0	3.0	1.6	16.0	21.0	2.0	3.6	3.8	3.8	6.7	7.4	13.3	46.8	3.8	9.5	9.8	4.5	2.5	9.5	1.2	1.7	1.1	1.8	0.9	0.9	2.4	2.4	0.8	1.2	3.8	1.5	1.6	5.7	0.8	0.7	10.8	13.7	13.4	16.0	11.0	10.8	10.9	10.3	10.5	7.7	8.9	7.2	26.7	7.9	10.9	35.5	6.3	45.9	8.1	5.7	8.7	13.7	8.8	3.3	9.0	23.9	3.0	55.2	0.0	9.2	18.3	5.5	8.0	18.4	25.2	17.3	23.8	7.5	3.7	28.3	128.6	1.1	15.5	10.1	3.6	39.6	13.2	14.1	35.1	3.9	10.9	25.6	0.0	5.9	0.9	8.1	15.9	4.3	8.7	67.9	7.8
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013007, HPA056420"	Approved		Supported	Cytosol		NA	Yes		100000	Cytosol		"CAB013007: , HPA056420: AB_2683125"	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	98.4	64.4	44.7	67.6	40.8	98.2	105.6	38.2	49.0	111.8	87.3	45.8	69.7	62.2	107.5	67.3	141.3	75.1	68.7	69.1	40.7	41.3	74.4	107.7	66.6	100.6	46.7	41.6	172.4	111.0	44.3	44.5	90.8	44.8	110.9	75.1	53.0	102.7	76.0	157.9	107.7	87.7	95.7	53.2	84.4	76.9	56.5	41.0	132.6	123.5	131.7	113.4	135.1	88.0	89.0	104.4	19.3	77.0	75.6	102.1	159.0	96.6	64.9	70.5	100.6	70.8	119.4	110.6	67.6	95.2	118.3	114.0	83.4	110.7	146.6	106.9	70.4	85.8	68.4	102.5	174.9	136.0	60.6	131.5	82.9	62.4	108.8	103.2	78.4	67.0	103.4	139.7	76.1	141.3	135.5	107.4	84.4	77.1	95.4	99.5	87.9	117.5	147.2	89.6	36.1	65.3	89.9	83.8	181.8	124.4	97.7	82.8	110.5	66.4	75.8	135.9	69.3	97.6	161.8	77.1	51.3	69.8	61.1	182.4	89.9	91.5	136.5	67.9	120.2	75.4	19.3	77.0	19.3	52.5	60.9	88.6	89.0	89.8	73.3	104.4	71.3	99.5	87.1	10.8	75.6	47.8	58.7	102.1	159.0	44.7	40.8	38.2	49.0	40.7	41.3	46.7	41.6	44.8	41.0	229.3	278.1	715.0	1745.8	1743.2	127.7	303.1	473.9	325.2	444.7	307.1	41.2	1161.2	771.0	802.1	569.6	816.5	667.0	303.7	1060.8	1748.3	874.0	889.8	408.6	437.5	930.1	81.0	569.4	571.5	843.2	380.0	1155.8	1046.3	750.8	1202.0	941.3	218.3	1129.2	785.5	795.5	944.8	96.9	633.8	1145.4	210.5	145.7	1707.3	1431.9	885.4	1216.6	1923.9
C19orf48	"BC006151, MGC13170"	ENSG00000167747	"Chromosome 19 open reading frame 48"	Q6RUI8	19	50797704-50804929	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042000	Uncertain		Approved	"Plasma membrane"		NA	Yes			"Plasma membrane"		"HPA042000: AB_10797377"	"unprognostic (2.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.39e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.80e-5)"	"unprognostic (6.59e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	5.0	9.7	6.5	11.0	6.2	20.7	9.6	7.0	8.9	7.2	9.3	7.0	4.1	6.8	7.8	6.9	13.2	13.5	9.5	4.1	4.0	3.4	7.4	12.0	8.0	22.2	6.8	8.7	13.0	40.7	3.2	4.0	7.5	5.2	32.1	5.8	6.9	8.3	5.6	6.4	15.9	6.4	6.7	5.1	8.8	7.0	19.8	5.0	23.6	17.9	9.1	12.5	5.1	7.3	29.0	20.8	2.8	8.7	12.4	21.6	9.9	21.4	34.1	16.1	10.1	3.1	9.6	14.9	19.4	13.3	28.7	28.7	41.1	20.0	36.8	9.0	7.5	11.1	15.3	26.8	27.3	9.9	11.5	64.7	24.5	14.5	23.9	8.7	25.6	12.4	15.6	28.4	29.9	32.6	7.0	15.3	36.3	26.8	18.4	13.3	18.5	34.3	31.0	12.9	26.4	43.7	25.8	26.3	34.8	9.3	35.9	26.6	12.8	19.4	25.3	26.4	6.1	14.9	25.2	7.2	13.3	24.6	8.1	26.3	10.8	12.2	30.3	8.1	23.3	17.8	1.0	6.0	2.8	9.9	8.7	14.0	29.0	14.1	11.2	11.8	27.3	21.6	16.1	0.4	12.4	6.3	20.8	14.5	9.9	6.5	6.2	7.0	8.9	4.0	3.4	6.8	8.7	5.2	5.0	3.0	6.9	49.4	35.3	51.9	8.7	4.7	12.7	1.4	6.8	17.4	5.9	84.7	28.2	25.6	6.7	15.8	10.0	23.3	94.0	106.2	23.6	54.8	8.1	11.5	36.1	0.0	23.0	6.7	8.8	12.6	16.4	21.5	16.9	39.7	66.4	9.7	47.0	14.0	7.1	15.2	7.0	6.5	21.7	27.2	39.4	60.1	51.8	15.0	100.4	27.5
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 29.3"									"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.1	5.6	14.8	9.2	1.5	2.0	8.2	7.5	2.8	5.3	5.2	2.5	9.0	8.8	1.9	2.1	6.2	9.8	3.9	3.2	1.6	9.2	8.6	14.1	14.6	1.4	0.3	4.0	8.1	0.9	0.7	3.7	0.9	1.9	3.3	22.0	8.0	23.5	4.3	5.0	19.8	5.4	6.3	3.4	2.8	29.3	6.7	7.8	1.6	2.3	12.2	7.6	5.6	4.0	1.8	3.3	9.9	8.0	2.2	3.2	9.3	3.2	4.5	9.5	4.2	4.2	5.7	17.5	8.4	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2	3.0	1.6	3.0	1.2	0.8	17.1	3.6	0.0	203.4	22.7	1.8	25.5	3.5	0.0	1.9	13.4	1.1	2.3	140.2	0.9	5.4	3.6	1.8	2.3	1.6	3.4	4.8	66.7	3.7	1.8	25.4	4.9	2.7	0.0	1.0	3.5	4.3	1.1	3.5	2.5	0.6	28.6	0.0	2.1	52.4	42.1	1.3	1.1	2.6	5.9	0.7
CALM2	"CAMII, PHKD"	ENSG00000143933	"Calmodulin 2"	P0DP24	2	47160082-47176601	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB007790, HPA044999"	Approved					NA	Yes					"CAB007790: AB_562257, HPA044999: AB_2679177"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (1.24e-1)"	65.6	87.3	153.0	41.3	162.1	25.3	89.8	132.9	169.5	58.4	88.7	62.8	38.8	68.4	60.1	73.8	50.8	71.6	51.3	55.0	160.4	133.1	57.9	62.0	63.9	48.4	135.8	147.6	57.5	28.1	37.7	51.2	59.3	119.6	60.4	92.3	29.3	60.4	77.7	30.2	31.0	77.7	81.7	139.9	77.3	50.0	79.1	114.9	43.8	60.0	31.0	57.1	56.5	37.1	53.2	82.3	190.9	141.0	38.4	40.3	130.5	165.2	63.6	73.6	32.6	42.0	47.6	47.2	163.8	101.5	97.6	84.2	62.5	62.2	70.4	74.4	119.1	72.0	43.0	62.4	57.7	128.7	53.9	29.5	60.0	38.3	90.9	54.1	72.8	47.5	27.2	56.2	87.0	98.6	85.5	65.4	23.1	56.2	58.0	232.8	43.3	84.9	62.8	57.1	201.5	32.5	21.2	86.9	66.5	109.4	30.3	54.0	137.6	52.9	52.5	71.2	82.5	39.0	38.9	75.4	72.8	80.7	43.6	114.7	46.1	40.3	74.9	49.5	50.4	93.3	140.3	98.3	190.9	29.8	141.0	32.3	53.2	37.2	35.8	82.3	36.9	33.2	36.4	102.4	38.4	122.1	78.5	40.3	130.5	153.0	162.1	132.9	169.5	160.4	133.1	135.8	147.6	119.6	114.9	1289.3	525.2	388.5	961.5	1581.7	610.3	547.0	499.4	2395.7	1222.7	720.6	92.3	798.8	1953.0	1859.0	214.5	598.0	903.4	654.1	600.7	481.0	1210.0	791.7	634.5	511.4	1131.6	322.6	573.5	257.8	884.6	184.8	977.2	1240.6	1680.3	1146.1	906.5	1779.4	1759.7	1027.7	811.8	737.6	257.4	892.6	1822.0	1588.7	733.3	1453.8	213.5	621.1	614.7	973.8
CARHSP1	"CRHSP-24, CSDC1"	ENSG00000153048	"Calcium regulated heat stable protein 1"	Q9Y2V2	16	8852942-8869012	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 1687.9;Late spermatids: 5640.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051911	Enhanced					NA	Yes		150000			"HPA051911: AB_2681660"	"unprognostic (4.08e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.76e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"prognostic favorable (7.24e-4)"	21.2	34.5	14.9	13.9	41.1	25.2	34.3	3.6	12.2	19.5	14.8	18.2	5.2	14.6	13.7	9.8	44.0	18.0	14.4	14.6	13.5	8.6	41.2	50.6	26.2	18.4	14.3	11.4	20.8	22.7	5.2	8.4	69.4	13.0	11.0	11.6	13.8	29.5	7.6	6.5	8.2	15.0	11.3	10.2	15.4	13.0	90.2	18.3	30.4	15.0	27.0	25.8	12.0	23.6	10.9	19.2	37.4	12.4	15.6	24.9	7.8	15.8	30.0	43.5	7.7	10.6	18.6	20.5	22.6	18.8	19.7	24.8	23.1	41.5	23.2	14.6	16.4	15.6	16.1	15.8	18.3	13.2	19.0	24.5	7.6	22.9	86.4	38.5	12.2	16.6	39.4	8.3	19.2	12.6	18.1	19.3	55.3	19.6	26.3	24.0	35.2	57.8	29.5	25.0	18.6	18.3	69.9	56.8	34.3	15.5	12.2	24.3	33.7	23.2	20.5	20.1	23.8	25.2	11.8	21.2	15.3	29.7	19.3	11.5	13.8	14.3	27.2	34.2	14.7	25.8	27.8	12.4	13.8	11.1	5.9	7.0	7.0	11.1	10.9	10.5	10.9	7.5	10.4	37.4	15.6	7.2	19.2	24.9	7.8	14.9	41.1	3.6	12.2	13.5	8.6	14.3	11.4	13.0	18.3	23.8	10.8	69.3	56.7	37.9	7.7	5.6	158.0	16.0	4.5	78.5	5.9	101.6	46.4	441.1	1687.9	120.3	99.7	93.5	208.0	260.9	56.4	97.9	39.2	278.9	61.2	11.1	139.1	135.1	73.7	5640.4	89.2	48.0	55.6	47.7	89.4	6.8	376.8	136.8	68.6	329.5	10.1	109.9	60.4	51.5	48.7	36.8	128.4	104.6	112.2	126.1
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213356	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		40000	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	40.7	49.4	41.2	54.3	38.8	65.8	69.4	37.4	45.9	33.9	38.4	20.3	39.0	49.8	39.5	42.1	36.4	33.9	28.6	43.3	39.0	40.8	51.1	45.8	37.0	68.6	44.9	37.2	45.3	31.8	22.4	27.5	45.4	51.1	30.7	43.7	23.7	35.0	45.6	60.4	27.1	56.4	46.7	66.9	54.0	29.3	45.1	33.7	92.3	32.1	38.2	65.0	39.8	38.1	38.8	37.4	55.2	48.4	39.5	60.7	35.1	50.3	22.3	47.7	47.1	17.2	31.3	37.6	39.6	30.2	30.2	30.7	26.3	42.6	76.6	32.0	26.1	64.7	40.3	39.8	33.0	49.4	21.1	29.7	43.7	29.4	29.3	18.9	69.0	42.5	22.9	29.0	23.8	34.2	37.5	40.7	48.9	69.9	37.9	51.1	28.8	66.5	83.3	60.7	43.8	32.3	43.6	44.3	63.2	44.0	28.3	58.4	64.8	32.8	69.8	36.3	52.9	59.3	62.7	30.2	27.5	49.9	32.0	52.5	56.3	81.1	130.3	23.9	59.5	123.9	47.8	38.4	55.2	34.6	47.6	42.8	38.8	51.7	42.7	37.4	35.8	55.0	54.0	39.3	39.5	48.4	30.5	60.7	35.1	41.2	38.8	37.4	45.9	39.0	40.8	44.9	37.2	51.1	33.7	101.3	77.8	131.1	75.5	127.6	104.6	114.5	129.9	139.2	130.8	61.1	72.6	154.4	119.3	152.3	115.5	136.8	88.3	303.7	123.2	293.9	107.2	64.5	211.9	239.9	127.2	47.7	105.7	149.1	266.0	31.0	126.2	175.5	99.5	110.0	127.3	132.2	139.2	87.7	92.3	112.3	126.4	77.6	91.0	234.4	415.8	94.4	226.4	163.9	186.9	86.2
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861450-38872314	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	15.0	15.0	44.7	14.5	35.1	21.7	7.4	27.8	53.8	14.0	19.5	15.3	9.8	6.5	19.3	14.2	12.9	18.8	10.9	14.0	40.6	18.3	12.1	5.9	13.0	12.0	15.8	21.8	23.4	13.1	62.2	15.5	4.7	19.3	16.1	7.4	17.0	12.5	25.4	5.5	7.7	9.2	23.8	12.1	11.2	12.0	5.0	12.0	11.3	13.4	4.5	13.8	16.6	9.5	4.7	26.9	2.6	7.4	5.2	11.7	9.2	16.6	17.7	3.9	13.4	30.4	17.1	1.2	18.2	10.5	9.5	8.9	8.8	15.6	27.3	13.7	12.4	6.6	19.9	7.3	7.7	5.2	26.2	22.9	2.7	7.6	3.0	16.6	13.4	13.6	25.4	3.9	21.6	10.3	13.1	10.7	7.9	6.1	13.9	6.4	18.8	8.2	3.9	3.5	9.6	13.7	12.5	13.2	10.7	13.4	15.8	19.3	4.3	11.7	15.6	9.8	1.4	10.7	8.0	13.8	8.3	25.5	14.3	12.4	14.3	13.7	10.0	16.2	14.1	17.1	1.1	5.5	2.6	11.7	7.4	9.7	4.2	8.1	8.2	5.4	4.7	6.7	8.2	2.3	5.2	6.8	26.9	4.6	9.2	44.7	35.1	27.8	53.8	40.6	18.3	15.8	21.8	19.3	12.0	14.9	14.3	23.1	30.9	30.1	95.1	23.3	38.2	5.3	13.6	69.8	37.3	9.4	29.9	79.7	0.5	30.3	1.3	0.0	43.0	1.9	41.4	21.2	5.8	29.7	17.5	117.6	117.7	33.7	40.3	0.9	68.7	20.0	77.6	119.0	0.7	80.1	41.4	7.0	76.0	41.9	56.5	71.1	86.3	2.1	6.0	29.6	3.9	35.8	0.5	68.7
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 610.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.6	40.6	55.8	49.6	2.9	5.0	131.7	26.0	19.5	68.6	58.1	60.0	55.4	36.1	31.7	23.9	78.7	37.0	56.1	56.8	77.0	35.4	27.7	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.3	27.4	6.3	36.6	35.4	27.6	28.7	55.8	55.9	27.2	23.7	31.0	19.5	25.8	28.7	40.2	37.0	25.1	21.7	28.4	17.9	44.7	21.1	19.2	32.8	40.3	20.9	15.3	15.3	49.7	27.6	64.9	14.4	26.6	50.4	21.2	34.9	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3	0.0	0.3	5.2	4.8	10.2	4.2	1.5	2.5	13.4	4.5	5.2	2.0	53.5	1.7	5.3	63.8	1.8	2.9	46.7	1.2	610.8	11.3	3.6	2.3	3.0	50.4	0.0	1.2	6.2	6.0	9.4	2.8	4.4	3.3	3.6	4.6	2.8	2.5	0.0	2.5	4.3	2.9	6.5	3.1	28.8	70.2	6.4	34.7	4.4	11.5	2.7
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.7	25.3	41.6	10.3	1.9	3.8	22.1	23.8	15.3	36.9	30.4	40.9	17.7	26.7	17.3	15.4	21.6	35.5	39.3	20.2	34.9	27.7	21.1	34.6	29.6	23.2	0.5	25.7	22.3	1.4	2.7	15.9	20.3	7.2	25.0	33.0	34.9	42.9	27.8	20.9	29.3	37.5	30.7	12.4	15.0	34.3	58.9	27.1	11.6	20.3	25.9	17.5	32.6	17.7	21.5	34.0	30.7	25.7	13.0	18.4	31.2	20.2	45.3	19.1	28.7	47.5	12.0	58.9	25.9	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2	0.0	1.1	7.8	1.0	4.2	0.0	0.3	0.0	1.4	2.3	0.0	0.0	26.7	0.0	0.4	102.4	0.4	1.7	163.5	0.2	106.5	1.1	1.7	0.0	0.8	25.3	0.0	2.9	3.1	10.7	30.4	4.0	4.2	0.0	3.6	5.5	0.0	0.5	1.7	1.8	0.0	0.2	0.0	0.0	88.2	36.6	5.4	13.6	3.2	12.4	2.0
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4273772-4305350	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	13.7	39.3	20.8	12.0	15.9	23.6	10.4	6.1	22.3	14.4	28.3	8.1	24.3	18.5	21.9	41.9	12.2	16.5	9.1	36.9	17.5	7.3	6.0	5.7	12.8	24.5	7.9	17.0	11.6	18.4	8.3	19.2	23.5	9.3	16.4	24.2	14.1	8.3	22.4	2.0	9.2	19.6	45.5	14.0	16.5	11.1	5.2	8.6	6.2	18.5	6.9	13.6	22.3	16.3	3.9	2.1	4.6	1.0	9.1	14.8	5.4	0.0	0.0	32.3	0.0	5.6	0.8	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.2	0.0	0.0	4.1	0.9	29.5	0.0	49.7	0.8	0.3	0.0	0.2	0.1	12.6	2.7	10.8	4.9	0.0	22.3	0.2	0.0	0.9	3.4	71.8	6.3	0.0	0.0	16.6	13.3	0.2	0.0	0.0	47.0	23.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.1	2.3	0.0	9.4	0.0	0.0	1.2	12.2	0.0	0.1	9.1	0.0	4.1	1.0	4.6	9.1	0.2	13.7	3.9	13.0	11.0	2.1	1.5	8.2	9.8	1.5	9.1	0.1	1.0	14.8	5.4	20.8	15.9	6.1	22.3	17.5	7.3	7.9	17.0	9.3	8.6	56.6	49.3	25.1	24.4	94.8	6.8	305.9	0.0	9.4	43.3	12.2	0.0	2.6	0.0	2.5	0.7	38.4	26.9	46.7	59.7	1.7	135.6	5.7	54.3	0.8	12.0	3.2	62.3	17.8	13.3	0.9	48.6	38.9	37.1	6.4	146.6	155.3	32.6	35.1	116.7	1.0	3.7	25.8	50.5	0.7	3.6	34.6	5.3	61.2	109.0	7.0
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934933-42050357	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 129.2;lymphoid tissue: 142.5"	"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 94.2;REH: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	20.2	39.8	16.1	28.9	17.5	74.7	36.0	13.3	19.8	13.3	17.3	11.3	14.1	16.0	10.8	10.4	13.5	13.4	19.0	16.3	15.4	14.5	13.7	8.0	32.1	83.8	14.1	15.5	11.1	10.9	5.0	10.1	21.9	9.3	14.2	11.4	10.2	18.1	14.4	6.5	14.6	22.0	11.7	11.5	51.2	18.0	7.4	10.0	142.5	26.8	9.3	32.8	13.0	16.6	24.1	42.4	129.2	45.8	39.0	52.8	66.2	9.2	33.7	3.5	7.8	6.4	13.2	40.9	10.8	6.2	11.2	8.2	6.3	4.2	39.7	18.4	7.2	10.0	5.7	9.4	13.2	5.8	6.7	6.1	62.9	15.0	5.1	14.1	10.2	55.6	12.5	8.7	10.8	4.1	3.4	13.7	26.7	31.7	3.9	16.0	12.5	94.2	49.4	1.5	28.4	7.2	89.5	13.7	4.4	25.9	6.2	12.0	3.1	9.2	11.8	5.3	4.7	7.3	40.2	22.9	12.5	6.9	10.7	12.1	2.5	2.0	62.1	7.3	21.7	7.5	129.2	30.5	87.7	52.8	35.1	37.0	16.4	36.4	42.5	42.4	24.1	42.8	45.0	42.8	39.0	45.8	27.8	23.2	66.2	16.1	17.5	13.3	19.8	15.4	14.5	14.1	15.5	9.3	10.0	56.6	64.8	78.2	82.2	24.0	9.3	21.8	56.0	16.0	18.2	19.2	5.9	150.0	24.9	17.1	12.1	47.0	34.6	93.5	21.5	66.5	22.6	44.0	25.5	3.9	39.8	11.1	9.2	55.9	111.4	7.4	38.3	68.6	35.4	7.2	16.9	35.9	21.6	28.8	48.8	13.2	14.6	45.3	26.8	1.7	5.7	19.7	197.8	130.7	19.5	56.2
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811898-29824308	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;placenta: 46.7"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1526.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 81.6"	"Low region specificity"	"Detected in all"							"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3.0	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1.0	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3.0	1.7	4.6	2.0	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0.0	1.4	0.5	4.1	8.6	6.6	9.4	1.4	1.6	81.6	6.6	1.4	2.9	3.6	8.7	8.4	3.5	15.7	2.9	3.8	1.3	7.8	3.4	4.2	11.1	4.8	2.9	8.4	9.1	1.1	11.5	7.9	1.7	1.9	4.0	0.5	0.9	3.5	3.5	11.8	1.6	4.4	6.2	6.3	3.3	11.0	9.4	2.0	9.5	7.7	2.6	2.2	6.6	5.6	4.7	9.5	11.7	1.0	10.1	2.6	8.6	2.0	6.9	25.9	4.1	4.4	6.6	4.6	23.9	3.9	1.4	3.7	0.0	0.1	0.0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0.0	1.9	0.0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6	0.0	1.1	0.8	1.0	4.2	2.4	2.8	0.0	0.0	2.3	0.0	0.0	112.5	0.0	0.4	7.1	1.1	1.7	0.0	0.6	1526.8	4.8	1.9	0.0	0.0	37.5	3.2	2.9	1.3	0.3	2.6	1.1	1.1	1.7	0.0	2.7	1.8	1.0	2.9	2.1	0.2	0.8	6.5	3.1	14.1	19.5	5.3	96.8	2.2	3.8	2.4
CCNE2	CYCE2	ENSG00000175305	"Cyclin E2"	O96020	8	94879770-94896678	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;brain: 22.2;testis: 18.9"	"Cell type enriched"	"Detected in many"	6	"Spermatocytes: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.8"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.2;T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007825, CAB019374"	Enhanced					NA	Yes					"CAB007825: AB_598148, CAB019374: "	"unprognostic (1.80e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (8.37e-4)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.01e-12)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.03e-1)"	1.3	0.9	3.1	4.9	11.3	24.2	1.5	3.3	6.3	1.7	4.0	10.4	0.0	2.6	1.3	0.1	3.6	1.0	1.7	0.9	5.7	3.5	0.9	1.6	1.7	7.9	8.0	6.5	1.4	2.3	0.5	1.1	3.1	11.8	1.3	4.3	0.6	1.5	0.0	0.8	4.4	3.1	1.4	22.2	1.9	2.9	18.9	4.9	12.7	1.1	2.4	7.0	1.9	1.9	1.1	1.3	1.1	0.3	2.2	8.8	1.1	17.9	2.4	9.6	5.9	1.2	2.2	6.6	18.5	6.4	11.6	11.5	4.3	8.1	9.4	12.6	7.8	3.6	9.5	7.4	6.7	15.8	6.6	6.8	19.0	10.1	1.6	0.1	7.6	11.6	0.6	0.4	8.4	0.8	2.5	5.9	11.7	8.1	39.7	16.5	5.2	29.0	3.5	3.2	14.4	5.5	20.7	16.5	4.5	3.2	10.1	13.9	5.8	12.4	3.3	2.3	1.2	16.7	8.0	5.0	12.4	8.1	9.1	16.5	7.6	7.9	22.9	10.0	13.9	9.0	0.0	0.3	0.2	1.6	0.3	0.5	0.7	2.0	2.3	1.3	1.1	0.6	1.3	1.1	2.2	0.3	0.1	8.8	1.1	3.1	11.3	3.3	5.7	5.7	3.5	8.0	6.5	11.8	4.9	6.0	1.7	0.0	0.8	3.8	2.0	1.7	0.0	1.4	2.3	1.8	5.9	2.6	0.0	0.2	5.6	2.1	8.2	0.0	0.2	7.0	1.1	1.0	0.0	0.9	3.8	7.9	0.0	3.1	2.7	6.1	1.1	1.7	0.0	0.0	2.4	1.0	0.1	0.6	0.4	0.0	4.2	6.5	2.1	50.4	5.0	3.3	1.6	6.9	1.7	0.4
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	52.6	25.7	35.9	23.4	1.2	3.2	34.4	24.4	21.9	71.2	38.0	40.3	43.8	30.5	14.3	22.4	25.1	37.1	39.2	46.6	59.5	23.9	29.0	44.6	25.4	24.9	0.3	31.1	16.3	1.0	2.2	49.4	44.8	6.2	30.1	29.3	20.1	21.0	32.2	20.4	29.9	19.1	45.4	25.1	34.6	43.5	49.3	19.3	17.3	14.0	21.2	10.4	43.1	29.2	13.5	28.8	20.5	39.4	15.6	21.3	50.0	23.6	75.6	16.1	14.3	31.6	15.3	38.8	31.7	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7	0.0	0.6	16.2	2.0	9.3	0.0	0.7	0.0	2.7	1.2	0.0	0.0	13.4	0.0	2.1	97.6	0.7	3.2	70.0	0.3	127.9	4.1	2.0	0.0	1.0	30.9	0.0	0.0	8.0	5.0	7.0	2.6	5.2	0.0	2.8	2.9	0.2	0.7	0.0	1.8	2.1	2.6	0.0	1.4	74.9	48.1	7.3	8.9	1.3	15.5	2.6
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	12.1	8.7	15.1	27.7	23.3	26.0	28.8	49.6	21.1	13.0	14.7	12.8	4.6	14.9	17.0	10.3	11.7	13.0	18.6	7.5	15.7	12.5	13.3	11.0	33.0	42.8	21.9	12.5	17.3	5.7	7.5	21.0	30.3	13.8	11.0	12.0	7.7	7.4	10.2	6.2	19.8	16.8	14.8	14.7	24.5	14.1	6.3	22.3	33.3	18.7	20.8	31.6	15.3	16.3	4.5	1.3	1.5	1.8	9.3	15.5	5.9	29.0	62.7	8.4	13.9	10.3	10.1	4.2	14.4	21.6	24.1	18.0	10.9	42.1	20.3	6.2	14.7	59.6	42.5	11.3	23.9	11.4	7.8	12.2	10.9	20.1	13.1	41.2	8.4	5.6	9.9	19.2	22.3	26.4	8.2	13.3	10.2	7.0	53.5	14.2	23.3	26.3	12.3	6.2	19.9	26.8	13.8	23.8	14.5	16.4	2.7	6.0	13.1	34.1	32.6	16.7	7.5	11.0	4.4	11.0	12.9	15.7	23.4	19.0	13.1	20.6	8.2	6.6	8.3	12.4	1.5	1.4	0.0	13.6	1.8	12.7	3.5	13.6	13.7	1.3	4.5	11.4	13.2	0.1	9.3	0.9	0.7	15.5	5.9	15.1	23.3	49.6	21.1	15.7	12.5	21.9	12.5	13.8	22.3	8.9	23.7	9.0	5.5	10.0	13.9	6.8	7.6	0.0	3.4	7.0	2.0	5.3	0.0	7.8	0.5	24.0	3.8	23.3	4.2	14.2	13.6	4.7	1.1	11.6	24.4	3.2	7.5	12.9	11.6	1.0	6.6	10.6	16.9	5.4	7.9	8.3	10.4	2.9	8.5	9.4	2.4	0.0	11.3	1.0	11.5	9.8	3.0	25.4	3.5	3.4
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.38e-4)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	29.2	18.9	19.4	18.7	25.2	23.0	23.3	26.0	33.0	23.7	17.2	14.8	13.8	14.4	23.2	19.6	17.6	17.6	18.6	22.8	18.3	22.6	16.8	23.8	20.4	21.3	19.4	23.9	19.5	14.3	27.8	26.8	25.0	31.5	17.6	18.2	14.6	15.7	16.5	31.6	15.5	15.3	24.4	17.7	24.2	16.1	23.5	17.4	25.2	42.8	15.5	22.9	23.6	17.3	9.0	7.7	9.6	10.3	12.8	11.6	5.4	23.6	25.4	21.3	17.1	14.4	22.9	12.7	33.5	30.2	32.0	32.8	16.2	12.5	31.9	22.6	28.0	20.5	11.4	22.9	18.9	44.2	45.8	23.5	37.1	26.8	14.4	15.6	21.7	16.9	16.6	9.3	28.8	22.8	15.5	33.0	18.7	29.5	17.8	26.0	20.1	26.7	9.9	10.1	13.4	20.7	14.4	54.7	14.1	19.3	15.0	14.2	17.3	16.8	5.9	18.6	19.0	17.9	15.4	35.1	33.5	29.1	21.1	24.7	18.2	31.5	28.9	18.5	13.0	23.1	9.6	4.4	6.2	8.1	10.3	7.8	6.0	6.8	8.5	6.0	9.0	6.7	7.6	5.7	12.8	7.4	7.7	11.6	5.4	19.4	25.2	26.0	33.0	18.3	22.6	19.4	23.9	31.5	17.4	8.9	22.9	28.9	16.0	23.1	20.2	34.3	22.9	10.7	28.4	19.2	15.7	24.5	13.3	23.9	23.6	38.7	10.6	163.5	23.1	29.3	36.3	14.9	25.5	25.2	24.1	33.4	13.3	37.4	24.8	22.5	26.2	19.8	6.8	31.5	13.5	19.5	24.1	10.5	28.0	17.4	13.9	19.4	33.0	88.5	35.1	23.5	9.6	21.0	14.3	13.1
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.2	11.1	13.9	10.9	0.6	1.3	5.9	16.4	7.7	18.9	18.8	8.5	7.4	14.8	5.8	4.9	7.5	12.8	14.8	10.8	17.0	18.0	25.0	19.8	12.6	9.3	0.7	28.7	10.9	0.4	0.5	14.5	6.5	1.8	9.5	15.3	87.8	18.7	11.0	17.7	23.3	13.6	4.2	25.7	8.4	19.4	23.1	6.5	4.4	12.7	18.0	9.5	8.9	9.8	2.8	6.5	6.4	12.8	3.6	14.8	23.7	11.2	14.9	6.4	11.8	17.2	7.8	14.4	19.7	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2	0.0	0.0	0.8	0.4	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.9	88.0	0.3	0.4	46.7	0.0	16.8	1.0	0.2	0.0	0.0	6.2	0.0	0.0	3.7	0.6	6.1	0.6	0.9	0.0	0.0	0.8	0.0	0.1	0.0	0.7	0.0	0.0	6.5	0.9	23.9	49.8	1.6	4.1	1.3	2.5	0.4
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 86.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.4	17.6	21.3	15.1	1.1	2.3	19.5	27.8	8.3	24.4	29.5	20.0	11.4	20.6	17.4	5.9	14.1	37.1	18.4	12.6	24.3	10.9	14.5	16.7	21.0	17.9	0.7	22.8	10.3	0.6	0.9	28.2	16.9	2.6	7.3	14.2	30.5	19.3	11.8	13.3	33.1	5.5	17.5	15.1	6.5	24.4	51.9	19.4	4.0	28.7	14.6	13.1	25.3	86.7	8.6	17.4	17.6	19.8	6.1	17.6	25.2	28.8	32.9	8.1	17.5	39.7	15.2	15.1	19.2	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2	0.0	1.3	2.2	1.1	3.8	0.0	0.6	0.0	0.0	1.2	0.0	0.0	12.0	0.0	1.2	1.4	0.5	1.1	23.3	0.6	27.7	2.4	1.1	0.0	0.9	6.8	0.0	0.0	1.8	1.3	0.2	2.6	1.3	0.0	0.0	1.7	0.3	1.2	2.9	0.7	0.2	0.3	12.9	1.0	11.4	23.0	1.4	14.0	2.5	4.6	2.0
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.3"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 133.3;Spermatogonia: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	4.5	2.6	1.7	11.5	2.6	38.3	4.1	8.3	3.2	8.7	3.7	2.6	4.5	4.1	5.6	4.0	16.6	4.1	4.2	2.4	1.5	1.3	2.8	3.0	5.1	9.1	2.7	1.4	5.0	6.2	1.6	1.9	12.4	3.3	4.6	2.7	3.3	5.3	2.2	1.3	21.8	4.4	3.1	2.3	6.7	3.6	12.8	2.3	24.9	5.1	11.2	15.0	3.7	8.8	7.4	4.2	8.3	4.3	10.6	14.7	5.5	15.2	15.9	18.4	13.9	3.1	5.2	24.1	22.8	7.0	17.9	15.7	19.4	19.5	20.0	12.5	8.0	13.7	24.5	12.8	26.3	10.5	21.9	10.1	12.7	13.6	16.2	3.9	22.4	10.7	3.7	8.2	13.8	13.0	6.0	12.1	17.5	13.9	20.8	12.4	37.4	20.8	15.1	13.6	13.3	36.4	20.2	26.8	7.4	6.0	17.7	10.8	13.3	21.8	8.8	17.5	8.5	17.2	15.1	18.7	15.9	20.2	21.7	30.2	7.7	9.5	20.5	13.3	11.4	26.2	0.9	3.6	8.3	10.9	3.9	13.3	7.4	11.4	14.7	3.9	5.2	6.8	8.0	1.3	10.6	4.3	4.2	8.9	5.5	1.7	2.6	8.3	3.2	1.5	1.3	2.7	1.4	3.3	2.3	0.0	2.1	10.4	19.9	57.1	3.0	0.6	0.0	8.1	3.4	1.8	0.0	53.6	3.3	12.9	6.4	9.0	1.1	23.3	6.2	133.3	12.5	7.7	28.8	2.1	21.5	12.7	2.9	7.4	6.2	4.3	7.8	10.6	16.9	10.8	4.4	3.4	9.1	3.5	5.6	1.4	2.7	6.5	10.3	31.0	64.2	58.6	21.6	17.5	6.0	48.5
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 40.4;Leydig cells: 49.8;Peritubular cells: 32.5;Undifferentiated cells: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 61.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 8.3;olfactory region: 21.4"	"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol		No	Yes			"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.1	0.6	1.2	28.0	1.5	9.7	1.8	0.5	1.4	8.3	12.3	2.8	2.6	14.9	7.9	1.7	12.9	2.3	6.6	0.9	2.0	1.4	0.8	0.4	1.3	17.2	1.3	2.2	1.1	2.9	0.0	0.4	7.3	3.4	3.2	14.8	1.1	3.3	0.6	4.3	8.3	16.4	1.5	2.0	2.9	7.6	8.1	2.0	71.4	0.9	10.5	24.0	2.3	8.0	2.6	4.2	0.3	0.7	3.6	9.4	2.7	9.8	7.6	17.9	19.4	0.8	3.3	18.7	6.0	2.1	14.2	16.0	11.7	12.6	27.6	7.6	3.6	5.5	10.3	28.4	10.7	20.7	13.2	15.6	6.2	5.5	14.8	0.9	40.4	5.9	2.7	0.9	7.7	6.5	1.8	6.4	36.5	14.9	6.3	4.1	7.9	61.8	40.7	21.1	23.4	5.3	43.7	13.6	17.5	6.9	8.7	5.2	9.2	9.4	3.1	5.0	16.7	0.0	15.9	2.9	9.3	4.0	3.0	10.9	1.7	3.7	38.8	5.8	22.5	7.8	0.0	0.7	0.0	1.4	0.0	0.5	2.6	3.9	7.6	4.2	0.3	0.3	1.4	0.3	3.6	0.0	0.6	9.4	2.7	1.2	1.5	0.5	1.4	2.0	1.4	1.3	2.2	3.4	2.0	0.0	1.1	1.4	12.6	18.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.4	1.1	6.7	0.0	0.2	21.5	2.6	2.4	0.0	0.0	8.9	0.0	11.7	0.0	0.8	1.8	49.8	1.6	3.3	0.0	19.1	0.6	0.7	7.0	32.5	0.0	0.0	0.0	4.3	9.4	30.1	13.9	8.5	6.9	66.1	1.7
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 2056.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16.0	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16.0	52.7	32.6	11.9	13.8	15.3	26.4	2.0	17.2	9.8	1.2	1.0	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14.0	5.7	54.1	46.0	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0.0	0.0	0.8	3.1	8.2	1.4	9.3	0.0	0.0	1.2	1.8	2.0	9.8	0.0	2.8	2056.4	2.0	2.9	256.9	2.1	27.0	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2.0	6.2	9.9	1.7	2.3	0.0	2.1	159.2	36.4	5.6	3.4	7.0	12.8	1.4
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803213-88809258	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease mutation, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.2;esophagus: 7.1"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 46.7;Extravillous trophoblasts: 78.3;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 39.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.4	0.4	0.7	2.7	0.9	25.2	0.4	0.0	1.2	1.2	2.5			2.9	0.3	0.0	7.1	0.3	0.0	0.1	0.6	2.2	0.5	0.6	0.9	3.2	1.7		0.0	0.4	0.9	2.1	2.0		0.3	1.0		0.8	0.1	0.0	3.3	3.2	0.3	0.8	3.1	1.7	3.3			0.1		2.1	0.2	1.9	3.7	2.1	3.5	0.9	1.7	4.0	0.7	9.7	10.2	4.4	7.5	0.2	0.9	17.9	6.6	1.8	5.2	3.3	20.8	10.0	14.4	7.4	1.4	3.5	12.6	5.6	4.5	1.7	5.1	23.9	13.5	9.0	17.4	0.0	7.6	5.9	0.4	0.3	5.3	1.1	0.4	1.6	18.6	21.9	4.8	1.9	24.1	31.3	39.6	11.5	3.0	8.2	33.5	6.0	12.6	1.1	7.4	10.7	7.9	11.5	3.6	5.0	2.0	11.4	15.7	1.7	7.3	11.7	11.0	9.7	17.9	15.5	19.8	5.4	19.5	8.8	0.5	0.9	3.5	2.7	0.5	1.1	1.2	2.7	2.7	1.0	3.7	4.0	2.4	2.1	1.7	0.7	2.1	3.0	0.7											0.0	0.6	7.5	3.4	10.0	0.2	1.6	2.5	2.7	2.3	1.8	0.0	24.8	1.7	1.0	0.2	1.2	2.1	46.7	0.0	78.3	1.3	1.7	0.0	0.9	16.4	0.0	2.4	0.6	4.1	0.7	0.3	2.5	1.7	2.8	9.3	1.1	0.5	0.0	0.4	1.0	1.8	0.0	2.0	2.7	28.5	6.1	20.7	3.2	18.0	3.4
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.6	18.5	39.9	20.8	1.5	2.0	15.6	20.2	8.3	12.2	12.0	14.7	20.2	31.1	12.0	11.2	11.0	20.3	24.6	13.2	20.7	27.1	15.4	25.5	28.4	20.9	0.2	36.1	14.0	0.7	1.0	17.5	20.2	3.5	12.7	14.3	23.0	18.6	21.7	12.4	21.3	14.4	35.3	9.8	8.2	22.7	56.4	10.2	11.9	8.1	18.7	25.5	27.3	18.2	10.5	22.2	21.7	13.8	16.7	22.1	26.0	18.3	41.7	14.3	15.4	29.9	9.6	26.1	19.5	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6	0.0	1.9	40.2	1.2	8.2	3.2	1.9	2.5	26.8	14.8	0.0	0.0	9.1	0.0	1.8	32.4	2.8	1.3	303.7	0.4	74.0	7.7	1.0	1.1	1.9	26.4	1.6	0.0	9.8	11.2	9.4	1.1	9.9	1.7	0.0	5.3	1.1	0.5	0.0	2.8	0.0	2.8	0.0	0.3	20.9	88.3	4.8	4.2	10.9	15.5	0.9
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.9	20.8	13.8	17.6	1.5	3.2	7.7	28.6	20.3	27.2	28.2	22.1	28.0	13.9	12.7	18.5	18.3	29.7	16.7	14.0	32.7	41.8	8.7	5.2	12.9	7.5	0.1	9.0	12.2	0.7	1.0	29.0	35.4	8.1	25.0	23.1	4.7	26.4	30.7	12.0	23.7	13.7	5.4	16.2	15.2	10.3	22.7	7.6	12.3	6.5	5.7	8.0	22.0	6.8	17.3	11.0	17.9	9.2	15.6	17.3	24.2	23.6	46.9	11.8	16.0	17.0	13.5	34.0	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3	0.0	2.2	0.8	0.6	3.2	0.0	0.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.6	15.9	0.0	0.3	0.0	0.2	14.7	0.4	0.1	0.0	0.2	10.9	0.0	0.0	2.5	4.1	3.8	0.3	5.4	0.0	0.0	1.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	35.6	19.5	1.1	1.3	1.9	2.3	0.9
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 89.5;Spermatocytes: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		460000	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	13.7	25.5	20.6	11.5	25.7	18.6	12.5	34.6	32.9	11.3	14.6	16.5	7.3	10.2	13.7	10.4	11.7	9.5	10.1	16.6	19.2	19.3	9.7	37.7	8.5	14.1	18.8	21.1	23.8	7.9	20.0	20.8	13.8	33.0	13.5	15.0	9.1	8.7	12.0	26.3	10.7	9.9	16.1	22.5	8.8	12.9	25.4	22.2	28.6	8.0	10.8	14.7	12.6	9.7	8.6	8.4	6.0	8.7	11.7	10.0	3.6	26.4	25.6	55.0	23.5	13.0	20.5	12.8	30.4	18.5	28.9	30.8	20.8	9.0	28.9	10.7	20.4	31.0	30.1	39.4	17.2	36.4	26.0	30.1	48.2	20.5	20.0	9.7	36.7	20.2	10.4	9.2	16.2	35.2	15.1	21.8	25.4	34.0	27.1	23.9	18.2	31.2	9.5	29.5	19.7	20.6	33.1	58.5	25.3	9.3	16.3	25.6	21.8	41.3	14.8	15.1	25.4	27.3	10.0	18.7	28.1	24.9	47.7	44.8	15.4	33.2	41.6	17.6	17.4	27.5	5.4	5.7	6.0	9.0	8.7	8.8	8.6	6.7	10.0	8.4	8.0	8.2	8.5	0.9	11.7	7.8	5.4	7.5	3.6	20.6	25.7	34.6	31.2	19.2	19.3	18.8	21.1	33.0	22.2	23.8	20.5	16.4	7.9	7.6	18.2	57.6	10.2	33.5	21.6	8.7	35.3	13.2	8.3	10.6	89.5	13.5	8.1	0.0	6.6	12.2	13.2	11.2	35.9	6.2	16.0	12.7	11.6	14.1	12.9	37.9	18.1	13.5	6.8	16.2	14.1	14.9	12.6	12.4	27.3	8.7	24.2	19.4	6.6	81.4	60.7	10.2	9.6	9.6	14.9	7.8
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 581.2;Spermatogonia: 464.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	84.0	72.1	44.1	29.5	13.0	11.9	32.2	50.1	27.0	55.5	44.5	29.6	41.8	63.0	29.7	18.7	98.8	59.2	52.9	38.6	63.9	49.1	42.8	31.9	52.8	78.5	5.6	65.0	36.4	4.3	8.9	39.7	35.1	21.2	51.3	51.9	38.0	55.2	71.1	63.1	51.0	114.6	64.4	99.0	66.6	44.2	48.5	37.6	43.5	19.3	37.4	22.3	41.6	40.4	40.4	43.2	48.6	37.8	29.1	24.0	45.6	58.0	72.8	44.8	90.7	50.8	35.4	37.7	34.1	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6	35.7	93.0	97.3	70.9	248.9	4.2	55.0	5.1	12.0	17.0	14.0	0.0	149.0	19.9	15.2	25.4	26.7	39.1	350.4	9.7	329.6	72.5	59.4	147.1	19.5	152.7	0.0	117.0	28.3	40.0	59.4	23.9	84.8	133.3	33.3	56.8	24.6	23.3	46.9	15.6	148.6	6.0	45.3	99.9	581.2	464.7	261.3	166.8	40.1	104.9	59.3
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.7	7.3	15.9	8.4	1.1	2.1	5.9	18.0	5.0	13.2	17.7	11.5	8.2	18.7	5.8	4.8	9.6	8.8	15.5	6.2	20.7	12.8	7.0	26.3	15.9	5.1	0.0	21.5	15.5	0.4	0.2	22.7	1.6	1.5	7.1	11.2	17.7	13.0	12.6	5.7	22.6	4.9	15.0	6.0	5.2	14.4	24.1	5.6	2.7	14.5	5.9	6.9	15.6	4.8	3.1	11.2	4.1	8.5	5.1	19.0	14.4	11.6	20.0	4.7	11.4	19.7	6.0	15.4	15.3	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5	0.0	0.3	1.5	4.6	4.9	7.9	1.1	2.5	0.0	3.4	0.0	11.8	5.5	0.0	1.3	6.2	1.9	0.4	0.0	0.6	33.9	3.9	1.4	1.1	0.0	14.0	1.6	1.2	3.7	3.2	4.9	2.3	6.5	3.3	15.4	1.6	6.6	0.9	1.9	0.4	0.0	96.1	6.5	2.5	71.5	133.3	1.8	8.7	5.1	4.1	2.6
DCLRE1B	"FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905141-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 15.4;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"HPA064934: AB_2685387"	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	8.7	4.9	6.7	8.3	6.8	13.1	7.3	15.4	7.8	6.7	6.8	8.3	0.4	4.3	6.9	4.3	8.4	7.0	5.8	5.4	7.0	5.6	5.3	4.2	8.0	15.1	6.7	4.5	7.7	3.8	3.4	3.1	8.7	6.5	4.4	7.8	6.1	4.6	5.0	3.4	7.0	5.5	8.7	8.5	12.8	4.7	7.2	6.4	20.9	5.1	8.2	9.6	5.9	5.9	2.3	4.2	2.4	7.0	8.7	4.4	3.5	8.3	3.1	5.9	6.6	4.4	3.1	3.7	6.6	4.8	9.1	10.0	3.7	2.7	7.9	4.5	5.1	4.7	4.3	8.1	7.2	11.9	6.8	5.7	6.5	4.9	3.2	1.1	7.4	6.6	3.9	2.5	13.1	7.2	2.5	4.8	9.9	9.8	6.7	9.8	34.0	11.4	5.6	4.6	4.2	7.3	9.2	17.8	3.8	3.1	3.0	5.2	4.6	6.4	5.4	4.3	5.3	3.5	7.5	2.8	11.1	11.8	18.0	9.3	3.2	3.3	8.9	9.3	7.7	18.3	2.4	7.0	1.9	3.4	6.4	4.3	1.4	4.4	3.1	4.2	2.3	2.6	3.6	0.3	8.7	3.7	1.5	2.4	3.5	6.7	6.8	15.4	7.8	7.0	5.6	6.7	4.5	6.5	6.4	3.0	1.3	2.7	1.0	3.2	2.8	0.8	2.5	4.0	0.0	0.0	2.0	3.5	1.7	4.0	0.8	2.3	0.2	0.0	2.4	8.0	1.5	1.2	1.1	1.0	8.9	1.6	2.9	3.1	5.9	0.0	1.7	11.7	0.0	15.4	1.8	0.8	2.7	0.0	2.1	1.4	1.3	25.8	3.8	3.4	12.0	2.4	1.1	2.9	3.4	1.1
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes		270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.6	32.7	14.9	19.2	4.2	5.7	13.8	12.8	7.7	19.4	19.8	24.6	22.8	36.1	27.0	8.0	12.4	21.0	30.9	25.1	24.3	19.0	48.8	21.0	15.0	32.0	5.5	37.5	32.8	6.6	14.3	21.6	12.5	5.9	19.9	19.4	26.4	12.7	13.7	46.5	44.5	42.1	19.7	27.0	26.4	63.2	16.6	47.0	22.4	17.3	31.8	18.0	8.5	30.5	12.0	10.2	26.3	16.1	10.0	15.0	13.4	19.3	23.0	8.4	25.0	46.0	9.9	31.2	17.5	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8	17.9	14.6	32.0	37.1	80.1	23.9	33.1	61.1	20.1	19.4	41.8	7.9	81.7	107.8	107.5	10.2	47.2	79.9	0.0	108.6	68.9	31.5	41.3	31.1	18.1	68.6	14.3	37.0	25.2	16.6	36.0	18.1	35.6	45.5	108.2	103.3	19.7	78.9	105.2	18.7	54.0	16.3	19.4	35.0	2.8	33.6	70.1	23.2	25.9	124.8	43.2
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073845-31104791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	Yes			Nucleoplasm	"Nucleoli fibrillar center, Centrosome"	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	6.3	5.3	6.4	8.0	8.7	21.0	5.9	18.1	10.5	7.6	6.1	6.0	8.8	7.1	11.0	3.7	7.6	7.5	5.1	4.0	7.0	2.7	6.5	7.0	4.9	14.9	8.4	4.6	9.6	19.0	7.7	9.3	5.6	7.1	8.0	8.6	5.0	11.3	7.1	8.8	14.2	12.1	8.0	6.7	10.9	8.0	8.2	9.4	33.2	7.2	6.4	11.1	5.8	7.8	5.8	4.9	1.3	7.3	4.3	5.5	1.9	12.5	12.2	14.2	12.7	2.2	4.8	20.9	7.8	3.9	9.1	9.8	14.5	21.4	16.4	10.9	4.1	8.5	12.4	11.2	10.7	7.3	15.0	23.0	19.5	20.3	8.9	0.8	13.7	12.7	4.5	4.8	11.6	9.1	5.9	4.4	19.7	9.5	36.8	6.5	10.4	23.5	20.5	29.9	15.3	6.6	18.9	22.2	22.8	4.8	14.3	10.2	7.5	8.0	12.3	3.9	24.8	10.4	8.7	3.6	8.0	15.7	15.4	14.1	14.9	11.5	39.2	9.4	11.0	7.2	0.0	2.3	1.3	4.2	2.5	3.3	5.2	4.0	3.1	3.1	5.8	4.1	5.5	1.1	4.3	7.3	4.9	3.4	1.9	6.4	8.7	18.1	10.5	7.0	2.7	8.4	4.6	7.1	9.4	3.0	7.4	12.7	4.5	5.4	7.7	2.2	5.1	6.7	5.7	0.0	13.7	5.2	0.0	2.2	1.3	3.0	4.0	0.0	2.9	5.8	4.3	5.0	5.7	6.6	4.3	7.9	0.0	6.2	4.6	0.9	6.6	4.6	6.8	5.4	5.0	2.3	2.5	2.9	4.2	1.1	25.5	0.0	3.5	3.2	17.6	5.6	2.2	6.9	7.4	4.1
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626228-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 163.5;Spermatocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria		NA	Yes			Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	17.7	6.1	16.0	11.6	13.9	28.3	10.9	10.2	14.0	7.5	12.6	18.1	11.7	14.5	5.9	9.0	9.8	4.7	6.9	9.7	17.3	14.4	13.1	35.5	8.6	23.2	18.9	9.4	7.5	4.9	9.6	7.2	8.5	13.0	5.9	15.5	8.6	8.0	8.4	10.4	5.9	14.5	7.3	25.3	9.1	7.4	10.5	11.5	13.4	9.2	2.3	22.8	7.9	6.1	2.4	3.3	3.5	2.6	2.1	4.0	2.1	19.8	13.8	35.1	25.9	6.6	7.0	12.9	15.9	12.2	27.8	32.1	13.1	24.0	40.4	7.0	9.2	22.7	14.0	45.1	20.5	45.0	17.9	27.8	19.3	23.0	12.1	1.4	22.5	8.6	4.8	2.1	24.9	2.8	4.7	13.4	29.7	21.7	31.1	28.1	19.9	55.4	9.1	17.7	9.9	8.1	36.0	68.9	40.0	16.0	12.7	28.7	20.0	22.5	10.5	11.4	18.6	20.8	22.3	8.0	8.8	13.4	24.6	30.4	14.6	29.2	43.7	19.7	45.8	22.6	0.8	1.2	1.1	2.3	2.6	1.1	2.1	2.7	3.2	1.9	2.4	2.1	2.7	3.5	2.1	1.7	3.3	4.0	2.1	16.0	13.9	10.2	14.0	17.3	14.4	18.9	9.4	13.0	11.5	6.0	9.4	21.6	5.3	6.2	3.7	13.2	7.6	8.1	6.8	14.0	2.0	13.0	8.3	6.6	4.3	3.6	20.0	163.5	3.3	35.4	9.5	2.1	2.3	41.2	36.1	3.2	4.7	9.2	13.2	4.6	13.0	8.3	0.0	2.8	11.1	10.0	4.3	5.8	15.2	33.5	3.4	12.9	9.0	92.4	48.0	4.8	11.1	10.1	21.0	3.7
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.6	15.0	39.4	17.7	0.9	3.9	12.2	21.9	14.5	32.4	30.9	12.2	20.8	21.9	12.1	12.7	13.0	23.4	25.2	17.5	42.6	26.4	12.4	22.5	14.1	10.5	0.1	22.0	13.8	0.8	0.6	15.2	7.3	5.2	35.6	22.5	18.2	22.0	30.1	18.1	27.7	11.2	20.3	16.8	15.6	21.7	38.1	10.1	10.6	12.2	20.1	11.3	23.3	8.8	8.6	17.5	19.6	8.2	13.8	14.5	38.0	14.0	25.1	5.4	11.7	29.1	10.1	15.7	23.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2	0.0	0.3	8.5	0.2	1.0	0.0	0.3	0.0	1.4	1.2	0.0	0.0	1.3	0.0	0.4	10.7	0.0	0.2	140.2	0.0	19.8	1.0	0.2	0.0	0.8	8.6	0.0	0.0	1.8	4.5	4.6	0.9	2.2	0.0	0.0	1.3	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.0	61.2	32.3	0.4	1.6	1.5	2.5	1.1
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 homolog, MIS12 kinetochore complex component"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 90.5;Spermatogonia: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	6.7	10.4	5.6	15.6	7.4	11.6	8.2	5.4	7.2	5.1	8.6	4.1	9.5	6.3	9.5	12.0	9.1	5.0	8.1	6.2	5.1	4.7	5.8	8.6	6.1	11.0	4.8	3.9	5.3	5.4	3.6	7.6	12.9	5.1	6.5	10.3	10.1	9.7	8.1	4.6	7.3	8.8	5.9	4.1	11.6	7.0	27.2	4.1	21.2	6.3	11.4	13.8	5.8	5.5	10.9	25.4	21.7	5.9	5.6	6.5	3.7	13.0	11.8	13.9	11.1	5.5	7.2	9.2	16.0	13.6	24.6	27.7	20.5	17.0	15.1	10.7	8.7	27.2	17.2	13.0	12.6	23.5	6.6	8.3	29.4	11.3	13.7	1.2	16.8	13.0	2.7	3.6	17.0	5.4	4.0	12.0	16.4	11.4	12.5	16.1	9.3	21.5	13.0	6.5	23.6	20.9	16.9	42.4	10.0	6.2	7.8	14.3	6.5	19.9	20.5	9.7	10.8	20.9	11.3	6.2	22.5	13.7	22.0	17.2	10.5	14.1	17.1	18.9	15.2	16.0	21.7	3.6	7.5	4.4	5.9	4.9	8.8	4.8	5.8	3.9	10.9	5.9	5.5	6.5	5.6	5.0	25.4	6.5	3.7	5.6	7.4	5.4	7.2	5.1	4.7	4.8	3.9	5.1	4.1	6.0	4.1	9.3	10.2	4.4	8.0	4.1	2.5	10.7	10.3	5.2	27.5	42.7	6.6	5.2	6.3	5.8	6.4	0.0	5.6	29.3	7.5	7.5	3.5	4.5	12.6	6.4	2.4	9.8	3.7	5.8	8.1	6.1	1.7	8.2	9.0	4.8	4.7	5.7	7.1	2.9	15.8	0.0	7.2	90.5	91.3	6.4	39.7	6.4	10.5	10.8
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.6	10.8	18.5	9.2	1.1	2.3	9.1	15.9	9.9	15.1	22.5	6.7	11.2	9.6	6.0	6.1	9.7	9.9	24.4	13.4	21.8	11.6	11.7	15.3	14.3	8.1	0.0	20.1	9.6	1.0	0.4	24.4	13.0	2.7	6.9	17.0	18.2	19.6	17.4	5.1	26.8	9.2	21.4	9.6	12.5	21.3	32.7	18.5	4.3	8.8	11.6	18.2	15.1	14.5	6.5	19.7	12.4	9.2	3.7	15.1	11.3	15.6	17.9	7.2	11.2	22.2	7.6	13.3	14.6	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1	0.0	0.0	7.8	0.4	2.1	0.0	6.1	2.5	0.0	1.2	0.0	0.0	7.5	0.0	0.2	17.8	1.8	0.5	23.3	0.0	13.2	1.2	0.2	0.0	0.0	3.9	0.0	0.0	1.3	0.3	7.9	1.1	1.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	35.9	19.1	1.5	1.3	1.9	2.9	0.0
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	26.9	32.9	23.2	51.1	31.8	69.0	31.9	31.7	27.6	26.8	26.3	24.4	27.2	14.5	29.8	31.8	33.7	26.9	28.2	35.5	23.2	26.5	25.4	19.8	25.7	44.7	25.3	23.6	33.4	22.2	23.7	30.7	26.0	22.5	30.3	24.3	28.1	27.5	26.1	25.6	27.3	22.6	25.6	23.9	30.1	25.8	31.9	20.7	120.3	40.5	37.7	43.2	23.5	28.4	34.5	32.3	17.0	24.5	22.2	40.2	24.3	26.1	8.2	20.1	19.0	14.1	15.0	12.0	27.8	17.7	25.7	31.9	9.5	18.1	73.0	15.0	15.2	21.0	36.0	21.1	19.0	25.2	51.4	21.8	59.6	21.7	12.9	7.8	62.4	28.4	9.2	12.9	17.4	9.2	16.7	17.0	43.7	32.2	41.5	18.9	10.6	55.8	73.5	12.7	26.7	15.9	45.5	44.0	76.7	16.9	17.8	29.2	29.7	20.6	16.7	23.8	21.4	23.6	49.8	14.1	26.9	26.0	32.0	36.4	33.5	69.7	71.9	20.3	107.2	29.5	11.3	19.5	17.0	21.7	19.3	28.1	34.5	38.9	34.2	28.2	31.6	40.2	26.5	11.1	22.2	24.5	32.3	34.4	24.3	23.2	31.8	31.7	27.6	23.2	26.5	25.3	23.6	22.5	20.7	50.6	29.3	108.7	177.4	159.5	41.9	99.9	84.1	24.1	61.4	99.5	13.7	138.0	172.5	82.7	26.1	112.3	21.0	140.2	40.7	245.0	140.4	116.4	84.1	71.8	150.1	77.9	92.4	100.1	85.2	25.7	171.2	102.9	146.8	57.7	93.4	81.1	44.6	42.1	166.9	204.1	36.1	155.2	162.6	380.2	218.4	147.3	81.2	113.3	168.7	147.0
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 2849.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		650000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	45.5	48.5	128.5	34.4	97.8	21.9	54.3	48.4	120.5	50.6	61.8	61.9	31.1	31.6	47.2	64.9	113.7	107.1	46.7	44.2	124.1	105.2	49.7	40.7	40.3	41.2	92.9	90.7	49.0	45.7	30.4	46.4	49.8	67.4	39.9	64.5	24.8	34.0	54.9	15.0	117.3	38.9	75.2	93.6	30.4	45.1	59.4	56.8	35.4	37.1	84.3	65.6	59.0	63.0	55.0	80.6	73.6	55.0	46.7	63.4	50.8	78.6	89.9	89.2	68.4	78.4	83.2	28.7	108.9	50.3	88.9	53.4	84.7	53.1	44.1	58.8	104.0	87.0	71.0	106.0	91.0	88.9	58.4	69.4	43.1	64.5	114.6	79.2	45.0	71.7	50.5	97.5	66.6	54.7	98.8	92.3	47.8	54.0	50.9	117.3	104.1	58.6	97.8	73.2	101.0	104.9	59.9	46.2	54.7	127.0	72.9	61.3	45.3	88.7	77.1	98.8	97.4	76.4	65.8	71.0	68.5	58.5	60.4	93.7	30.6	58.8	43.8	75.9	70.3	87.6	73.6	49.5	63.6	37.7	51.4	28.7	55.0	39.0	39.0	49.1	36.5	25.2	31.5	9.1	46.7	55.0	80.6	63.4	50.8	128.5	97.8	48.4	120.5	124.1	105.2	92.9	90.7	67.4	56.8	181.7	88.8	250.9	293.4	819.1	137.3	144.1	321.0	1203.2	211.5	378.6	78.5	490.2	943.3	628.7	1147.1	421.8	466.9	116.8	472.1	694.2	640.5	264.0	307.3	460.6	658.6	81.0	461.6	421.7	304.4	2849.5	478.4	414.2	565.2	861.2	700.1	95.2	648.6	662.9	659.7	842.5	153.7	362.2	584.0	638.3	583.5	1407.5	841.8	195.6	373.7	348.8
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Cell type enriched"	"Detected in many"	5	"Spermatogonia: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	16.0	15.6	18.1	14.1	1.8	1.3	13.8	15.4	7.5	19.7	16.6	27.6	16.6	29.6	15.6	6.9	23.9	12.1	8.8	8.2	8.8	8.9	12.6	24.2	23.2	16.0	0.1	11.3	15.3	1.0	0.5	10.8	1.9	2.0	5.0	18.6	6.4	20.9	12.1	14.2	24.0	24.0	5.4	16.2	22.5	23.9	49.4	12.2	3.3	9.8	27.1	19.1	18.8	13.1	7.6	5.4	16.4	14.3	2.7	23.0	13.5	15.9	21.8	20.5	13.8	24.4	19.2	6.7	13.6	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0	0.0	0.6	2.9	0.7	2.6	2.2	0.4	0.0	0.0	2.3	0.0	0.0	2.6	0.0	0.9	0.7	0.1	0.5	0.0	0.2	7.9	1.1	0.6	0.0	0.8	3.8	0.0	0.0	0.6	0.0	2.3	2.0	0.9	1.7	0.0	2.9	1.2	0.5	0.0	1.1	0.0	2.0	0.0	0.9	3.8	37.5	1.5	1.5	0.7	4.6	0.9
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506430-23531220	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 22.8;lymphoid tissue: 69.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 45.0;Late spermatids: 84.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9;Karpas-707: 20.5;U-266/84: 18.3;U-698: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016313	Uncertain					NA	Yes					"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.4	0.2	0.1	6.1	0.2	22.8	1.0	0.1	0.2	1.1	3.5	0.2	0.0	1.6	0.1	0.2	11.2	0.1	0.2	1.5	0.0	0.0	0.4	0.7	1.2	3.3	0.2	0.0	0.2	0.6	0.0	0.0	2.2	0.2	0.3	2.3	0.3	1.2	0.0	0.0	4.4	3.4	0.4	0.2	6.8	0.9	4.4	0.1	69.7	0.3	3.9	6.1	0.5	2.3	0.9	1.1	6.7	2.0	0.2	2.8	0.4	2.7	2.0	3.4	5.4	0.1	0.1	2.4	1.3	0.6	1.2	1.6	1.2	1.6	23.9	1.6	0.6	0.6	5.5	6.8	0.3	1.1	6.0	2.2	3.8	5.1	1.4	0.0	2.7	5.0	0.0	0.0	0.9	0.1	0.2	0.4	11.2	2.9	20.5	0.6	1.6	12.2	2.5	0.7	2.9	1.0	13.4	7.3	8.1	0.5	0.7	4.4	6.2	2.2	2.8	0.6	0.4	2.1	2.0	0.2	1.2	3.3	3.7	1.8	15.2	18.3	19.8	1.1	3.0	2.2	6.7	0.6	1.7	0.2	1.5	0.1	0.9	0.7	0.5	1.1	0.6	0.1	0.2	0.4	0.2	2.0	0.9	2.8	0.4	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	7.0	0.1	0.7	0.0	0.5	0.0	0.0	0.0	1.8	0.0	1.0	0.0	0.0	45.0	0.0	2.0	0.0	0.0	4.0	0.2	0.4	0.0	0.0	2.0	0.0	1.2	0.6	4.4	84.0	0.3	0.9	0.0	0.0	5.6	0.0	0.1	7.0	0.4	0.0	0.0	0.0	0.0	1.1	3.3	0.9	0.5	0.0	7.4	1.0
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.2	33.0	26.1	13.5	2.7	5.6	13.0	20.5	16.8	30.8	30.0	18.3	49.1	11.5	31.2	12.0	29.5	20.4	21.0	13.1	42.1	16.4	11.6	7.2	18.1	9.3	1.2	11.1	8.3	1.8	2.2	18.3	18.7	8.7	13.2	17.1	7.4	16.9	24.3	16.3	11.3	8.3	21.2	38.3	18.0	8.1	25.6	14.8	23.4	10.8	17.4	11.2	25.9	29.5	10.4	13.7	49.1	8.3	11.4	15.0	14.4	20.1	42.6	8.3	11.1	21.7	13.2	9.7	19.5	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8	6.0	2.7	9.0	4.3	17.3	3.4	3.1	7.6	10.7	4.5	3.5	60.9	4.9	0.0	9.0	2.7	6.4	3.2	70.0	7.9	13.0	7.0	8.8	0.0	1.5	6.1	0.0	4.6	5.5	3.1	2.3	0.9	5.1	6.8	1.8	10.8	2.9	14.3	3.5	1.4	1.9	13.4	0.0	3.3	33.1	37.4	11.2	3.2	1.5	6.2	7.8
EID1	"C15orf3, CRI1, EID-1"	ENSG00000255302	"EP300 interacting inhibitor of differentiation 1"	Q9Y6B2	15	48877886-48880183	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA051122, HPA051123"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA051122: AB_2681350, HPA051123: AB_2681351"	"unprognostic (1.38e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-1)"	42.6	75.4	69.7	33.0	66.6	18.4	38.1	65.0	77.2	56.1	47.9	36.9	33.6	30.4	58.1	46.0	41.2	46.8	52.9	95.4	63.4	73.2	53.0	42.5	35.1	35.1	58.6	63.7	71.7	38.3	42.0	71.7	32.7	67.6	56.2	24.6	44.9	34.4	53.3	92.7	19.9	29.1	55.3	59.8	39.6	33.4	26.9	44.4	32.8	48.3	38.0	26.9	57.1	35.0	36.4	72.7	55.3	62.9	43.9	65.0	73.4	20.8	17.8	40.6	38.1	35.9	47.9	2.7	55.2	45.7	33.7	44.4	15.4	9.5	28.1	51.3	31.4	24.9	18.9	19.5	19.6	36.6	77.3	20.2	48.2	39.5	0.6	28.1	29.0	22.1	41.8	16.8	22.7	13.6	32.8	37.9	24.6	28.6	27.0	37.3	30.1	20.9	24.4	0.0	14.9	15.7	29.5	50.5	45.8	41.7	23.1	38.7	38.8	34.4	13.1	62.5	33.1	23.9	38.3	42.9	53.7	29.9	50.9	48.1	34.9	95.2	20.0	44.4	64.1	37.7	55.3	62.9	53.7	47.8	56.6	45.1	34.0	54.6	49.5	72.7	36.4	39.9	36.6	8.3	43.9	56.0	72.2	65.0	73.4	69.7	66.6	65.0	77.2	63.4	73.2	58.6	63.7	67.6	44.4	360.3	149.9	104.9	122.0	155.9	338.8	422.3	160.5	255.6	306.0	247.7	113.9	301.2	514.0	334.6	14.7	353.4	52.3	116.8	234.2	122.3	472.2	84.6	181.5	144.0	183.1	225.6	224.3	276.2	202.2	21.3	650.4	211.2	462.2	264.3	93.9	629.6	172.4	94.5	612.4	325.8	264.9	316.9	445.7	102.8	59.4	127.2	91.7	198.0	88.5	76.7
ERH	DROER	ENSG00000100632	"ERH, mRNA splicing and mitosis factor"	P84090	14	69380123-69398627	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	42.6	45.4	54.9	43.9	46.7	47.0	51.3	45.1	48.4	46.6	43.5	31.1	39.4	42.1	53.3	63.3	44.8	46.4	35.9	40.6	47.6	51.1	56.1	62.2	34.5	52.5	43.5	48.5	47.8	38.7	23.9	45.5	55.2	45.4	40.4	50.3	41.3	58.5	40.3	43.3	31.0	47.3	46.9	43.6	55.2	35.6	54.6	28.4	72.2	55.2	37.5	64.4	47.7	36.8	38.7	37.3	24.2	32.4	34.1	35.3	38.8	90.9	59.0	59.1	39.4	29.7	21.9	35.8	47.7	27.5	43.1	40.4	60.1	37.8	86.3	21.0	31.9	32.9	26.7	59.8	39.6	51.3	45.0	36.5	43.3	39.2	67.1	45.8	37.6	31.5	24.9	21.3	38.5	34.6	24.5	35.2	56.0	41.7	29.0	35.2	104.0	56.8	53.6	46.1	48.2	56.0	46.1	58.6	29.5	43.4	62.2	45.5	42.4	45.5	41.7	26.1	35.0	51.3	52.7	37.6	42.2	62.5	28.0	47.4	32.6	30.9	96.5	31.3	40.0	40.7	15.3	32.4	24.2	26.1	30.1	25.7	38.7	32.5	28.6	34.0	30.6	30.7	27.2	15.4	34.1	27.1	37.3	35.3	38.8	54.9	46.7	45.1	48.4	47.6	51.1	43.5	48.5	45.4	28.4	56.6	48.3	181.6	193.1	242.6	132.5	105.5	158.0	116.4	66.0	240.8	35.3	400.5	570.3	308.1	69.0	200.3	146.7	93.5	240.5	449.3	263.5	196.9	126.7	237.4	297.7	69.9	181.0	155.9	148.1	29.8	250.8	172.7	291.8	355.3	176.1	207.1	246.0	166.8	243.6	389.2	92.5	187.5	273.0	273.2	229.3	278.7	234.1	150.3	215.6	194.6
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039142-64130819	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 76.4;Melanocytes: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.9;MAIT T-cell: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 41.3;RPMI-8226: 18.5;U-266/70: 39.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB009495, HPA027730"	Supported					NA	Yes					"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	5.5	24.9	2.2	10.6	1.6	8.0	7.7	2.3	1.8	15.8	10.0	3.5	36.1	5.1	11.9	15.0	7.4	7.9	10.6	4.1	1.9	1.7	6.4	21.5	12.3	12.6	2.1	1.6	14.7	44.1	2.9	32.8	10.1	1.8	6.6	3.9	5.0	23.2	34.9	4.2	6.6	11.5	4.1	2.2	9.9	8.8	2.8	1.6	11.6	7.5	5.9	16.7	10.0	7.7	0.1	5.7	12.9	0.7	3.0	12.2	1.0	2.2	1.8	0.9	2.4	2.2	1.8	4.5	1.9	4.3	1.3	1.2	1.2	1.2	2.9	1.3	1.4	2.1	1.5	1.2	1.9	3.3	0.8	1.1	2.6	0.9	1.8	13.9	1.2	0.9	2.1	5.3	3.7	11.8	1.9	2.5	2.8	1.8	41.3	1.2	1.5	1.8	0.5	0.4	2.1	1.6	2.0	2.0	18.5	1.1	3.0	3.2	2.0	1.8	3.1	4.5	1.8	1.7	2.7	2.4	1.1	2.7	2.6	1.2	39.0	10.2	2.2	2.1	1.4	1.9	12.9	0.7	0.2	4.6	0.4	12.2	0.1	3.0	3.2	0.3	0.1	0.7	1.3	3.3	3.0	0.2	5.7	0.7	1.0	2.2	1.6	2.3	1.8	1.9	1.7	2.1	1.6	1.8	1.6	0.0	42.2	9.0	42.2	19.6	3.2	5.6	15.3	6.7	7.9	12.2	5.9	6.5	1.7	9.4	1.8	10.8	7.1	0.0	24.0	6.6	16.0	38.4	8.1	21.3	7.7	3.2	76.4	14.1	12.1	1.1	4.4	18.6	70.9	8.2	7.8	4.0	16.0	7.6	5.6	3.7	26.0	0.0	15.1	3.9	4.1	39.4	45.9	42.7	7.6	52.1
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.1	10.1	16.7	11.0	1.0	2.7	14.1	20.2	6.8	18.1	19.8	12.6	8.6	16.6	9.9	4.7	9.5	15.1	21.1	8.4	21.5	25.6	18.5	15.4	10.8	6.4	0.3	21.9	11.5	0.6	0.4	18.0	4.9	2.2	5.6	16.3	30.8	21.9	14.4	7.0	23.6	12.4	22.8	18.5	10.0	17.1	15.6	17.7	3.7	9.6	18.7	23.7	13.2	10.7	7.1	8.2	9.9	13.6	2.0	17.6	15.5	16.5	27.2	16.1	21.3	26.7	6.1	17.9	20.9	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1	0.0	0.0	0.0	0.1	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	0.0	0.0	0.0	14.1	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	9.8	6.9	0.1	3.3	0.7	0.6	0.1
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.4	6.3	9.4	0.1	1.0	1.8	0.1	18.6	9.3	11.1	16.5	13.3	9.7	30.5	12.6	5.4	9.3	19.0	13.7	12.6	19.8	15.8	3.3	3.3	12.0	5.8	0.0	0.1	3.9	0.4	0.4	10.7	0.8	2.1	5.9	8.3	0.9	28.8	13.0	9.2	19.2	0.2	0.1	14.8	7.4	20.3	14.0	11.9	5.9	21.1	1.8	6.0	15.4	17.8	3.0	3.6	19.7	1.7	3.2	8.6	18.8	26.0	16.9	22.2	16.0	0.2	12.5	0.1	12.3	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6	0.0	0.0	4.8	2.0	3.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.8	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	2.4	0.1	0.5	6.3	0.9
FAM161A	"FLJ13305, RP28"	ENSG00000170264	"Family with sequence similarity 161 member A"	Q3B820	2	61824854-61854143	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Ciliopathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 133.3;Late spermatids: 200.8;Rod photoreceptor cells: 391.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA032119	Approved					NA	Yes					"HPA032119: AB_10602806"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-5)"	"unprognostic (7.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.93e-1)"	"unprognostic (8.08e-3)"	"unprognostic (7.04e-2)"	2.6	3.7	8.2	1.9	8.9	1.3	3.4	6.8	10.4	6.1	2.4	5.2	4.3	1.5	4.4	3.9	3.2	10.5	4.1	3.9	4.6	5.6	5.5	2.5	3.0	2.2	7.8	4.8	13.5	5.7	5.4	10.9	3.1	6.6	3.1	2.2	20.5	2.0	3.7	3.0	2.1	1.9	2.5	5.5	2.1	5.3	13.0	9.5	1.7	9.4	2.0	2.0	3.1	3.5	0.9	0.7	1.7	0.1	0.5	2.3	0.3	3.4	3.3	7.5	2.9	3.6	3.6	2.3	3.0	1.6	3.7	4.5	2.1	1.8	6.7	1.6	0.5	6.4	1.7	4.6	0.5	8.5	4.4	4.6	2.6	3.1	3.2	3.2	2.7	0.4	1.5	0.0	6.5	2.1	4.3	3.6	6.6	0.9	2.3	2.5	1.4	4.6	4.9	11.3	4.3	3.3	8.1	12.4	3.5	2.6	0.8	9.2	7.8	6.5	0.9	4.9	7.0	1.6	1.8	0.7	5.9	5.7	4.5	6.7	4.0	3.0	8.5	4.2	4.4	1.2	0.0	0.1	1.7	0.3	0.0	1.1	0.8	2.3	0.2	0.1	0.9	1.3	0.6	0.0	0.5	0.0	0.7	1.3	0.3	8.2	8.9	6.8	10.4	4.6	5.6	7.8	4.8	6.6	9.5	3.0	8.9	0.8	8.4	4.8	32.7	12.5	7.6	61.6	14.8	19.2	94.2	10.7	1.7	3.6	133.3	4.7	0.0	0.0	3.3	6.3	8.2	3.7	4.6	4.0	3.1	15.9	5.8	2.5	2.2	200.8	19.2	2.4	8.5	2.8	1.1	33.5	1.9	0.0	15.6	9.0	391.6	0.0	7.1	85.9	37.2	3.6	9.3	3.1	3.3	2.0
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.5	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	18.6	10.8	15.3	10.3	22.6	30.1	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.9	3.9	12.0	10.6	9.2	19.5	11.7	9.2	9.4	7.1	25.1	29.8	29.7	2.8	13.5	21.0	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	15.5	7.4	13.6	6.2	12.1	18.2	8.8	15.0	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2	17.9	18.3	5.8	13.7	9.2	12.4	13.2	5.1	20.1	10.3	8.7	3.9	25.0	10.0	6.9	1.7	10.5	7.3	0.0	3.6	12.2	8.9	6.8	10.4	10.4	9.4	7.9	8.6	10.4	8.5	1.7	10.0	6.9	25.3	9.0	16.3	20.3	4.6	13.1	13.4	4.1	18.8	12.9	8.1	47.7	30.4	5.9	6.2	5.0	13.6	5.9
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592823-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9"	"Cell type enriched"	"Detected in many"	9	"monocytes: 1791.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		4500000	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	26.3	13.3	23.7	29.6	30.1	6.3	8.1	5.5	56.9	9.9	5.5	35.1	0.0	5.4	11.7	2.3	22.3	5.9	8.9	10.6	27.7	16.8	5.5	7.1	11.3	15.2	26.9	23.6	21.8	5.1	2.3	7.0	29.4	20.1	4.1	3.0	8.1	11.0	3.9	7.8	17.3	6.6	7.0	29.6	39.3	7.6	15.9	28.3	9.3	8.5	15.9	11.4	14.7	12.3	0.2	5.4	1.0	1.9	0.0	0.1	1.4	8.0	18.6	12.4	44.5	4.8	9.2	82.1	19.3	8.6	3.3	3.6	12.9	2.0	0.1	23.6	8.5	3.2	30.5	7.1	31.0	0.2	9.1	3.8	0.5	19.8	60.8	2.5	0.0	1.6	5.7	9.2	6.2	5.1	5.5	16.2	0.0	68.7	0.1	4.2	0.8	0.2	78.0	32.5	0.5	68.7	18.1	2.9	0.3	4.8	0.7	9.9	65.9	16.1	0.2	0.6	8.4	0.4	4.9	32.8	22.9	40.3	13.3	19.8	0.1	0.1	0.0	14.8	0.0	43.0	0.0	1.9	0.1	0.0	0.5	0.0	0.2	0.1	0.0	5.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	1.4	23.7	30.1	5.5	41.3	27.7	16.8	26.9	23.6	20.1	28.3	3.0	5.5	2.4	19.0	161.1	7.2	6.9	2.5	1.4	0.0	1.8	0.0	4.4	0.0	6.8	13.1	49.6	1.3	0.0	4.2	90.3	72.6	6.3	16.1	0.8	207.2	0.0	40.2	97.6	22.0	7.9	23.6	10.6	49.0	1791.8	0.7	69.1	10.4	0.0	8.5	0.2	2.3	0.0	16.5	4.7	9.0	128.6	12.2	4.3	0.9	28.3
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.2;testis: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 65.9;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 72.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA057285	Uncertain		Approved	Nucleoplasm		No	Yes			Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	0.9	1.5	3.5	15.9	3.7	13.2	3.6	3.8	2.1	1.9	6.5	1.9	1.5	4.7	1.8	2.6	7.1	0.9	2.2	1.6	4.8	1.5	1.3	3.3	1.4	8.7	2.2	1.5	1.9	4.4	2.6	1.4	4.6	1.6	2.6	7.4	1.9	2.0	0.7	3.2	3.1	5.9	1.5	2.3	7.6	2.1	21.3	1.8	25.2	1.8	8.0	13.3	1.9	3.0	1.4	1.7	1.5	3.3	4.3	11.1	2.4	13.4	9.7	19.0	7.9	0.5	1.9	5.0	9.3	3.7	13.7	8.5	12.8	9.0	15.9	5.1	3.2	7.2	10.3	20.0	7.6	13.3	5.5	17.3	7.8	7.4	14.4	0.1	5.4	4.3	0.5	0.9	8.2	3.2	1.7	5.8	12.9	21.4	3.8	7.9	28.2	19.1	20.5	10.6	11.9	7.4	26.8	11.5	8.8	4.4	5.6	26.2	8.3	13.4	2.7	2.7	7.9	27.6	7.4	3.5	9.0	12.1	8.4	10.6	7.1	12.5	72.1	5.2	11.5	10.2	0.7	0.3	1.5	1.4	1.3	0.2	1.4	4.7	3.1	1.7	1.0	2.2	1.6	1.2	4.3	3.3	1.0	11.1	2.4	3.5	3.7	3.8	2.1	4.8	1.5	2.2	1.5	1.6	1.8	3.0	0.0	6.7	6.6	8.1	7.1	1.1	0.0	2.7	4.5	3.5	2.0	17.0	3.3	6.0	8.2	0.6	1.6	23.3	1.3	22.7	3.1	2.7	1.1	1.7	19.7	7.9	2.9	0.0	0.6	22.2	1.1	2.8	0.0	1.0	8.2	3.4	1.5	5.8	1.8	0.3	8.0	19.4	3.1	65.9	96.9	3.3	10.6	5.1	29.9	1.6
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 398.1;Distal tubular cells: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	17.2	9.6	11.3	28.6	8.7	7.5	32.0	14.2	26.1	24.7	27.1	21.7	14.1	16.9	4.9	11.9	21.0	21.7	25.8	18.7	27.4	5.8	11.0	6.4	12.3	28.2	46.5	18.3	11.0	11.9	20.2	21.0	57.1	16.8	12.0	11.2	16.5	26.5	15.8	15.6	9.8	13.8	7.2	27.0	13.4	10.7	10.8	17.6	43.2	9.5	4.9	7.2	10.7	15.2	52.9	17.4	29.0	6.3	5.5	6.3	14.1	6.8	16.2	18.9	22.3	17.3	16.6	9.6	8.4	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7	14.9	14.4	29.9	39.5	10.5	86.5	398.1	96.8	26.8	14.8	69.8	58.9	29.8	203.9	43.4	86.1	13.5	75.3	46.7	27.1	14.9	9.9	11.6	32.2	145.9	26.2	71.5	18.9	17.2	11.6	9.5	10.3	9.5	47.2	14.4	30.8	29.4	25.5	30.3	13.4	123.7	55.6	12.9	14.1	28.9	11.5	9.2	46.1	12.1	50.2	36.7
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990058-143993415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 331.5;monocytes: 538.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	Yes			"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	76.4	48.8	46.6	52.3	61.0	89.0	70.2	73.8	85.8	37.1	28.4	34.5	37.1	35.6	33.1	42.1	30.5	41.4	37.5	35.2	54.2	45.1	61.7	143.7	49.7	67.4	47.4	51.5	46.1	32.0	66.8	29.3	42.4	46.5	42.6	17.7	49.3	44.4	99.4	32.8	37.4	33.5	38.0	43.3	82.0	23.2	52.2	24.3	24.3	54.7	19.2	26.8	43.2	31.3	4.5	12.4	10.2	19.3	1.6	2.6	6.4	12.8	25.2	12.9	21.9	68.8	34.7	19.1	18.4	43.6	31.4	29.1	15.3	10.8	9.2	20.3	41.5	21.9	11.6	23.0	27.2	12.9	13.1	15.8	9.6	14.6	18.1	72.9	2.0	15.5	44.7	75.4	22.7	33.2	33.0	15.2	4.0	8.9	13.0	27.0	77.6	5.3	5.2	9.0	12.4	38.2	7.3	6.5	17.8	16.1	36.5	8.8	14.3	26.8	30.2	35.8	18.3	58.1	12.7	15.2	19.9	21.9	26.5	13.4	21.1	12.1	6.9	25.2	12.7	11.3	0.9	16.6	4.6	1.4	19.3	2.0	4.5	1.4	1.6	7.1	4.3	2.6	2.3	10.2	1.6	18.0	12.4	1.2	6.4	46.6	61.0	73.8	85.8	54.2	45.1	47.4	51.5	46.5	24.3	17.9	65.6	14.3	28.0	33.1	86.7	19.7	40.8	17.4	18.2	50.6	74.6	108.2	19.9	63.5	214.4	42.1	42.7	46.7	60.2	47.1	58.4	38.3	15.1	167.7	158.2	31.8	40.5	54.0	188.9	331.5	57.0	128.7	35.4	538.4	24.1	77.3	64.0	46.0	63.6	61.9	71.2	45.3	40.6	89.2	11.3	32.2	220.9	15.9	22.4	21.6
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 69.2;Spermatogonia: 174.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.4	2.0	1.2	28.8	1.5	14.8	3.0	11.9	3.2	4.2	5.0	0.7	3.3	3.5	5.8	6.0	8.6	2.5	3.6	2.1	1.3	2.0	3.9	2.0	2.5	11.9	1.4	1.7	4.3	1.9	2.7	4.7	9.0	1.3	3.4	5.5	3.3	2.8	2.0	0.6	5.2	5.3	2.1	1.7	8.3	3.6	18.7	0.7	46.4	1.7	8.1	15.1	3.6	4.4	13.6	22.0	0.7	0.8	5.6	10.9	1.5	19.9	19.7	25.5	32.3	1.0	2.4	13.8	15.3	9.9	12.8	20.2	26.0	16.2	24.7	6.1	5.1	10.8	20.2	14.6	12.2	18.3	23.9	16.8	13.1	20.0	20.8	0.6	24.7	11.9	1.3	0.7	15.3	7.3	3.5	8.8	16.7	7.1	15.8	15.1	20.1	26.0	12.3	26.4	14.6	8.8	24.3	22.7	5.7	8.7	25.8	10.2	8.3	18.1	5.2	2.7	22.2	22.1	8.0	6.2	14.0	7.1	12.8	18.3	8.2	15.6	26.4	7.0	15.3	6.4	0.1	0.5	0.0	4.4	0.8	1.5	10.9	7.2	6.2	1.3	13.6	3.5	5.0	0.7	5.6	0.6	22.0	10.9	1.5	1.2	1.5	11.9	3.2	1.3	2.0	1.4	1.7	1.3	0.7	8.9	3.8	23.8	8.2	19.2	13.6	0.8	7.6	8.1	17.0	21.0	0.0	25.8	3.3	5.8	0.8	4.9	2.1	23.3	5.5	31.3	11.0	3.1	5.7	2.6	12.8	6.4	10.4	8.0	1.3	3.6	8.3	6.2	1.7	9.0	6.5	5.0	3.9	0.0	5.3	1.4	9.4	19.4	6.2	69.2	174.0	8.7	9.3	12.5	23.7	4.4
HIST1H2AG	"H2A.1b, H2A/p, H2AFP, pH2A/f"	ENSG00000196787	"Histone cluster 1 H2A family member g"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 305.4"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"K-562: 9.9;SiHa: 11.5;U-266/84: 31.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	2.4	1.6	1.1	25.1	1.2	6.3	8.7	0.7	1.0	3.3	9.7	0.0	1.0	3.8	2.0	3.7	15.7	1.0	3.2	2.7	1.3	1.6	1.1	2.6	6.0	13.5	2.3	0.0	1.4	0.9	0.3	1.0	8.7	0.3	2.5	2.3	0.3	2.1	1.5	1.1	1.4	7.1	0.9	2.3	20.2	1.8	16.1	0.0	305.4	1.5	12.3	28.9	2.4	2.0	4.4	1.3	9.7	0.8	1.1	3.8	7.7	1.3	1.8	1.6	1.4	4.9	1.0	1.0	0.5	0.7	1.6	0.2	0.8	1.4	0.4	2.0	0.5	1.5	2.8	1.9	0.8	1.1	2.4	1.1	0.7	3.6	0.0	1.0	0.7	1.5	1.8	0.4	0.5	0.5	0.8	0.5	1.3	9.9	4.7	0.1	1.7	1.8	1.1	0.9	2.0	1.2	1.2	1.5	5.1	0.3	0.3	6.1	1.5	11.5	1.8	0.6	0.7	0.0	0.4	0.6	1.8	4.0	1.4	0.7	8.4	31.2	3.2	0.3	1.1	1.1	9.7	0.4	0.7	0.6	0.3	1.3	3.0	2.3	1.6	0.6	4.4	2.2	1.8	3.5	1.1	0.8	1.3	3.8	7.7	1.1	1.2	0.7	0.9	1.3	1.6	2.3	0.0	0.3	0.0	0.0	1.4	2.2	1.4	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	16.3	0.3	7.3	0.0	0.0	2.9	0.3	1.4	0.0	0.4	2.1	4.8	1.2	0.0	0.6	10.6	0.0	1.0	0.0	1.0	3.1	1.2	0.1	10.5	0.0	0.0	0.0	0.0	0.3	2.2	3.0	0.4	2.5	2.5	2.9	1.0
HIST1H2AJ	"H2A/E, H2AFE"	ENSG00000276368	"Histone cluster 1 H2A family member j"	Q99878	6	27814354-27814740	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 357.7"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8"					"Low region specificity"	"Detected in some"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.6	0.1	0.0	7.2	0.0	16.5	0.2	0.0	0.2	1.0	5.2	0.0	0.0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0.0		0.3	0.4	2.2	3.1	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.4	3.9	0.1	0.0	10.5	0.8	5.2	0.0	357.7	0.1	7.9	23.1	1.5	0.0	4.2	2.7	2.5	0.5	0.4	5.9	5.0	4.0	0.0	1.2	0.0	0.0	0.0	1.0	1.2	1.2	1.1	2.6	2.1	0.2	3.9	0.4	0.7	0.1	1.1	0.0	1.1	0.6	1.9	0.6	5.6	0.5	10.0	0.3	0.0	2.1	0.0	0.3	0.5	0.3	0.0	1.5	2.1	0.0	12.1	0.3	16.8	6.7	6.1	2.0	1.7	3.5	6.0	0.0	2.3	0.2	2.4	0.5	0.8	1.1	1.2	0.5	0.3	0.4	4.1	0.0	0.0	2.4	0.4	0.2	6.2	3.9	3.8	1.3	4.5	2.8	0.0	0.1	0.0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5.0											0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	46.7	0.0	1.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.3
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 105.0;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.2;U-266/84: 39.2"					"Low region specificity"	"Detected in some"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.2	3.7	2.1	29.3	2.7	1.1	4.7	2.7	6.2	3.9	4.1	4.4	2.4	30.1	5.6	6.9	8.5	2.1	2.0	2.9	11.0	5.2	1.6	9.8	4.3	3.1	2.1	4.6	19.2	3.2	1.7	2.4	2.4	1.5	2.3	16.9	13.5	1.1	19.3	4.8	5.4	3.9	23.1	5.7	1.9	2.4	16.0	5.8	3.9	12.0	5.1	29.9	7.8	4.6	7.6	19.8	0.8	0.9	7.7	20.1	3.1	1.0	37.2	39.2	6.1	1.0	10.0	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6	3.0	5.6	15.9	54.2	1.5	13.9	21.3	12.7	53.5	10.3	21.0	0.0	6.4	19.9	4.3	27.1	2.8	22.0	0.0	3.8	6.2	3.0	105.0	2.3	20.7	3.9	41.3	44.7	1.3	4.0	5.4	6.6	6.9	3.3	3.6	20.2	4.0	12.0	33.1	1.4	75.4	10.4	0.0	1.4	0.9	0.7	2.4	33.0	6.9	14.3	63.6
HIST1H3H	"H3/k, H3F1K, H3FK"	ENSG00000278828	"Histone cluster 1 H3 family member h"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 55.3;lymphoid tissue: 204.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 9.9;Intestinal endocrine cells: 5.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	6	"basophil: 15.9;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"K-562: 17.8;SiHa: 15.5;U-266/70: 13.2;U-266/84: 32.1"									HPA042570	Approved					NA	Yes					"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.2	2.6	0.0	25.2	0.0	7.5	1.7	0.2	0.3	1.7	4.7	0.0	2.5	2.3	1.6	2.5	9.0	0.6	3.0	1.3	0.0		0.4	3.1	4.4	8.1	0.0	0.0	2.2	1.5	1.4	0.0	3.4	0.1	2.7	5.3	0.5	0.9	2.8	0.8	0.3	3.9	1.0	0.2	11.0	3.1	3.4	0.0	204.8	1.3	10.6	22.6	1.7	0.9	1.1	1.8	15.9	1.1	0.3	2.0	55.3	1.0	3.9	1.7	1.4	2.4	0.3	0.2	0.6	0.4	1.9	0.7	1.2	1.1	0.7	3.7	0.4	1.1	2.1	0.6	0.9	1.2	4.9	2.4	0.9	3.5	5.0	0.6	0.8	1.5	3.2	0.3	0.4	0.4	0.8	0.8	0.9	17.8	8.6	0.3	7.8	1.6	1.9	0.8	7.2	1.5	0.8	0.0	8.9	2.0	0.4	5.2	1.0	15.5	3.2	0.6	0.9	7.5	0.2	0.8	0.8	2.5	0.5	0.2	13.2	32.1	2.7	0.0	4.2	0.2	15.9	1.1	2.1	0.3	0.3	0.4	0.3	0.6	0.5	0.8	1.1	0.4	0.3	10.3	0.3	0.3	1.8	2.0	55.3											0.0	1.0	2.7	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	9.9	0.0	0.2	2.9	0.8	4.6	0.0	1.5	1.8	0.0	5.8	0.0	1.8	0.0	0.6	0.0	1.7	1.0	2.9	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.1	4.3	4.3	1.7	1.4
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 128.7;Syncytiotrophoblasts: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.3	2.8	0.9	4.1	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.6	2.4	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.6	0.8	3.2	0.3	5.4	9.4	3.4	0.7	2.8	2.1	0.5	1.7	4.9	24.3	2.1	6.9	1.2	2.1	1.2	9.4	2.5	1.5	0.7	5.5	1.6	0.9	13.1	2.1	14.1	1.9	1.0	4.8	10.0	0.9	0.7	1.3	14.7	0.9	0.3	40.5	21.7	1.1	1.7	1.5	0.8	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6	8.9	11.7	10.4	57.7	5.4	47.2	56.8	2.5	12.0	5.7	34.9	21.6	22.3	23.2	13.5	1.1	4.5	15.3	23.3	5.9	10.4	14.1	128.7	10.5	5.9	22.3	20.6	53.7	8.6	11.0	0.0	4.6	16.7	18.6	4.6	18.8	12.9	8.3	21.0	0.4	8.8	32.5	0.0	9.8	0.5	6.1	11.8	134.0	22.4	9.0	59.1
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.2	14.5	1.4	2.7	20.3	20.1	9.8	25.2	22.9	27.0	40.9	35.2	19.2	6.2	34.4	24.5	31.4	19.1	43.1	31.9	9.7	21.0	9.5	13.2	0.4	18.6	19.4	0.7	1.1	23.7	18.6	4.2	14.3	24.2	19.9	28.8	26.2	7.7	19.6	10.6	23.4	14.2	14.6	21.4	36.4	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	13.5	27.7	15.0	9.3	18.1	15.4	14.5	26.9	15.5	25.9	28.4	12.0	28.9	17.4	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3	0.0	0.6	15.5	0.8	2.3	0.6	1.7	7.6	4.0	4.5	0.0	0.0	5.1	0.0	0.6	60.3	0.1	1.3	256.9	0.2	50.4	2.4	0.8	0.0	1.7	17.7	0.0	1.2	3.1	3.5	44.1	2.0	4.3	0.0	3.6	1.6	0.0	0.1	0.0	0.7	2.4	0.7	6.5	0.0	80.6	18.5	1.3	3.8	1.0	4.2	0.9
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 3438.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		62000000	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	79.9	116.1	88.0	65.9	105.0	74.6	107.8	92.1	118.2	92.3	60.4	61.7	80.9	40.6	113.3	107.6	71.6	138.4	63.8	115.0	89.0	110.5	72.0	70.7	76.2	73.8	109.7	94.4	238.4	113.9	151.6	95.3	83.6	133.7	93.5	76.4	52.7	64.8	100.3	197.1	67.9	49.0	102.1	93.9	57.5	77.3	45.9	100.2	58.3	133.8	89.8	102.5	86.2	223.4	75.9	50.5	7.2	45.7	55.7	82.5	74.9	135.6	87.0	77.3	95.0	53.1	55.6	81.0	61.3	60.1	113.6	80.0	130.1	41.6	173.8	66.5	63.8	115.6	79.1	188.1	91.3	140.6	57.5	76.1	135.2	49.3	170.0	38.5	135.0	93.7	51.4	61.8	89.2	77.1	99.7	108.6	89.9	180.5	64.9	77.2	137.0	112.4	81.4	90.2	251.8	66.7	108.5	79.1	95.4	76.8	82.5	113.3	69.2	47.6	69.1	86.0	109.7	89.8	67.6	68.1	67.8	113.5	55.4	140.0	75.2	117.8	313.9	73.7	99.3	77.2	7.2	30.2	6.8	49.3	45.7	82.5	75.9	55.2	56.4	50.5	63.2	75.2	71.3	3.7	55.7	43.3	31.4	42.6	74.9	88.0	105.0	92.1	118.2	89.0	110.5	109.7	94.4	133.7	100.2	833.7	606.4	539.1	3438.1	940.9	289.3	1217.7	456.0	1493.6	1074.9	347.2	214.0	960.1	618.4	836.0	145.7	761.3	375.2	163.5	596.7	897.4	930.6	1319.6	967.8	307.7	711.8	321.0	544.1	275.6	256.9	156.5	635.1	727.9	698.5	738.6	374.5	296.6	721.4	313.4	574.6	560.9	223.5	342.8	894.3	197.9	740.6	807.2	939.3	460.3	567.6	2341.3
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 2008.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		210000000	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	70.0	96.8	93.7	78.1	102.8	58.1	73.8	119.5	125.1	52.8	64.1	72.0	77.3	77.7	59.9	98.3	83.4	76.2	76.7	106.4	83.1	102.4	128.6	114.2	68.9	93.3	105.7	72.4	66.7	191.1	97.2	98.3	71.6	169.2	65.3	81.0	53.1	62.4	69.9	224.6	31.2	74.4	75.4	91.8	79.7	92.7	58.3	98.1	92.9	90.9	98.3	124.4	76.1	123.2	77.4	47.5	41.1	84.2	76.1	124.3	200.0	81.9	124.3	82.5	71.3	76.5	82.0	109.4	163.1	90.4	199.5	120.1	186.5	108.0	133.6	103.0	90.7	141.2	111.7	235.9	59.1	199.2	115.5	35.8	144.9	58.5	90.9	20.9	140.8	111.4	43.7	95.7	61.3	19.1	103.7	106.7	18.2	156.8	69.6	159.8	73.0	146.4	104.5	130.6	200.3	110.8	132.1	58.9	75.5	103.3	60.0	84.8	64.2	118.8	129.0	45.0	91.8	112.5	55.1	104.9	100.3	80.5	86.1	144.5	47.0	115.8	114.7	111.7	201.3	120.9	30.3	41.5	41.1	96.5	82.9	115.9	77.4	113.4	105.2	47.5	53.7	109.6	105.1	14.9	76.1	84.2	34.4	124.3	200.0	93.7	102.8	119.5	125.1	83.1	102.4	105.7	72.4	169.2	98.1	178.6	194.1	380.7	2008.3	250.8	192.6	358.3	247.1	397.5	238.8	123.9	119.8	806.4	447.6	560.1	23.5	383.9	634.1	256.9	544.3	848.9	487.1	803.7	432.1	181.5	715.5	171.6	498.1	192.8	238.1	50.8	206.0	453.5	501.0	661.9	246.7	285.3	500.3	403.3	253.8	795.2	189.9	239.3	546.5	180.9	436.7	248.7	1264.6	601.2	394.7	698.3
HSPE1	"CPN10, EPF, GroES, HSP10"	ENSG00000115541	"Heat shock protein family E (Hsp10) member 1"	P61604	2	197499994-197503457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 1679.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 198.2"	"Low region specificity"	"Detected in all"							"CAB017366, HPA038755, HPA048272"	Supported					NA	Yes		9000000			"CAB017366: AB_10998950, HPA038755: AB_2676190, HPA048272: AB_2680336"	"unprognostic (2.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.83e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.08e-3)"	24.9	134.7	38.4	25.0	35.0	17.8	50.6	17.1	41.2	19.1	39.9	16.3	20.3	30.8	15.8	31.7	24.3	21.1	16.7	33.8	33.7	37.3	62.5	120.9	18.6	23.8	51.5	26.8	22.7	35.9	14.9	27.2	26.0	48.3	21.9	39.0	9.1	25.1	27.6	39.1	13.0	27.7	17.9	46.7	18.6	21.7	9.4	45.7	10.4	30.6	31.5	30.8	20.2	116.3	50.8	44.9	3.6	29.0	31.5	48.1	28.0	34.6	46.0	42.6	31.4	29.5	14.8	52.7	38.0	17.1	33.1	31.0	138.9	29.4	65.3	49.0	18.1	92.3	30.0	107.1	36.9	38.6	31.4	45.8	70.0	92.2	198.2	13.0	94.3	30.4	20.2	25.2	33.3	16.5	22.8	29.4	42.4	87.6	21.7	22.3	50.0	70.8	92.1	62.3	53.6	84.6	43.2	37.9	77.1	45.2	52.2	33.5	21.6	36.0	42.5	30.0	95.0	16.5	50.1	22.7	27.4	39.0	30.2	61.5	25.9	58.8	112.0	30.7	42.7	37.0	3.6	16.7	3.3	30.2	29.0	38.4	50.8	40.3	37.1	27.0	37.1	45.8	48.1	1.8	31.5	22.1	44.9	32.0	28.0	38.4	35.0	17.1	41.2	33.7	37.3	51.5	26.8	48.3	45.7	181.7	129.3	467.6	1344.0	386.6	76.4	317.3	379.6	385.4	249.1	184.9	235.6	750.2	772.6	308.6	18.4	226.7	477.1	93.5	200.4	473.8	338.6	622.6	325.8	978.6	444.4	60.4	422.2	93.9	139.9	24.0	200.5	371.3	388.0	277.7	348.0	186.8	281.8	323.0	133.3	1679.7	139.2	129.4	405.8	130.8	230.0	325.0	816.8	296.2	541.0	1039.4
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134974-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"vagina: 286.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 738.6;Urothelial cells: 485.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		820000	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	13.7	19.8	36.6	12.2	57.1	9.8	33.7	11.7	44.0	14.7	10.6	9.8	13.0	6.1	13.3	21.7	13.9	31.0	18.1	14.2	34.8	40.3	16.6	14.8	15.9	17.4	36.5	16.3	13.4	10.1	15.1	24.1	19.8	32.7	14.5	14.5	3.6	7.0	17.3	10.5	11.0	6.4	15.7	34.8	9.0	12.2	35.0	34.6	12.1	22.5	7.8	23.8	17.0	286.1	9.0	6.8	2.1	14.6	13.7	12.8	5.5	13.7	26.5	21.8	2.1	21.0	11.9	14.5	23.9	21.3	37.2	17.3	31.1	21.5	35.8	15.0	16.6	52.9	26.8	84.1	21.2	48.1	28.0	10.6	31.0	14.6	27.4	6.9	21.5	24.8	7.5	49.2	24.8	14.3	19.5	21.5	12.6	25.9	5.7	26.1	18.8	30.8	24.6	31.0	67.6	19.8	24.3	17.9	11.8	28.1	16.8	22.6	18.8	21.8	21.4	11.0	34.9	7.2	21.0	13.1	12.8	16.3	18.4	26.4	4.5	14.7	30.7	10.7	26.1	21.4	1.0	3.9	2.1	6.6	9.6	8.1	9.0	8.4	10.0	6.8	7.8	12.8	11.9	0.4	13.7	14.6	5.3	5.3	5.5	36.6	57.1	11.7	44.0	34.8	40.3	36.5	16.3	32.7	34.6	122.1	81.5	33.2	738.6	190.6	38.7	130.6	17.8	302.5	185.4	43.6	392.7	17.7	24.9	44.8	71.1	92.6	26.2	0.0	31.1	55.8	207.2	407.7	251.8	21.5	79.0	28.6	217.9	24.5	27.7	22.4	31.4	113.0	155.3	47.7	22.5	16.6	37.1	45.6	36.7	22.8	57.7	38.8	156.8	128.9	138.0	125.3	35.6	28.0	26.7	485.8
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028699	"Plasma proteins, Predicted intracellular proteins"		Transferase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	24.2	21.6	12.7	13.7	13.0	7.9	24.4	20.3	17.9	21.0	21.0	9.8	18.2	11.0	19.3	13.3	16.3	26.3	23.4	21.3	12.9	12.3	19.7	16.3	15.6	12.7	13.8	7.4	36.9	18.2	35.8	17.2	13.7	15.7	20.2	6.0	19.7	26.2	20.2	15.9	17.0	11.1	18.4	13.5	18.4	13.9	15.3	13.4	27.4	27.6	7.1	9.8	21.8	24.6	2.1	12.2	9.9	2.4	6.5	3.4	0.7	6.8	6.0	14.9	16.7	4.5	4.2	21.3	7.2	5.9	2.0	2.7	2.8	11.3	2.4	5.3	6.1	5.8	10.7	2.5	5.3	1.7	11.4	8.8	3.0	5.9	3.8	5.9	0.8	13.8	5.6	4.2	3.6	3.2	16.3	2.7	5.0	4.5	27.4	2.6	18.7	9.2	6.4	6.7	2.9	31.3	1.9	4.2	5.6	7.1	10.1	11.6	16.8	10.2	10.7	17.8	4.2	7.4	1.5	4.7	9.5	9.3	3.1	4.6	10.6	11.3	4.1	14.7	2.1	11.8	1.5	1.6	1.4	3.4	2.2	3.2	1.7	3.0	3.1	1.4	2.1	2.5	2.6	9.9	6.5	2.4	12.2	2.9	0.7	12.7	13.0	20.3	14.1	12.9	12.3	13.8	7.4	15.7	13.4	20.8	14.7	25.3	28.2	65.5	56.8	14.7	38.2	8.1	9.1	61.1	27.5	17.1	31.5	19.5	1.2	24.8	5.6	0.0	16.4	44.6	44.5	25.7	25.5	42.3	28.3	9.5	45.8	48.5	47.9	2.7	27.9	17.0	33.7	0.0	13.5	45.5	16.0	3.5	32.2	19.3	10.0	38.8	33.3	1.7	28.8	44.3	38.4	25.5	11.9	17.6
KANK2	"ANKRD25, KIAA1518, MXRA3"	ENSG00000197256	"KN motif and ankyrin repeat domains 2"	Q63ZY3	19	11164267-11197791	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 310.0;Leydig cells: 116.8;Peritubular cells: 212.2;Smooth muscle cells: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 64.6;ASC TERT1: 71.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015643	Approved					NA	Yes					"HPA015643: AB_1844839"	"unprognostic (2.37e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.63e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	28.7	10.5	4.6	27.5	9.2	2.7	21.3	3.1	6.2	78.9	68.2	5.0	42.3	7.1	81.3	29.9	45.3	35.1	45.3	52.1	4.9	3.0	12.2	9.2	22.4	6.8	8.2	5.3	57.6	6.8	2.8	5.9	12.3	5.8	47.0	12.2	32.7	6.9	38.1	17.6	8.5	19.3	90.6	8.5	14.4	24.9	16.6	6.3	2.5	14.1	10.5	4.7	72.9	74.9	0.6	0.2	1.7	1.1	1.0	1.1	0.7	7.9	17.1	5.4	5.7	64.6	71.9	3.8	35.2	30.6	17.7	14.7	6.8	5.1	32.9	17.0	43.6	11.6	7.4	4.9	2.5	11.8	1.6	3.5	14.1	20.4	6.8	24.2	2.1	4.1	30.9	3.8	12.9	1.7	45.9	7.1	1.0	9.3	2.7	27.1	13.8	0.4	1.8	5.9	5.1	18.8	11.0	44.4	7.7	12.3	4.2	3.1	10.1	35.1	3.1	4.3	6.6	4.7	7.4	25.8	25.5	10.3	32.5	13.9	2.6	5.8	11.3	21.8	12.3	25.9	1.1	0.9	0.2	0.5	1.1	1.1	0.6	0.2	0.2	0.0	0.4	0.3	0.2	1.7	1.0	0.6	0.2	0.5	0.7	4.6	9.2	3.1	6.2	4.9	3.0	8.2	5.3	5.8	6.3	53.6	21.2	0.5	4.8	5.6	1.9	310.0	30.6	6.7	14.8	19.2	19.6	5.1	3.3	7.0	1.9	24.8	1.3	70.0	4.0	4.0	44.3	5.8	7.0	21.2	17.2	0.0	0.0	34.4	8.2	1.5	116.8	4.3	8.5	0.0	0.7	35.2	8.4	0.0	212.2	3.5	24.7	90.5	132.8	1.5	7.5	6.8	1.9	1.3	5.4	4.2
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 181.0;Spermatocytes: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	10.6	4.3	28.9	13.9	13.7	12.4	24.4	7.3	11.3	7.7	8.2	3.6	11.3	0.0	5.0	11.4	5.7	16.4	13.6	12.0	9.9	0.1	5.2	5.8	4.1	5.8	11.7	18.0	7.7	12.9	20.0	11.0	14.5	20.8	17.1	7.2	18.0	0.0	7.7	10.8	5.0	21.5	19.6	7.4	7.6	21.2	0.0	0.0	11.1	18.4	8.8	19.5	15.5	9.5	12.9	39.6	19.5	12.9	12.6	6.8	5.1	0.8	4.2	1.1	0.7	4.5	6.0	6.7	2.8	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2	83.4	33.4	5.4	32.8	57.2	30.9	7.3	10.2	54.9	40.9	15.7	58.9	35.8	5.0	41.9	155.3	25.3	16.1	0.0	19.5	25.5	34.2	40.2	25.5	9.6	7.0	14.3	41.9	19.0	17.8	181.0	33.6	10.8	25.3	10.0	31.3	68.3	38.0	17.3	30.8	5.9	133.9	32.3	21.7	261.1	71.6	101.6	68.9	12.5	27.0	45.7
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187715	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.7;testis: 18.2"	"Cell type enhanced"	"Detected in some"	23	"Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 10.0;T-reg: 3.2"	"Group enriched"	"Detected in many"	64	"NK-cells: 10.0;T-cells: 3.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036909, HPA036910"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cleavage furrow"		Yes	Yes			"Nucleoplasm, Cleavage furrow"	"Cytokinetic bridge"	"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	2.3	1.7	0.3	3.6	0.4	10.4	0.7	0.3	0.7	1.7	2.7	0.4	0.3	2.7	1.6	2.2	10.7	0.3	0.3	0.8	0.3	0.3	1.2	1.2	2.3	6.7	0.6	0.4	0.8	0.5	0.0	0.3	6.6	0.5	1.0	4.2	0.4	2.0	0.3	0.5	3.5	2.7	4.4	0.5	3.8	2.1	18.2	0.3	47.7	0.5	6.1	11.7	1.8	3.0	0.1	0.0	0.0	0.0	10.0	3.2	0.4	22.2	15.0	33.2	22.0	1.7	3.3	14.3	19.3	17.7	42.1	31.8	28.2	20.8	9.6	10.4	24.3	15.8	22.1	31.1	36.1	42.2	14.0	14.7	14.2	26.8	17.9	0.1	6.9	6.6	1.2	0.6	22.4	12.9	7.1	27.2	13.7	5.9	18.4	29.1	20.4	11.6	6.8	21.0	13.1	16.4	12.8	33.3	9.9	11.5	11.0	9.9	9.8	36.5	12.4	8.5	44.5	15.8	7.2	12.9	11.0	16.4	9.9	32.2	9.5	9.1	10.7	7.1	20.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.2	0.4	0.3	0.4	0.3	0.7	0.3	0.3	0.6	0.4	0.5	0.3	0.0	1.7	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.4	46.7	0.0	10.5	0.4	0.1	4.6	0.0	4.9	0.0	0.0	3.7	1.0	1.0	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	17.9	4.6	0.4	0.8	0.0	1.6	0.0
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009010-32056431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		260000	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	26.3	19.9	55.7	20.2	55.5	34.1	23.0	22.2	42.4	23.8	34.2	21.7	20.9	23.5	25.7	17.8	28.0	20.3	28.0	48.4	51.5	39.3	21.1	15.3	23.8	16.5	62.9	26.1	18.2	18.9	56.8	22.4	27.7	38.3	31.8	30.0	8.9	20.1	25.6	34.3	17.6	28.6	37.2	80.4	21.1	23.1	27.7	43.7	25.0	23.5	21.5	16.1	33.8	28.1	13.8	27.6	30.0	18.9	13.4	16.5	9.2	30.0	25.6	34.6	24.3	24.8	27.5	14.8	41.5	19.7	32.1	27.5	28.1	33.3	20.6	18.0	49.2	18.3	25.0	31.6	26.5	43.1	17.7	17.2	26.2	23.9	27.3	28.6	18.2	28.9	22.2	37.7	37.0	25.9	25.6	41.0	18.3	31.5	21.8	44.3	18.1	18.9	10.3	5.6	28.9	11.7	24.9	64.6	8.5	24.7	21.1	33.7	24.6	32.1	12.8	30.9	25.2	15.5	26.1	34.1	32.7	30.7	37.8	30.7	6.6	7.5	24.3	31.1	37.7	30.7	20.8	15.2	24.2	11.8	18.9	11.4	13.6	14.9	12.5	14.2	13.8	13.3	13.0	30.0	13.4	18.9	27.6	16.5	9.2	55.7	55.5	22.2	42.4	51.5	39.3	62.9	26.1	38.3	43.7	169.7	163.3	57.7	133.6	189.3	172.7	357.9	96.8	192.7	126.3	99.5	94.2	100.8	38.1	183.2	92.5	169.2	111.4	46.7	153.7	110.6	139.0	208.1	87.9	41.0	117.4	143.0	127.0	87.2	110.1	28.3	54.7	125.3	96.2	194.8	188.9	82.6	173.1	143.2	123.1	50.5	125.5	84.1	199.1	513.7	177.6	206.9	277.6	86.3	159.0	207.4
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215560-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 35.8"	"Group enriched"	"Detected in some"	11	"Sertoli cells: 12.9;Spermatocytes: 16.1;Spermatogonia: 45.1"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 26.1;K-562: 18.8;Karpas-707: 22.8;U-2 OS: 27.2;U-266/70: 44.8;U-266/84: 46.8"									"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol		NA	Yes			Cytosol		"HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	27.2	0.0	0.0	44.8	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	16.1	45.1	0.0	0.0	0.0	0.0	0.0
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333832-32336379	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.5"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 1596.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 54.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 54.9"	"Cell line enhanced"	"Detected in many"		"AF22: 108.3;NTERA-2: 104.4"	"Low region specificity"	"Detected in all"							"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	Yes		120000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: AB_2673514"	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	9.9	12.7	59.9	22.1	45.4	10.9	27.7	22.0	58.0	22.3	27.5	126.3	5.3	15.9	25.8	42.3	3.6	15.9	24.9	10.7	64.2	47.2	6.4	9.7	9.0	41.5	83.6	35.4	74.1	4.8	1.3	4.9	11.0	56.6	22.5	30.7	5.2	19.9	14.2	2.0	5.3	13.9	11.3	166.5	12.5	34.8	30.3	52.3	41.4	29.0	2.2	49.2	17.0	5.5	6.4	2.2	54.9	6.7	0.2	3.9	1.2	8.4	7.6	108.3	44.2	2.4	0.9	19.2	3.5	2.2	10.6	7.0	18.0	6.2	19.0	13.3	2.4	0.0	4.5	34.9	0.4	7.8	0.4	25.8	1.0	2.9	39.7	7.5	4.9	0.1	12.4	1.4	7.9	0.2	16.5	30.9	32.8	29.1	0.2	14.2	20.0	61.7	20.9	104.4	27.4	17.6	77.1	11.6	9.0	15.9	16.8	67.2	63.9	18.6	20.6	58.5	46.0	14.3	8.8	9.1	4.5	26.3	0.4	6.7	2.9	0.2	49.9	0.5	7.5	23.7	0.7	1.0	54.9	0.9	5.4	0.3	4.6	1.9	1.2	1.5	6.4	3.9	1.6	4.4	0.2	6.7	2.2	1.0	1.2	59.9	45.4	22.0	54.9	64.2	47.2	83.6	35.4	56.6	52.3	0.0	2.2	147.6	95.4	83.2	17.7	7.3	163.1	2.7	4.5	57.6	5.9	9.9	69.6	353.9	21.7	181.6	54.0	0.0	269.1	98.8	68.7	341.5	23.0	3.8	20.1	9.5	716.9	486.2	57.0	35.8	567.8	77.4	285.1	1596.0	443.0	406.9	517.8	228.0	602.9	1.2	12.4	129.4	72.9	6.2	129.4	72.6	11.2	47.2	387.2	506.2
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.9	9.6	18.4	6.8	2.8	4.2	10.9	17.9	7.5	29.7	36.6	11.6	12.0	9.6	6.8	7.5	14.4	11.6	11.7	7.1	21.1	8.1	11.3	11.3	6.7	6.7	1.6	4.3	8.5	2.5	3.2	17.9	3.5	3.9	6.4	7.8	8.6	21.6	18.0	7.9	14.0	4.7	13.7	6.7	3.9	9.0	30.7	7.9	7.3	4.5	8.2	11.8	11.3	7.6	7.9	12.7	7.6	9.1	5.5	7.4	15.6	18.9	15.7	2.6	4.2	14.1	8.1	13.1	6.1	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3	6.0	8.5	7.2	4.0	9.7	1.9	1.6	0.0	4.0	9.1	1.8	0.0	3.3	0.0	3.2	1.7	3.6	3.0	0.0	2.2	20.7	5.8	3.3	12.7	1.7	5.1	3.2	4.1	2.5	12.0	1.5	2.8	5.6	0.0	1.8	3.4	1.5	3.6	1.9	2.5	1.4	0.9	0.0	5.9	11.2	16.4	8.7	5.1	8.7	3.5	5.9
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.7	15.5	18.4	13.9	0.6	1.1	8.0	14.4	2.2	16.2	16.9	15.1	9.8	20.7	6.5	3.6	6.0	16.1	25.8	8.5	15.0	10.8	12.3	25.8	6.9	10.0	0.0	13.2	11.7	0.2	0.3	16.4	1.5	1.3	5.2	16.8	30.4	14.2	8.8	12.3	31.3	5.7	10.9	13.2	3.8	24.8	16.3	12.8	3.7	5.0	3.7	14.0	11.6	8.3	2.2	10.0	10.4	9.1	3.2	10.3	19.4	15.5	15.5	4.4	17.1	27.2	6.6	14.6	8.0	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3	0.0	0.0	1.5	0.2	1.4	0.0	1.2	0.0	0.0	1.2	0.0	0.0	4.1	0.0	0.4	1.1	0.1	0.0	23.3	0.2	17.2	1.0	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	1.9	5.9	14.0	0.4	2.9	1.0	1.8	0.0
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		8600	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	25.1	21.4	23.5	20.5	1.4	3.0	23.0	13.2	8.5	26.6	29.0	35.5	16.7	27.1	12.9	6.5	22.8	20.3	41.9	15.2	16.6	22.4	26.2	44.9	28.7	25.8	0.9	41.9	19.6	1.6	1.7	18.0	2.7	3.2	8.3	29.6	22.3	24.9	9.8	33.3	38.8	30.7	34.4	21.6	18.9	43.6	33.7	38.8	5.5	19.5	29.3	22.2	33.9	10.1	3.5	9.9	21.7	32.9	4.2	20.7	17.7	25.5	17.8	25.8	29.2	67.4	14.3	31.7	7.9	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9	3.0	1.3	6.7	1.7	4.0	2.2	7.6	0.0	10.7	5.7	0.0	0.0	45.7	0.0	4.1	0.7	1.7	1.0	0.0	1.6	22.4	3.3	0.7	1.1	1.7	15.2	0.0	3.5	1.3	1.6	0.7	1.7	1.6	1.7	15.4	5.1	1.5	1.7	0.0	1.4	0.5	1.7	0.0	2.8	6.2	27.1	2.6	28.0	3.2	12.0	0.6
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264009-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 82.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		29000	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	17.3	10.9	8.5	29.7	10.5	22.3	15.3	10.7	9.7	15.9	17.2	9.5	20.2	9.0	21.2	13.0	21.7	15.5	15.8	15.4	7.4	6.6	16.1	12.6	13.7	30.1	8.9	5.8	20.0	13.8	16.0	7.4	24.7	10.0	15.9	19.2	12.7	12.6	23.4	12.1	15.0	17.8	17.7	9.5	23.2	15.3	16.1	10.5	82.5	12.9	20.1	35.7	19.1	15.3	21.1	12.9	11.4	13.3	22.2	29.4	18.6	30.2	20.1	35.1	33.0	7.6	6.8	23.0	22.5	17.3	38.4	39.4	41.1	16.5	33.0	22.6	13.1	25.1	24.1	46.2	27.5	38.8	37.1	43.7	62.4	40.4	57.9	2.0	61.2	25.6	4.1	6.4	28.2	7.9	9.4	19.5	40.0	50.7	76.2	19.7	19.9	61.6	47.3	29.1	60.3	14.2	54.7	53.7	44.1	17.0	32.2	35.6	27.3	23.6	13.6	20.4	51.4	26.8	43.4	10.0	26.2	28.2	27.1	33.5	22.6	25.8	58.8	22.5	53.1	30.7	11.1	8.0	11.4	22.9	13.3	19.7	21.1	23.3	23.0	12.9	19.2	22.6	24.0	1.1	22.2	7.4	8.3	29.4	18.6	8.5	10.5	10.7	9.7	7.4	6.6	8.9	5.8	10.0	10.5	20.8	10.5	30.5	14.0	17.1	13.8	13.9	12.7	22.7	20.5	21.0	3.9	85.3	11.6	21.3	0.6	24.8	4.9	23.3	17.7	53.2	16.0	7.5	36.9	9.3	30.8	0.0	7.0	14.7	8.9	2.3	25.0	13.8	6.8	10.8	16.7	19.0	13.0	10.5	19.8	6.5	11.2	6.5	24.7	21.7	59.4	8.8	22.9	27.7	31.0	11.2
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 117.9;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.5	21.5	39.9	14.6	3.9	6.9	17.6	26.4	17.3	33.3	37.7	22.8	31.5	37.5	14.8	13.1	25.0	25.5	50.3	21.4	37.6	11.8	33.2	64.3	25.8	25.3	1.1	34.3	14.1	4.1	4.3	26.5	9.5	5.1	11.7	25.3	35.4	31.2	22.9	21.4	75.8	25.0	43.3	41.1	9.3	48.2	31.3	24.4	12.0	31.0	38.4	18.4	53.4	22.3	7.9	23.8	26.6	18.1	7.8	25.4	24.7	28.5	24.2	10.3	24.6	76.5	20.4	31.9	22.7	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1	0.0	4.6	3.0	9.5	19.3	11.6	22.4	0.0	17.4	10.3	5.2	9.8	26.7	3.3	6.0	117.9	5.2	5.0	46.7	5.2	33.9	7.4	4.3	1.1	3.4	10.4	15.9	6.4	1.3	3.5	57.7	4.9	9.9	3.3	2.8	9.6	6.5	4.1	3.5	2.8	2.2	15.3	0.0	8.0	45.2	31.3	16.7	24.9	3.8	20.2	8.2
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 115.2;monocytes: 225.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	39.3	28.6	22.6	23.0	2.2	4.5	19.9	26.3	14.0	39.4	37.5	19.0	19.7	26.1	15.3	13.4	16.3	19.7	22.6	20.9	12.6	21.0	41.5	37.2	28.7	38.0	0.8	76.8	33.7	2.4	1.9	23.5	6.4	3.6	17.4	23.9	23.0	39.0	14.9	32.5	62.5	25.6	30.1	26.9	17.0	70.8	32.1	32.8	7.7	22.9	17.5	18.6	36.2	14.5	8.1	12.4	15.2	29.4	10.3	39.8	30.2	24.7	27.1	21.7	26.8	49.1	25.8	29.1	30.3	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8	6.0	8.2	53.6	8.0	9.4	1.5	3.4	12.7	5.3	4.5	7.0	0.0	115.2	5.0	14.8	1.9	7.5	3.8	70.0	11.1	61.5	6.2	3.3	15.0	5.1	47.1	1.6	3.4	13.5	21.1	3.6	10.0	25.5	6.8	225.4	9.2	4.5	9.4	7.0	5.6	3.7	3.2	19.4	6.4	11.2	52.2	5.5	68.8	20.8	32.2	4.7
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876426	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 66.3"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	11.3	6.3	7.2	17.7	8.4	23.1	9.5	12.3	9.4	9.1	11.9	5.1	2.9	8.7	10.4	8.8	12.6	8.7	7.6	6.0	5.0	5.5	6.8	7.0	8.5	23.9	4.9	8.0	10.9	4.3	6.2	3.4	10.9	5.9	8.6	12.2	6.2	6.9	6.7	8.2	8.9	16.7	10.4	7.2	14.1	8.0	13.2	3.7	66.3	5.1	11.4	27.5	10.8	9.8	5.5	9.4	5.3	4.0	7.0	13.9	5.6	23.3	14.3	31.3	19.9	6.7	8.8	12.3	17.0	12.9	19.8	22.1	29.3	17.9	40.8	12.5	12.3	8.7	13.9	31.6	15.5	21.2	20.9	21.8	40.5	21.3	9.2	3.1	48.5	18.1	5.2	2.0	14.4	4.4	4.0	13.4	32.2	28.9	34.5	14.5	23.8	59.2	35.7	28.2	20.6	14.4	29.4	37.5	37.3	9.9	20.6	19.7	16.8	22.4	10.7	10.7	23.4	12.3	30.6	6.6	13.8	11.5	14.8	12.8	20.7	33.7	53.7	19.3	37.2	16.4	5.3	1.4	0.9	7.6	4.0	7.1	5.5	10.5	9.2	4.6	3.2	9.6	11.8	0.8	7.0	3.6	9.4	13.9	5.6	7.2	8.4	12.3	9.4	5.0	5.5	4.9	8.0	5.9	3.7	0.0	2.4	2.2	3.8	6.0	2.2	3.2	2.5	4.0	6.8	3.5	0.0	26.1	0.0	4.4	2.1	7.1	1.3	46.7	5.8	20.9	11.3	1.5	9.2	3.0	20.4	3.2	2.4	9.8	4.0	1.6	8.6	5.8	5.0	3.6	9.2	2.3	2.8	3.5	15.9	1.0	0.5	0.0	4.2	15.6	41.4	3.6	8.9	17.5	9.7	1.0
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	8.6	5.2	17.5	13.6	21.7	37.3	11.2	20.0	20.6	8.2	14.2	19.2	15.0	10.4	16.0	6.3	10.7	8.6	9.9	5.1	18.1	12.4	5.5	8.5	7.4	22.4	23.7	9.5	12.6	13.1	7.5	10.3	10.7	15.5	10.0	15.7	7.2	9.2	9.2	11.5	10.1	10.3	11.7	23.5	10.7	7.8	14.9	22.3	7.5	9.4	4.1	28.2	10.3	10.0	7.3	5.7	1.9	5.7	7.6	9.0	6.0	24.9	28.8	31.8	24.0	3.1	4.1	16.3	15.2	18.4	42.5	45.3	22.0	26.4	42.3	14.5	10.8	27.1	19.8	46.7	22.1	35.9	21.6	39.9	26.9	16.2	15.2	1.7	45.7	17.5	2.8	4.2	31.1	18.7	5.4	16.1	24.4	51.5	34.7	21.5	53.3	77.6	18.7	27.9	23.2	20.9	41.8	46.7	51.6	8.2	15.1	20.8	31.7	24.0	22.3	7.5	18.6	10.2	19.2	6.8	16.0	29.1	31.4	30.1	14.5	24.8	76.1	11.1	36.7	28.6	1.8	2.5	1.9	8.1	4.1	6.2	5.3	5.7	7.9	5.5	7.3	5.9	5.7	1.6	7.6	5.7	5.7	9.0	6.0	17.5	21.7	20.0	20.6	18.1	12.4	23.7	9.5	15.5	22.3	8.9	17.0	23.7	20.7	41.4	8.7	7.9	15.3	24.1	9.1	3.5	13.7	90.8	8.3	17.6	40.0	14.5	15.8	70.0	22.4	78.1	17.3	11.3	24.2	10.4	34.4	6.4	16.7	8.0	10.8	22.7	19.5	16.5	18.6	17.2	34.7	10.1	16.0	20.1	14.5	9.1	11.9	12.9	22.7	83.2	67.3	30.9	60.2	28.7	60.9	12.3
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47402969-47663146	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	7.3	9.8	14.2	12.2	25.5	11.4	14.1	22.6	18.1	9.4	11.6	7.6	5.6	6.5	10.5	13.3	10.8	11.1	4.9	8.4	13.0	14.0	7.3	5.5	7.1	19.7	12.5	17.0	7.9	8.4	15.3	9.1	9.9	18.5	7.9	13.8	12.3	9.4	7.3	6.7	10.3	8.0	7.8	13.8	9.4	6.7	13.4	13.5	37.0	13.9	6.6	21.4	8.5	7.6	7.4	2.9	3.9	4.2	12.2	12.6	6.2	28.3	9.7	26.5	14.3	2.0	5.6	16.1	16.9	8.4	21.0	20.3	18.2	12.3	34.9	22.8	5.9	14.8	12.1	19.8	9.6	31.7	18.0	14.8	25.1	11.2	16.5	2.0	24.5	8.8	3.1	2.8	17.8	4.8	4.7	11.5	0.8	41.8	8.1	16.0	11.3	28.4	18.5	49.9	17.2	11.5	38.1	47.4	20.4	9.1	15.0	22.0	23.9	14.9	11.6	11.9	22.3	11.6	9.6	4.6	13.9	18.3	14.4	18.8	5.2	18.5	48.9	8.5	18.1	8.6	2.8	1.0	3.9	7.9	4.2	8.6	6.3	7.4	9.5	2.3	7.4	12.6	11.9	0.7	12.2	3.2	2.9	10.1	6.2	14.2	25.5	22.6	18.1	13.0	14.0	12.5	17.0	18.5	13.5	8.9	11.5	13.7	5.7	7.3	16.8	13.8	5.1	25.4	13.6	8.7	43.2	14.2	3.3	9.6	13.1	11.7	4.6	23.3	7.3	16.3	8.7	3.4	11.5	1.0	9.6	11.1	3.4	3.7	4.0	17.6	4.9	4.0	8.5	6.4	9.1	20.0	6.0	5.8	6.0	3.5	38.3	0.0	5.5	34.2	59.5	5.6	4.2	8.7	9.8	2.7
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	13.0	20.5	9.7	13.1	18.8	13.6	13.0	20.5	13.1	17.9	13.3	17.6	10.7	6.1	28.2	11.0	12.4	18.3	8.4	8.6	11.4	8.8	9.5	14.6	11.0	21.7	23.9	9.6	43.2	27.6	16.2	17.3	14.9	15.0	14.6	10.3	8.7	12.0	13.2	10.4	10.3	10.5	22.1	14.9	11.6	11.1	25.1	22.0	40.4	13.4	10.4	25.8	14.2	16.4	8.4	8.4	7.6	9.8	9.7	15.1	5.7	27.5	20.6	38.3	9.1	11.6	12.2	17.3	15.3	13.5	15.9	16.7	15.1	9.6	45.5	23.0	16.6	21.9	11.6	34.5	19.5	20.8	19.8	17.2	29.1	16.3	15.3	7.1	29.2	10.7	9.9	6.2	16.2	10.8	14.9	9.9	1.1	25.3	16.7	15.5	19.9	31.1	13.8	33.6	18.6	9.5	73.8	50.2	20.5	9.7	17.9	21.5	23.3	21.3	10.2	9.3	35.1	12.2	10.3	6.0	18.5	22.6	14.0	19.8	15.7	21.2	76.2	15.6	18.7	11.3	7.6	5.8	4.9	8.4	9.8	10.4	8.4	9.5	8.3	8.4	8.1	15.1	7.6	3.9	9.7	9.3	4.2	9.5	5.7	9.7	18.8	20.5	13.1	11.4	8.8	23.9	9.6	15.0	22.0	26.8	18.4	9.7	20.1	22.3	26.4	6.9	0.0	28.1	31.8	7.0	33.4	24.9	3.3	12.8	25.7	15.3	2.6	0.0	8.4	16.9	17.4	11.4	17.3	8.5	11.1	14.3	4.6	12.3	5.1	11.5	23.6	12.1	3.3	7.2	7.9	27.0	8.8	3.5	21.2	5.3	29.7	6.5	17.2	40.0	40.2	15.3	8.0	13.3	9.3	10.7
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		NA	Yes		250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998"	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.5	41.3	15.7	34.2	16.9	13.8	25.5	28.5	19.6	37.0	36.7	40.1	33.4	30.5	13.5	16.9	18.6	35.7	48.4	28.3	43.3	30.3	31.9	37.8	41.4	30.4	12.5	29.0	20.6	10.7	9.2	33.0	17.9	15.3	23.0	30.9	28.1	25.1	28.0	60.2	46.7	17.0	28.7	46.2	43.8	37.3	54.6	27.6	27.8	42.5	34.0	13.2	47.6	25.9	14.3	15.3	40.3	14.7	14.1	27.9	48.4	25.7	34.1	16.8	20.6	53.8	25.6	33.5	31.6	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4	17.9	26.3	11.5	9.9	12.2	0.0	38.1	17.8	12.0	20.5	15.7	0.0	20.0	34.9	15.4	0.9	9.9	5.2	0.0	9.0	24.2	10.6	8.3	49.7	125.3	21.6	0.0	2.9	7.4	11.3	0.9	12.0	10.9	13.5	14.4	11.9	0.0	10.8	2.9	12.4	49.9	0.0	19.4	18.6	0.9	7.5	9.4	8.2	20.0	21.3	9.9
MZT1	"C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2"	ENSG00000204899	"Mitotic spindle organizing protein 1"	Q08AG7	13	72708357-72727687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.6"	"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063299, HPA066715"	Approved					NA	Yes					"HPA063299: AB_2684980, HPA066715: AB_2685709"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.65e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.28e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (9.01e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	7.5	14.1	19.8	9.7	44.6	19.9	10.6	26.9	24.1	8.3	7.6	4.4	7.3	7.2	7.6	8.5	8.9	5.4	5.4	10.3	17.3	16.6	10.1	4.6	8.6	14.1	11.3	14.8	6.8	6.1	5.3	7.2	9.3	9.2	9.5	9.1	5.3	8.0	10.7	15.5	8.4	6.4	7.0	9.1	8.1	7.9	5.3	8.2	12.1	10.9	7.8	11.2	9.2	6.2	9.6	7.5	13.8	8.6	9.0	11.5	4.8	30.7	4.9	17.6	12.9	3.6	6.1	14.4	25.0	10.4	15.8	18.4	9.3	20.3	21.4	19.2	9.9	10.0	10.0	17.5	9.3	28.9	25.5	17.9	27.7	10.5	13.9	5.1	46.3	22.7	3.3	9.5	9.5	19.9	9.6	16.0	25.0	15.2	16.8	31.2	5.5	23.4	25.9	13.4	18.8	9.4	16.7	20.1	10.5	14.1	7.7	20.7	19.0	10.6	15.7	15.1	10.1	11.8	23.0	10.8	14.0	16.0	19.7	30.2	15.5	23.8	16.8	32.9	28.4	28.6	13.8	4.7	9.9	6.2	8.3	7.7	9.6	8.4	7.7	5.8	8.5	11.1	8.8	2.4	9.0	8.6	7.5	11.5	4.8	19.8	44.6	26.9	24.1	17.3	16.6	11.3	14.8	9.2	8.2	0.0	17.5	49.1	23.0	48.9	27.5	16.1	10.2	5.3	11.4	29.6	13.7	37.4	49.7	24.7	2.4	23.0	7.8	116.8	21.2	78.8	23.9	23.9	18.4	6.6	36.9	60.4	20.8	18.4	23.5	3.1	18.4	31.4	57.3	36.1	14.4	16.2	20.9	17.5	15.6	27.5	22.1	32.3	21.7	45.4	41.0	50.2	25.3	38.3	17.5	28.1
NACA	NACA1	ENSG00000196531	"Nascent polypeptide-associated complex alpha subunit"	"E9PAV3, Q13765"	12	56712428-56731628	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Activator, Chaperone, DNA-binding"	Allergen	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA073152, HPA073648"			Approved	Cytosol		NA	Yes			Cytosol		"HPA073152: AB_2686575, HPA073648: AB_2686621"	"unprognostic (3.35e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.58e-11)"	"unprognostic (9.47e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.79e-2)"	106.9	85.3	72.2	77.6	63.0	120.7	149.8	71.7	65.5	115.5	89.1	40.5	76.7	57.3	83.3	107.7	142.6	95.2	69.2	111.5	58.9	52.7	79.8	130.1	68.5	148.3	63.7	51.3	213.8	119.9	58.1	61.3	80.8	63.7	112.3	79.7	45.9	95.5	72.9	241.6	124.5	71.2	115.1	74.1	81.9	72.3	53.2	53.8	97.8	109.0	149.1	125.1	144.8	139.1	91.8	101.6	45.4	160.0	66.3	97.4	146.6	78.5	91.5	109.0	86.1	130.5	223.6	108.3	78.8	113.8	107.4	74.8	110.2	87.3	141.4	88.3	73.9	44.3	69.2	96.5	126.6	114.5	69.2	150.1	102.6	64.1	109.6	122.4	144.6	66.2	176.7	162.8	87.2	178.1	193.1	118.5	83.8	127.1	184.9	104.9	76.4	93.4	178.8	111.2	76.1	102.2	106.3	91.9	150.0	149.2	79.8	80.9	87.4	58.5	139.6	121.0	79.5	152.0	166.3	76.7	56.8	69.7	60.3	79.1	88.6	98.6	125.9	83.3	99.2	72.2	33.2	88.1	45.4	58.5	124.6	85.6	91.8	83.4	72.5	94.4	74.6	97.4	83.9	33.2	66.3	160.0	101.6	85.9	146.6	72.2	63.0	71.7	65.5	58.9	52.7	63.7	51.3	63.7	53.8	413.9	563.5	1474.2	1870.1	1800.9	294.5	578.3	937.6	440.3	720.0	375.1	62.8	1562.4	1507.1	1062.8	561.3	1209.8	673.8	420.4	1761.3	2399.9	1079.6	1341.5	713.0	646.1	1391.2	173.2	622.3	710.2	1196.9	484.6	2231.3	1465.0	1175.9	1424.7	1175.0	458.5	1465.8	1052.1	1345.3	1857.7	337.7	789.0	1297.8	499.0	489.8	1950.7	1943.0	1208.8	1657.0	2037.8
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 344.6;Spermatogonia: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	20.7	15.2	19.3	33.4	32.0	64.0	21.2	20.1	24.0	22.8	21.9	30.2	26.4	15.9	22.3	19.8	20.1	23.0	12.5	18.1	22.4	17.3	17.5	21.0	17.6	39.0	40.2	17.8	28.3	17.4	21.9	22.9	28.5	24.2	18.9	24.7	12.6	17.8	21.8	14.3	16.1	20.5	21.3	30.3	31.7	17.5	35.8	40.2	49.1	17.7	28.2	43.0	18.5	19.6	16.9	11.8	8.1	9.7	7.3	17.5	6.9	24.6	14.6	70.1	24.8	11.8	6.2	33.0	20.0	14.9	31.1	39.1	26.9	17.9	46.5	14.1	8.6	34.2	23.9	46.7	21.3	39.9	21.2	29.6	60.1	26.3	42.1	4.1	62.7	25.3	7.2	5.2	34.3	11.9	8.1	21.2	39.2	50.5	27.5	21.0	16.8	71.4	57.5	101.9	24.6	12.4	90.3	61.5	44.7	15.4	24.9	26.9	32.6	32.9	18.8	20.3	55.3	13.5	49.1	11.4	14.4	44.2	27.6	32.5	16.9	31.8	80.7	14.7	40.1	14.3	4.9	7.3	8.1	12.3	9.7	14.2	13.5	13.9	14.0	11.5	16.9	12.3	11.8	3.1	7.3	5.7	11.8	17.5	6.9	19.3	32.0	20.1	24.0	22.4	17.3	40.2	17.8	24.2	40.2	53.6	89.6	88.0	115.5	69.4	46.4	46.2	35.7	160.6	146.7	34.9	35.3	265.5	26.6	48.1	12.2	85.7	26.9	23.3	32.6	179.3	75.1	49.2	111.0	32.6	90.0	41.3	49.2	76.1	37.0	19.1	87.8	52.1	38.8	54.1	39.4	64.0	29.7	41.2	73.6	27.1	77.6	84.1	71.5	344.6	575.6	49.8	224.3	87.3	90.3	75.0
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes		600000	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	63.3	59.3	71.9	52.7	42.5	46.2	74.0	71.7	48.7	67.7	60.0	97.9	45.6	84.2	61.8	55.3	90.9	62.2	143.9	96.3	116.1	49.2	60.3	140.5	56.3	131.9	46.6	160.1	53.3	43.8	55.9	84.5	89.0	38.9	71.0	76.8	125.1	28.9	59.5	86.2	140.1	99.4	107.1	66.9	42.6	104.6	129.7	73.9	49.7	84.2	62.3	44.4	48.0	55.1	63.3	61.3	41.4	81.1	60.3	54.3	56.2	63.4	94.2	54.8	53.8	181.3	39.5	104.5	56.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4	271.0	357.6	280.1	370.4	408.5	137.1	290.7	137.6	385.4	589.2	184.9	45.2	333.3	195.6	173.5	15.4	228.8	106.1	210.2	218.7	336.0	249.6	218.4	431.8	217.9	213.5	76.3	191.8	122.8	135.8	18.9	201.0	194.7	156.9	238.1	192.5	194.0	213.8	138.2	150.3	209.2	125.5	148.8	282.2	390.1	563.8	385.9	316.9	226.1	268.8	321.5
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889313-96897881	"Disease related genes, Predicted intracellular proteins"		Calmodulin-binding	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	7.9	10.1	16.1	5.4	19.0	2.7	9.0	20.4	27.4	8.9	9.1	5.0	5.7	6.2	7.3	6.4	7.1	6.0	6.0	30.2	18.7	17.3	17.3	18.1	4.3	5.4	18.1	12.3	10.4	7.2	7.3	6.5	6.1	28.5	9.5	9.7	4.5	7.7	12.8	25.0	6.2	6.5	7.3	9.6	7.6	6.4	5.7	8.4	4.9	9.5	11.2	5.8	8.2	5.1	6.4	4.5	0.6	4.3	3.3	10.0	4.1	1.5	4.3	7.5	10.1	7.5	4.4	4.0	4.2	4.0	6.3	4.8	5.8	2.6	14.1	7.7	3.8	6.0	3.1	17.4	6.5	6.1	9.9	13.7	15.7	2.3	5.0	8.2	16.4	6.6	4.1	10.1	5.4	5.5	3.2	4.9	10.0	14.1	9.6	9.8	4.8	10.5	8.9	14.2	7.8	7.1	5.0	4.2	7.3	10.4	4.2	12.8	6.0	2.1	7.6	11.9	7.7	2.3	11.0	4.0	3.3	2.5	11.5	6.8	2.2	3.6	13.9	4.5	12.4	4.8	0.2	2.2	0.6	5.1	4.3	6.6	6.4	6.7	6.7	3.8	6.3	10.0	8.8	0.4	3.3	2.6	4.5	6.8	4.1	16.1	19.0	20.4	27.4	18.7	17.3	18.1	12.3	28.5	8.4	8.9	16.6	43.3	52.1	96.7	15.5	108.1	25.5	17.4	27.3	22.7	0.0	40.6	142.6	37.3	2.3	31.6	17.5	23.3	23.9	34.6	34.7	26.3	19.7	43.9	47.0	25.4	37.6	25.8	18.0	4.4	24.2	27.4	52.3	15.4	38.0	14.0	21.1	10.5	23.3	99.4	12.4	25.8	69.8	36.9	55.8	84.6	27.5	27.9	48.2	38.3
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected"	"Not detected"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.7	22.2	17.0	12.2	1.0	1.7	18.8	11.9	11.2	21.0	18.1	11.8	30.3	16.4	5.7	9.2	13.3	16.5	14.8	8.9	26.5	25.0	12.3	7.8	19.4	15.9	0.1	15.4	10.7	0.5	1.1	16.1	17.4	5.1	13.5	16.7	21.4	28.8	21.0	8.6	16.8	10.4	16.1	19.9	11.4	16.6	26.1	24.9	7.3	8.8	15.4	17.1	17.2	19.2	14.9	15.2	29.6	9.2	7.0	10.5	20.8	20.6	31.9	11.9	22.0	21.7	9.1	11.9	17.4	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.8	0.5	2.6	0.7	0.4	0.0	2.7	3.4	0.0	0.0	0.9	0.0	0.1	44.4	0.1	1.1	93.5	0.2	11.4	0.2	0.3	0.0	0.0	4.7	3.2	0.0	2.5	2.8	28.5	2.3	1.1	0.0	0.0	1.2	0.8	0.0	0.8	0.7	0.0	1.9	6.5	0.0	191.1	25.4	1.5	1.1	0.7	2.3	0.9
NOL4L	"C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424"	ENSG00000197183	"Nucleolar protein 4 like"	Q96MY1	20	32443059-32585074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 78.2;Late spermatids: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2;HEL: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041768, HPA043600"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041768: AB_10964172, HPA043600: AB_10961001"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.10e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (2.63e-4)"	7.7	8.0	13.1	9.0	14.9	18.9	8.7	19.4	14.8	6.5	16.3	35.6	8.7	19.9	6.5	13.8	2.8	9.9	11.0	5.0	13.9	11.7	9.8	5.7	10.6	8.0	20.5	8.7	3.7	12.1	5.0	19.9	12.1	16.3	7.5	15.0	12.5	11.0	9.8	1.9	3.8	20.7	7.4	17.9	11.3	14.3	33.2	20.1	16.7	8.5	2.6	6.5	10.0	8.7	1.9	2.2	7.2	11.7	8.9	8.7	4.7	3.9	12.1	7.6	5.2	1.6	2.5	1.0	2.5	2.1	3.2	2.2	32.2	9.2	0.2	7.5	3.3	5.0	1.1	2.4	7.0	1.4	0.9	1.9	25.3	5.9	23.0	4.3	0.3	1.5	6.3	1.0	2.3	1.5	7.3	19.2	5.5	7.5	3.4	1.5	2.2	8.2	7.7	4.4	12.0	11.3	3.5	0.9	1.3	5.3	0.7	10.1	8.2	7.9	0.2	4.3	8.2	1.6	7.7	20.1	3.0	10.5	2.7	2.6	2.5	0.8	1.7	3.3	13.7	9.0	3.0	2.2	1.1	6.6	4.9	5.8	1.9	4.4	3.8	2.2	1.4	8.7	7.1	7.2	8.9	11.7	0.3	7.0	4.7	13.1	14.9	19.4	14.8	13.9	11.7	20.5	8.7	16.3	20.1	6.0	3.5	1.7	9.0	0.0	34.0	7.4	5.1	4.0	2.3	12.2	62.8	0.2	8.3	6.4	78.2	21.3	50.9	0.0	6.9	1.6	5.0	14.5	11.5	3.9	8.2	7.9	16.8	26.4	3.0	112.0	5.2	4.7	0.0	5.4	33.1	14.8	10.1	34.5	4.6	17.7	55.8	19.4	6.3	53.6	3.9	0.0	0.3	12.8	28.2	20.1
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615327-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	35.8	40.5	45.2	41.4	42.3	44.9	36.6	26.7	38.7	30.5	36.7	25.9	29.2	37.2	35.2	36.7	38.6	33.0	36.6	53.4	39.9	38.4	56.9	58.6	28.8	36.6	41.6	30.2	42.4	42.6	54.0	40.5	45.6	36.8	39.5	32.4	23.1	42.3	35.6	59.3	30.6	46.4	36.7	47.7	45.2	34.8	32.5	40.4	34.3	49.5	36.9	36.0	43.3	56.0	50.7	45.5	38.3	38.0	28.8	49.6	30.9	29.8	15.5	14.6	21.0	11.4	13.2	29.7	27.4	14.9	25.7	24.4	29.4	12.6	38.5	54.3	16.6	31.4	18.5	22.0	20.7	25.2	21.6	36.0	33.1	15.4	49.4	24.5	49.1	26.1	12.4	21.8	23.5	14.5	13.4	16.7	21.7	51.3	10.5	22.2	19.2	27.9	54.5	19.1	17.5	26.6	30.2	20.8	59.2	25.6	9.9	37.2	23.9	16.0	38.8	35.8	19.0	24.1	17.9	25.3	23.7	22.3	24.3	48.1	24.6	47.7	47.0	13.6	29.1	35.8	16.0	30.2	38.3	31.0	35.3	36.6	50.7	45.5	38.3	35.9	41.4	49.6	37.8	14.0	28.8	38.0	45.5	46.9	30.9	45.2	42.3	26.7	38.7	39.9	38.4	41.6	30.2	36.8	40.4	86.4	58.0	93.0	81.6	80.6	62.4	203.3	63.7	148.5	80.8	54.1	21.6	114.5	104.5	133.3	133.2	97.2	61.4	70.0	226.4	127.6	86.4	80.3	87.8	56.9	100.9	46.1	35.6	46.6	45.5	19.9	76.5	83.5	96.2	155.9	59.8	89.8	148.3	72.9	74.6	135.1	46.0	64.7	96.7	142.1	122.5	79.2	129.9	82.8	73.6	94.7
NOLC1	"KIAA0035, NOPP130, NOPP140, P130"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"		No	Yes		10000	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109"	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (7.68e-2)"	29.5	17.1	18.8	27.8	35.0	23.2	21.3	37.9	39.2	19.1	20.4	23.5	13.8	14.2	25.1	12.4	30.4	25.1	20.7	20.0	18.5	19.2	16.1	38.1	23.6	27.7	20.2	21.4	28.0	25.5	33.9	34.3	25.4	28.0	20.7	27.0	14.8	21.0	18.0	46.6	20.3	17.3	23.4	20.2	26.2	21.0	13.8	19.9	32.9	26.1	19.8	35.1	24.3	20.9	12.7	11.6	7.8	11.2	11.8	19.3	11.2	32.7	30.2	17.1	36.0	14.2	11.3	29.1	18.7	15.0	26.4	22.6	51.9	23.0	68.6	20.9	11.9	13.2	38.1	49.2	40.9	28.3	21.5	32.2	45.9	25.1	30.2	19.1	66.5	21.5	14.5	26.8	28.0	58.7	15.1	16.1	32.9	48.1	30.4	15.8	28.8	62.1	14.0	32.7	22.8	23.7	46.6	46.9	38.2	15.3	21.1	25.6	24.1	18.1	20.8	22.9	16.3	36.1	14.4	13.8	11.9	16.5	13.9	42.0	28.5	42.1	77.3	19.2	68.5	10.2	1.4	8.4	7.8	15.5	10.3	19.3	12.7	12.4	14.5	11.6	10.0	14.5	17.1	0.9	11.8	11.2	9.0	8.8	11.2	18.8	35.0	37.9	39.2	18.5	19.2	20.2	21.4	28.0	19.9	56.6	59.5	35.0	80.3	107.0	19.9	27.3	7.6	83.0	97.8	15.7	13.7	42.4	21.6	30.1	23.7	36.5	9.7	23.3	20.0	49.5	43.1	49.9	41.7	18.7	24.1	9.5	26.5	17.2	13.2	7.7	21.3	28.5	25.3	20.8	27.7	13.7	35.8	20.1	19.8	13.4	17.1	6.5	49.5	23.2	47.2	102.8	40.6	26.6	35.2	75.0
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265716-202303666	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	25.1	26.5	16.7	41.6	24.6	47.1	32.2	30.2	24.2	28.8	21.6	13.7	19.5	20.3	31.0	25.9	31.9	26.4	17.7	21.7	21.4	20.3	23.4	36.2	21.7	40.4	16.9	19.1	32.9	31.5	22.3	47.8	24.0	21.9	26.7	27.0	17.1	25.5	29.5	36.9	22.7	25.2	24.1	19.3	33.0	23.5	17.5	17.8	40.0	24.6	32.8	41.4	31.1	41.3	23.5	22.2	4.3	15.2	21.2	26.7	13.5	26.9	19.2	19.0	23.6	14.2	12.8	45.0	26.0	14.0	20.1	18.8	42.3	24.4	41.8	21.7	15.7	25.1	25.1	37.6	32.0	35.5	16.3	34.5	50.4	28.8	41.6	21.1	49.8	24.3	16.5	19.1	28.0	64.3	10.9	18.0	24.9	55.0	31.9	25.1	28.7	45.4	55.1	47.4	30.1	33.3	38.4	28.7	55.1	23.7	32.7	29.3	21.7	24.1	34.7	29.9	31.8	23.7	39.4	15.5	25.7	30.2	22.9	44.4	26.0	47.4	59.8	19.0	35.5	30.5	4.3	10.2	3.1	16.8	15.2	24.5	23.5	24.0	22.7	15.9	18.7	26.4	26.7	1.0	21.2	10.9	22.2	23.7	13.5	16.7	24.6	30.2	24.2	21.4	20.3	16.9	19.1	21.9	17.8	101.3	103.5	73.0	102.7	76.2	27.1	68.8	38.2	96.4	150.2	38.4	39.3	67.7	24.9	45.7	11.5	57.0	15.0	23.3	58.3	76.0	49.7	70.7	131.9	44.1	43.1	23.8	33.8	29.4	17.4	7.9	40.0	46.4	23.6	73.1	32.3	17.7	45.7	10.5	28.0	32.1	43.5	25.8	81.9	59.1	54.7	65.4	56.9	61.8	56.1	83.8
NR1D1	"ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092787-40100725	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 57.4;Bipolar cells: 62.8;Suprabasal keratinocytes: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 16.3"	"Group enriched"	"Detected in many"	6	"monocytes: 4.2;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"		NA	Yes			"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	19.4	15.1	12.2	7.6	14.7	6.0	30.5	30.7	32.5	45.9	13.9	6.4	17.3	15.2	16.5	6.1	16.8	10.7	8.2	43.7	8.8	5.2	9.8	14.8	12.7	8.8	4.7	11.7	33.3	8.3	4.8	10.9	7.3	6.1	15.5	5.5	28.0	53.0	18.6	51.2	79.3	8.8	27.3	6.0	7.8	7.9	7.3	6.8	1.8	13.9	11.7	10.6	28.0	25.4	1.8	1.1	0.1	4.2	0.8	16.3	1.5	2.8	4.2	0.9	3.4	5.0	3.4	1.2	6.4	10.5	2.1	2.7	2.7	10.5	3.5	3.9	7.3	7.1	8.3	2.2	9.6	1.6	3.0	2.3	2.5	4.2	7.1	8.1	3.8	3.8	7.5	7.0	7.2	15.5	7.0	2.6	4.2	3.7	32.9	2.0	2.0	5.6	3.3	1.6	5.8	6.7	4.0	1.3	10.8	2.9	2.6	2.8	1.6	4.0	5.3	6.5	1.6	2.5	3.2	2.6	9.5	9.4	7.7	5.0	11.9	18.1	1.4	12.9	2.2	7.3	0.0	0.4	0.0	3.9	1.6	16.3	1.5	4.9	5.7	0.9	1.8	4.5	3.2	0.1	0.8	4.2	1.1	6.5	1.5	12.2	14.7	30.7	32.5	8.8	5.2	4.7	11.7	6.1	6.8	3.0	1.3	2.4	32.1	57.4	62.8	5.2	5.1	0.0	6.8	1.8	3.9	2.2	6.6	11.9	1.6	10.5	24.4	0.0	10.1	1.0	6.6	19.6	2.3	25.4	2.2	39.7	7.9	4.3	1.8	0.4	20.1	4.6	18.6	0.0	4.3	27.8	19.9	6.6	36.4	6.9	29.2	6.5	18.6	0.5	7.5	70.9	1.9	6.1	3.6	21.3
NR2F6	"EAR-2, ERBAL2"	ENSG00000160113	"Nuclear receptor subfamily 2 group F member 6"	P10588	19	17231883-17245940	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 123.8;Hepatocytes: 131.0;Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 59.1;EFO-21: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079917			Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Nuclear speckles"	Cytosol	"CAB079917: AB_2635238"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.62e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.37e-3)"	10.0	8.0	5.4	9.3	5.6	1.1	15.2	6.9	7.4	9.0	23.4	4.7	10.9	26.0	7.9	26.3	16.8	7.7	11.3	14.8	4.6	5.9	17.7	49.3	10.0	2.8	4.8	4.7	9.8	23.5	7.0	8.6	26.5	4.0	10.5	8.2	8.0	13.4	10.3	20.2	9.4	36.2	6.6	2.4	5.0	26.8	9.7	4.5	1.7	13.8	9.3	6.7	10.7	11.5	2.7	1.8	1.6	1.1	7.4	6.5	1.3	19.4	11.7	6.4	11.6	2.5	2.8	59.1	11.0	4.0	4.8	4.1	7.9	17.2	4.6	34.6	4.9	2.8	9.7	4.8	6.3	2.1	6.1	28.0	4.2	7.5	14.2	5.6	2.0	5.9	3.7	7.3	2.2	3.6	5.0	2.9	2.1	9.9	1.1	2.0	10.4	1.7	7.4	17.6	14.6	18.2	3.5	4.0	3.9	6.6	12.7	5.1	14.8	6.1	21.5	12.4	6.5	11.9	6.4	4.8	3.4	8.3	6.5	8.7	6.6	2.3	3.3	4.2	3.0	4.1	0.0	1.1	1.6	2.7	0.0	2.4	0.5	3.9	2.5	1.8	2.7	6.5	2.2	0.2	7.4	0.1	0.8	3.5	1.3	5.4	5.6	6.9	7.4	4.6	5.9	4.8	4.7	4.0	4.5	8.9	18.5	4.7	14.9	9.4	63.1	33.0	33.1	10.7	11.4	24.4	72.6	54.8	24.9	20.6	7.8	12.6	123.8	0.0	41.6	54.2	11.1	17.2	1.1	131.0	13.7	143.0	44.1	17.8	2.9	4.1	16.4	3.3	10.1	1.8	71.7	40.3	40.0	73.0	17.7	29.4	53.0	6.5	15.5	1.0	7.7	9.3	66.7	2.9	56.2	14.1
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 1.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	10.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309268-41332621	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.7;testis: 41.7"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 19.9;Spermatocytes: 82.8;Spermatogonia: 66.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"		NA	Yes			"Nuclear speckles"	Vesicles	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	1.3	2.1	0.5	3.8	0.8	7.5	0.7	1.5	1.1	1.1	3.4	0.7	2.3	3.0	0.6	0.6	4.6	0.6	1.3	1.9	0.9	0.4	1.1	1.1	1.0	4.3	0.6	0.4	1.2	0.6	0.0	0.3	1.6	0.5	0.5	3.1	0.2	1.2	1.3	8.3	2.5	3.1	0.6	0.8	2.7	1.4	41.7	0.7	16.7	0.5	6.3	4.0	0.7	1.5	2.5	7.7	1.1	1.3	1.9	5.9	1.7	13.3	7.1	14.1	10.3	0.7	0.9	13.4	8.3	3.8	9.9	10.7	12.7	6.6	8.0	7.3	3.0	15.6	20.9	14.3	6.4	7.9	17.2	16.5	16.9	20.8	13.1	0.1	18.4	9.5	0.3	1.3	5.6	5.9	2.1	8.4	16.8	23.1	15.4	6.6	6.4	10.8	13.7	12.8	19.9	15.5	13.3	11.8	12.0	4.4	6.2	22.4	7.5	13.7	14.0	3.8	5.9	13.9	10.5	4.1	10.2	15.8	10.2	14.7	7.4	32.4	28.3	3.0	22.5	14.7	0.0	0.8	1.1	0.6	1.3	1.5	2.1	1.8	1.6	1.4	2.5	2.6	1.7	0.0	1.9	0.8	7.7	5.9	1.7	0.5	0.8	1.5	1.1	0.9	0.4	0.6	0.4	0.5	0.7	0.0	0.3	0.0	0.6	3.7	0.0	0.2	0.0	0.0	2.3	0.0	0.0	7.1	0.0	0.5	5.5	0.1	0.9	0.0	0.3	19.9	1.5	0.3	1.1	0.8	6.5	0.0	0.0	0.0	0.6	9.2	0.9	1.6	0.0	1.0	1.7	0.6	0.1	0.0	1.1	0.2	0.2	6.5	0.9	82.8	66.8	2.0	3.2	0.7	3.0	0.1
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404459	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.9;lymphoid tissue: 29.1"	"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 4.6;Extravillous trophoblasts: 8.3;Spermatogonia: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.9	1.2	0.2	9.9	0.4	22.9	0.8	1.4	1.1	1.1	3.4	0.4	0.1	1.4	0.6	1.5	5.3	0.5	0.8	0.9	0.3	0.4	1.0	1.1	1.4	5.7	0.3	0.4	1.0	0.7	0.2	0.9	1.6	0.9	0.8	3.8	0.5	1.4	0.8	0.9	2.0	3.0	0.7	0.4	4.2	1.2	8.7	0.5	29.1	0.5	8.0	11.3	1.0	1.7	1.0	1.3	0.7	0.4	7.5	2.3	0.7	7.4	8.2	13.3	8.7	0.3	1.1	12.8	5.3	4.9	15.8	16.4	10.1	4.2	17.2	4.7	3.3	7.2	10.3	19.5	6.7	13.8	7.3	11.2	20.6	12.2	10.0	0.0	27.6	11.8	0.6	0.3	15.4	1.7	1.1	4.6	10.9	23.9	8.4	5.1	5.5	21.6	13.1	29.4	4.5	11.8	23.3	20.7	16.8	2.7	9.8	7.5	6.3	12.3	7.5	4.2	13.0	4.1	11.1	2.1	6.4	9.3	10.0	13.2	4.4	11.7	21.3	6.3	20.6	7.8	0.1	0.2	0.0	0.5	0.3	0.6	0.4	0.8	0.8	1.3	1.0	0.3	0.7	0.7	7.5	0.4	0.1	2.3	0.7	0.2	0.4	1.4	1.1	0.3	0.4	0.3	0.4	0.9	0.5	0.0	0.0	0.8	0.2	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.2	4.6	0.1	0.0	0.0	0.2	8.3	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.8	0.6	0.2	0.0	0.0	0.7	0.2	0.1	0.0	0.4	3.3	0.9	0.0	0.1	3.2	7.3	1.0	1.5	0.5	1.9	0.1
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 45.4;MCF7: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.9	45.4	6.8	10.3	2.1	2.3	20.5	8.6	3.5	5.8	5.9	29.7	15.3	4.1	13.1	5.4	7.6	6.6	3.7	6.8	2.2	10.9	10.4	4.8	8.3	14.4	3.4	4.9	7.1	2.7	3.0	5.4	3.9	3.8	7.5	6.3	9.7	3.2	3.4	50.0	5.2	5.4	12.3	15.9	10.9	5.3	5.3	3.1	5.6	19.8	21.7	15.0	8.7	39.0	9.7	3.7	17.3	8.2	12.5	9.9	17.0	11.3	15.3	3.7	3.5	3.4	12.1	2.9	11.8	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5	0.0	1.0	0.5	15.0	12.8	14.8	1.2	20.4	6.7	0.0	17.4	23.6	35.6	26.6	18.7	2.7	15.8	35.5	0.0	17.2	46.7	10.8	17.8	5.7	10.5	8.3	20.6	43.0	12.3	5.6	4.9	10.9	2.5	6.8	14.4	30.6	14.1	16.5	40.3	9.9	10.6	13.1	0.0	7.2	5.7	17.7	16.4	54.7	8.7	29.9	20.6
PAQR4	FLJ30002	ENSG00000162073	"Progestin and adipoQ receptor family member 4"	Q8N4S7	16	2969245-2973489	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4;parathyroid gland: 32.8"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"non-classical monocyte: 6.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068394			Approved	Vesicles		NA	Yes			Vesicles		"HPA068394: AB_2685980"	"unprognostic (1.93e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.62e-2)"	"unprognostic (7.59e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.01e-6)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.06e-3)"	3.1	3.2	14.1	5.2	19.2	10.3	2.3	8.0	26.3	2.4	4.8	49.6	1.3	4.9	1.8	1.0	4.2	3.0	5.5	4.2	24.1	11.7	1.7	1.6	3.9	6.3	30.6	11.1	0.4	6.6	32.8	0.9	2.2	19.1	9.6	4.5	16.8	17.0	1.3	12.3	12.3	4.9	2.8	54.4	3.2	7.4	1.6	20.3	3.6	1.5	3.5	7.8	2.1	1.7	0.5	0.9	0.1	6.7	0.0	0.4	0.5	12.9	11.0	12.5	18.0	2.0	3.7	4.2	4.9	5.9	9.1	8.6	6.6	13.8	12.9	6.7	5.6	6.4	18.2	12.9	7.7	3.8	13.7	5.6	3.9	21.6	8.9	0.2	8.4	14.4	0.9	4.1	4.9	1.3	4.6	5.9	11.0	7.7	35.1	7.7	25.9	12.1	9.0	10.5	19.4	7.5	24.1	16.4	41.6	6.2	4.5	28.6	13.3	18.2	17.6	13.2	1.7	18.9	13.1	3.6	16.0	9.8	7.3	6.9	15.3	10.6	17.2	7.0	11.4	17.5	0.0	1.0	0.1	0.4	0.5	0.0	0.5	0.2	0.1	0.9	0.1	0.0	0.3	0.1	0.0	6.7	0.5	0.1	0.5	14.1	19.2	8.0	21.2	24.1	11.7	30.6	11.1	19.1	20.3	0.0	0.0	2.9	1.4	2.7	14.6	0.8	12.7	10.7	6.8	0.0	55.0	0.7	0.0	4.4	0.5	1.0	2.0	0.0	9.9	7.2	0.8	7.5	2.3	0.0	11.5	6.4	4.1	3.7	9.5	3.0	0.6	4.5	5.0	1.0	5.3	15.7	6.5	2.9	0.0	0.3	145.7	0.0	1.2	1.6	5.2	4.4	0.5	0.0	9.3	0.8
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 115.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes			Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	13.9	21.4	11.1	31.8	15.8	87.2	13.7	17.2	14.6	13.7	23.1	15.6	13.7	18.9	15.7	13.7	36.0	12.7	17.5	13.6	11.6	9.8	21.7	14.9	17.8	41.6	18.8	10.8	14.4	14.3	14.0	13.9	24.0	14.3	10.8	26.1	18.7	17.7	15.6	11.0	16.5	20.5	12.8	16.1	24.5	15.7	40.5	17.4	115.8	18.1	40.7	38.7	17.3	17.2	16.9	16.0	8.7	11.6	19.6	24.4	16.9	74.2	58.5	59.3	25.5	14.1	13.2	41.6	48.9	28.8	46.1	65.6	45.6	59.4	75.5	15.9	17.4	40.4	55.8	35.0	58.9	42.3	22.4	38.7	53.0	22.5	106.2	6.0	72.5	23.8	9.6	14.0	39.2	9.3	9.7	26.3	50.4	47.2	63.8	44.9	26.8	138.7	80.3	44.4	58.0	32.4	76.6	52.2	60.9	20.8	43.4	51.0	34.6	34.3	53.0	33.6	22.8	37.4	37.0	17.5	33.3	38.3	46.8	55.8	32.4	92.5	127.9	15.0	69.1	42.6	2.4	11.6	8.7	19.2	10.9	23.8	16.9	24.4	19.3	16.0	13.6	22.4	20.1	3.8	19.6	11.4	14.7	23.3	16.9	11.1	15.8	17.2	14.6	11.6	9.8	18.8	10.8	14.3	17.4	41.7	27.0	42.4	43.7	60.1	36.0	11.2	17.8	34.8	43.3	55.8	25.5	92.8	51.4	37.7	137.5	25.2	25.5	46.7	34.8	161.2	34.6	21.0	20.9	24.7	83.0	30.2	19.1	35.6	27.3	83.6	33.4	41.7	35.4	67.7	35.2	57.6	24.8	21.0	37.8	36.6	74.2	51.8	33.9	133.4	89.3	43.4	55.5	43.6	63.4	25.0
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	24.4	28.1	26.0	26.1	30.1	28.2	29.6	19.0	31.8	19.7	21.9	27.2	18.1	20.4	28.0	21.3	31.2	28.0	22.7	18.1	26.3	18.5	24.2	34.9	19.8	30.0	27.2	26.6	30.5	49.0	31.3	17.0	20.2	23.6	24.2	19.2	18.6	22.2	22.1	34.1	32.3	19.8	22.9	24.3	26.4	25.2	34.5	27.2	21.2	25.3	23.1	24.9	21.8	22.6	14.4	17.8	3.9	19.4	12.4	16.2	16.3	34.3	39.2	14.5	30.8	16.7	16.4	22.3	22.9	18.8	39.1	30.5	45.4	14.8	46.6	20.5	26.0	30.2	24.0	44.5	40.8	28.8	19.9	42.8	22.6	22.5	39.1	41.7	54.5	23.8	23.1	25.7	40.6	40.9	18.7	25.1	16.7	37.2	19.0	23.6	43.3	26.4	55.3	28.1	33.8	28.8	33.8	25.3	45.6	21.4	23.8	25.1	26.0	22.6	25.8	30.3	12.1	18.1	28.0	19.8	45.9	34.8	23.3	38.2	24.2	20.7	47.6	32.2	25.1	29.3	3.9	15.8	3.9	13.3	19.4	16.2	14.4	12.4	12.7	17.8	13.8	14.2	12.7	0.6	12.4	13.9	15.4	9.5	16.3	26.0	30.1	19.0	31.8	26.3	18.5	27.2	26.6	23.6	27.2	3.0	17.6	13.7	18.1	20.0	6.4	3.4	25.5	26.8	19.4	24.4	7.9	30.6	21.6	36.3	38.4	21.1	24.6	0.0	38.0	33.3	14.9	13.1	17.4	20.7	33.9	3.2	22.5	28.8	29.7	10.4	18.4	20.8	20.3	31.5	19.9	13.1	33.1	14.0	19.1	39.6	8.1	19.4	18.4	23.5	19.3	19.9	23.8	15.0	24.7	12.2
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 54.5;U-266/70: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	2.1	2.3	4.4	4.8	1.8	1.6	3.3	1.7	1.4	1.0	0.8	2.0	6.1	0.0	2.2	2.0	2.1	1.3	0.3	0.7	0.1	5.2	1.6	1.0	1.5	2.6	2.2	0.1	9.4	5.9	0.6	0.3	0.3	3.7	3.3	54.5	4.0	6.5	0.5	3.1	8.9	4.7	3.4	0.7	0.3	8.5	0.8	3.0	2.3	0.7	0.0	1.0	0.6	3.2	2.9	2.0	2.3	1.1	3.0	2.1	2.9	0.6	0.2	14.3	0.4	2.3	0.3	1.7	2.4	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5	148.9	104.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	58.0	31.4	0.0	0.3	0.0	4.9	0.0	0.0	0.0	0.0	7.1	2.9	0.0	0.0	5.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	14.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PIGW	"FLJ37433, Gwt1"	ENSG00000277161	"Phosphatidylinositol glycan anchor biosynthesis class W"	Q7Z7B1	17	36535020-36539310	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023499			Approved	"Plasma membrane"		No	Yes			"Plasma membrane"		"HPA023499: "	"unprognostic (4.96e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.14e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.88e-1)"	3.0	2.4	2.5	4.9	2.9	3.0	4.5	1.8	6.4	2.5	3.8	2.4	0.4	3.3	3.2	4.4	5.7	2.0	2.7	3.5	2.3		6.7	12.0	2.9	4.7	3.6	2.2	4.3	4.8	3.3	6.0	2.6	6.3	2.1	4.8	3.7	3.7	2.8	6.5	5.0	3.9	3.1	3.2	4.3	3.3	3.4	2.2	4.0	4.1	8.1	5.5	2.4	1.2	4.4	6.2	1.1	4.9	4.8	5.8	3.3	7.3	9.7	6.8	6.2	2.9	2.6	8.9	8.9	3.9	8.1	6.7	8.5	7.7	11.0	2.7	4.9	8.9	10.4	11.9	5.0	11.1	6.1	12.6	9.5	6.1	6.8	2.3	19.5	10.5	3.0	5.8	8.9	4.0	1.8	4.5	3.6	16.0	7.0	5.6	5.4	9.6	5.8	9.7	4.3	6.6	8.6	16.0	10.8	4.3	9.7	13.5	10.2	12.7	4.7	6.3	6.4	17.0	3.0	6.1	13.9	16.9	13.4	15.7	5.9	18.6	13.2	3.7	9.9	12.5	1.1	2.8	0.5	3.6	4.2	5.6	2.5	4.7	3.6	6.2	4.4	5.8	5.2	0.9	4.8	4.9	2.9	2.4	3.3											3.0	1.9	1.5	7.4	3.1	2.0	1.2	10.2	2.7	3.4	0.0	0.0	5.2	6.6	4.6	0.1	2.8	1.4	0.0	5.5	5.1	3.7	4.9	0.0	5.3	4.0	3.2	1.2	1.3	2.1	0.2	2.6	2.7	0.0	2.8	3.5	5.6	4.7	3.1	2.1	3.8	2.7	0.0	3.1	2.6	7.3	5.9	3.4	4.3	5.0	4.8
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.9	17.5	6.8	9.8	0.1	0.3	18.6	19.4	4.6	12.3	11.8	13.6	14.8	15.6	8.7	2.1	7.3	32.1	4.8	6.2	2.2	20.0	15.7	7.9	15.8	11.9	0.0	8.8	22.5	0.2	0.5	7.3	2.0	1.5	2.5	17.3	22.7	27.7	4.0	37.4	24.6	24.5	11.2	11.7	9.3	26.9	15.3	30.2	2.3	5.5	13.0	13.8	9.4	24.5	7.3	3.9	14.0	17.6	2.3	16.6	21.0	24.2	20.3	21.0	15.6	26.8	6.3	11.8	19.2	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2	0.0	1.4	0.0	0.8	2.3	0.1	0.4	2.5	0.0	2.3	1.8	5.9	3.0	0.0	1.1	11.2	0.3	0.2	0.0	0.5	39.8	0.4	0.5	0.0	0.2	10.2	0.0	1.7	0.0	1.3	7.5	0.3	1.3	0.0	1.0	1.2	0.3	0.3	0.0	0.4	0.0	6.7	0.0	0.0	108.0	40.5	0.5	6.2	0.7	3.5	0.4
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.3"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 25.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 53.8"	"Low region specificity"	"Detected in many"							HPA007721	Approved		Approved	Cytosol		NA	Yes			Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	7.4	1.5	6.5	5.3	42.3	18.8	8.7	24.6	19.1	8.9	3.7	2.1	2.1	5.3	9.1	2.1	11.4	3.5	5.3	2.8	7.1	4.2	3.1	5.4	3.5	10.0	4.8	3.6	19.3	4.3	2.3	5.5	12.5	29.2	3.5	3.5	2.1	7.0	2.4	4.5	11.6	5.9	2.1	22.2	10.5	17.3	3.6	6.7	2.1	5.1	2.1	5.4	4.7	7.9	5.8	2.9	6.3	11.9	1.8	4.1	2.7	8.8	33.9	8.2	12.3	1.7	1.3	6.5	8.0	0.9	4.3	4.2	13.7	9.6	11.4	5.6	3.5	6.4	2.8	2.0	5.3	2.3	6.8	15.1	53.8	11.0	18.2	5.3	5.5	21.2	7.0	0.7	15.8	1.6	2.9	3.3	18.6	14.0	6.2	3.1	2.8	16.6	8.1	17.4	2.3	6.6	9.4	4.4	16.6	1.3	4.1	8.8	4.7	8.1	4.8	7.4	5.9	9.2	7.7	2.3	5.7	9.1	6.2	8.8	2.1	5.6	26.3	3.7	14.6	6.1	4.3	3.8	6.3	2.8	8.1	3.9	2.3	2.2	3.4	2.9	5.8	2.8	2.7	4.9	1.8	11.9	2.7	4.1	2.7	6.5	42.3	24.6	19.1	7.1	4.2	4.8	3.6	29.2	6.7	8.9	25.9	6.1	8.4	6.2	8.1	2.2	7.6	0.0	2.3	0.0	2.0	8.4	0.0	5.1	0.6	3.9	11.5	0.0	1.6	9.0	3.4	4.9	3.5	6.4	4.8	7.9	2.9	6.2	6.5	0.6	2.3	6.4	0.0	1.0	7.5	2.8	12.0	8.7	3.5	1.4	6.1	12.9	4.1	7.9	18.3	7.5	22.5	4.4	7.4	7.1
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867768	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Enhanced	"Lipid droplets"		NA	Yes		9300000	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	13.2	28.9	7.4	16.9	16.3	25.5	12.7	2.8	10.8	17.8	17.5	37.9	4.2	29.1	9.3	12.6	46.9	9.5	14.8	12.4	9.2	7.0	10.4	19.6	9.9	13.6	32.4	8.3	23.4	8.1	3.1	3.9	28.3	17.8	11.0	8.9	6.7	18.1	9.7	40.0	31.8	38.6	11.1	26.7	13.1	11.1	13.6	25.1	20.0	13.1	35.8	29.1	14.1	19.7	12.5	28.9	45.9	37.5	9.4	8.4	19.0	28.2	16.7	11.7	10.6	12.9	42.1	5.1	41.2	38.4	33.3	30.8	10.9	25.8	14.6	9.4	51.7	17.6	13.0	5.3	23.2	19.6	16.7	7.6	15.9	9.5	19.9	9.3	11.3	24.2	32.9	9.7	23.5	5.1	19.0	17.3	4.7	24.1	6.5	40.2	11.6	16.1	15.3	8.8	12.9	27.1	27.7	15.7	8.2	28.3	6.5	0.5	5.5	12.8	11.6	10.1	9.9	14.9	25.7	25.7	17.7	17.5	70.7	21.2	9.2	11.7	10.1	53.3	16.1	20.4	28.3	37.5	16.1	3.8	26.2	3.8	12.5	6.7	4.3	28.9	9.3	5.4	3.4	45.9	9.4	18.0	21.4	8.4	19.0	7.4	16.3	2.8	10.8	9.2	7.0	32.4	8.3	17.8	25.1	17.9	24.6	17.5	48.4	126.4	0.2	2.5	10.2	64.3	42.1	10.4	2.0	124.8	31.5	90.9	8.1	25.3	190.9	0.0	74.9	62.3	89.7	37.6	54.3	14.4	92.9	0.0	39.0	29.4	63.2	9.8	33.1	85.3	52.3	65.9	60.5	22.6	161.7	98.2	49.8	32.3	0.6	51.8	50.5	46.1	15.6	200.5	162.9	17.5	40.8	62.6
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.9;Erythroid cells: 23.3;Extravillous trophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA051638, HPA053229"	Approved					NA	Yes					"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.5	45.5	37.6	20.4	1.1	2.6	21.1	24.9	16.5	39.1	29.1	39.7	28.8	21.8	13.0	16.8	20.6	25.1	51.2	20.5	47.1	31.0	28.9	27.7	35.9	54.2	0.3	31.9	30.4	1.0	1.1	27.7	28.6	4.9	28.5	28.6	43.0	30.1	30.1	39.8	30.1	31.9	42.9	17.9	23.2	46.9	25.5	34.6	11.1	9.5	21.2	14.7	28.5	20.0	12.9	22.4	25.4	19.7	14.4	18.6	23.8	18.2	42.5	21.5	33.3	37.8	15.8	27.8	30.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5	3.0	0.0	0.8	1.0	1.1	1.3	0.6	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.6	86.9	0.5	1.5	23.3	0.7	48.0	0.7	1.0	1.1	0.9	17.0	0.0	0.0	3.1	3.7	4.8	1.1	2.6	0.0	0.0	2.9	1.1	0.8	0.0	0.7	0.0	1.1	0.0	0.3	3.2	5.0	1.6	3.2	1.3	3.9	1.8
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544864	"Predicted intracellular proteins, Transporters"	"Antiviral defense"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2"									"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.9	14.9	11.9	39.7	21.4	27.0	31.1	5.7	19.0	20.9	29.6	7.2	22.1	18.4	19.6	25.7	25.4	19.5	30.8	22.7	16.1	12.7	32.0	36.5	33.8	38.6	17.6	4.9	40.0	26.1	10.3	18.4	25.7	22.1	25.0	28.0	12.6	32.3	34.2	16.4	9.9	24.6	19.4	29.8	46.0	20.5	15.4	14.8	16.4	27.5	14.9	19.5	27.5	48.0	6.5	27.5	26.2	41.2	14.3	8.1	17.6	17.2	6.9	4.4	2.0	6.6	11.2	6.8	5.4	14.8	55.1	73.3	5.5	14.4	1.3	12.9	3.4	43.1	14.2	3.5	5.1	9.3	5.3	3.5	11.1	2.2	4.1	50.5	6.3	5.8	17.8	8.7	6.1	31.1	8.8	8.0	3.2	7.1	17.2	11.2	6.7	4.9	2.4	4.2	11.7	6.2	4.4	4.9	0.4	15.5	4.7	2.7	0.0	6.9	3.4	91.2	6.3	3.4	7.7	4.8	4.4	3.8	9.9	9.0	13.2	2.4	0.0	4.5	4.6	3.8	8.2	41.2	11.0	5.6	40.4	8.1	6.5	3.7	5.0	27.5	4.9	2.6	3.8	26.2	14.3	22.7	7.3	2.1	17.6	11.9	21.4	5.7	19.0	16.1	12.7	17.6	4.9	22.1	14.8	32.8	47.9	22.6	70.0	32.7	0.4	4.0	86.6	81.7	60.3	90.7	0.0	46.8	63.0	225.1	1.5	110.1	67.7	0.0	192.6	100.1	54.5	74.2	26.7	25.9	121.5	0.0	31.9	91.4	84.8	2.2	106.4	157.8	45.5	24.4	60.9	52.6	150.7	102.1	43.2	33.8	1.3	38.8	58.7	0.3	2.2	25.0	37.2	21.3	51.4	160.1
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 1093.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 54.1;hTCEpi: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	70.5	58.1	21.3	46.1	28.3	105.4	48.1	30.8	31.8	55.9	51.5	30.3	27.0	23.6	60.3	30.9	45.4	73.6	45.0	48.5	20.8	17.9	32.9	97.9	59.5	87.1	23.1	22.3	83.4	41.3	31.3	29.5	38.8	20.4	56.6	26.0	46.5	35.5	40.8	154.1	49.0	32.4	63.6	31.1	46.9	38.2	35.5	20.8	91.2	38.4	30.8	45.4	113.2	41.0	9.6	7.3	37.5	7.1	6.9	10.4	3.8	2.9	2.8	6.1	10.3	24.8	41.8	4.2	3.8	26.8	7.2	16.9	2.4	8.2	6.4	18.7	4.6	29.6	10.1	3.2	5.8	11.0	8.0	10.0	1.1	16.5	7.7	54.1	5.9	14.8	30.0	57.5	4.8	22.2	27.2	11.8	7.6	0.9	19.7	7.9	2.9	1.5	31.3	1.7	3.3	6.1	7.0	7.4	5.1	16.9	5.2	3.9	11.0	9.9	13.6	10.0	19.0	6.7	29.9	11.2	5.7	3.4	4.0	1.4	31.0	15.1	2.1	11.5	5.1	3.5	10.3	6.6	36.7	7.5	7.1	7.8	8.3	8.9	7.8	4.2	9.6	10.4	10.4	37.5	6.9	6.3	7.3	7.1	3.8	21.3	28.3	30.8	31.8	20.8	17.9	23.1	22.3	20.4	20.8	131.0	125.0	333.4	716.3	860.7	129.0	174.7	124.9	45.5	52.4	85.5	47.1	189.8	198.9	158.1	59.9	195.6	165.4	23.3	206.9	57.7	278.7	681.2	165.7	181.5	204.0	68.3	237.9	148.0	328.8	20.9	446.1	557.5	416.7	926.1	131.7	222.1	145.2	115.8	354.7	216.2	99.3	413.9	840.5	47.0	44.3	1093.4	229.5	380.5	99.7	411.4
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261762-65305589	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	7.5	6.6	4.9	11.9	8.8	9.8	7.5	14.1	8.8	12.0	9.6	9.8	6.4	6.7	10.1	5.5	10.4	9.3	5.9	6.1	5.2	4.5	7.9	7.0	7.5	14.7	10.3	5.5	10.3	7.9	8.0	4.8	9.3	6.5	7.1	9.6	6.7	8.9	7.5	6.5	8.0	9.2	10.7	10.2	13.6	8.8	15.0	8.4	35.7	7.9	10.3	19.7	8.6	7.3	6.0	13.3	8.0	10.1	4.9	7.3	7.7	14.4	13.3	22.0	10.2	3.3	3.9	7.5	9.9	15.8	32.0	23.7	5.3	12.7	17.4	11.4	8.6	15.5	9.1	17.9	14.8	27.4	9.4	6.7	13.1	20.2	6.0	1.9	12.1	10.8	2.7	2.1	27.7	5.8	5.8	11.9	8.9	12.6	11.8	21.6	20.0	26.0	5.4	16.4	10.7	8.5	14.1	12.8	16.8	9.6	10.0	14.4	8.6	9.5	10.4	3.3	14.4	13.0	6.2	4.3	11.8	9.5	15.6	7.2	5.5	6.6	17.9	8.5	7.7	15.8	8.0	10.1	3.9	6.5	9.5	7.3	6.0	6.9	7.1	13.3	5.6	5.6	5.1	5.0	4.9	7.6	10.4	7.1	7.7	4.9	8.8	14.1	8.8	5.2	4.5	10.3	5.5	6.5	8.4	0.0	4.3	0.8	3.8	1.4	2.5	2.7	5.1	2.7	3.4	5.2	2.0	8.3	3.3	5.7	2.1	3.5	1.0	0.0	3.0	14.9	4.4	2.2	0.0	1.6	8.4	3.2	2.9	3.7	2.1	2.9	6.9	4.3	0.0	10.8	2.2	2.3	3.6	2.6	7.1	1.4	4.9	6.5	3.6	12.0	14.5	1.3	6.1	5.1	5.3	3.2
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA050543: AB_2681165"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	4.5	2.4	3.9	9.5	7.1	4.3	3.5	16.3	8.7	3.9	15.6	1.6	16.3	13.1	5.4	2.6	9.0	5.5	6.2	10.0	3.3	4.1	2.3	3.7	7.4	3.0	3.3	4.8	3.2	3.4	17.7	2.0	3.2	7.2	6.4	11.6	7.6	4.0	19.7	10.3	6.6	16.6	18.6	2.7	4.2	7.9	2.0	1.3	2.2	1.7	8.4	5.8	11.5	5.6	1.9	2.4	2.2	6.2	0.8	0.7	0.5	0.5	1.9	0.8	4.6	1.8	0.6	7.4	0.3	0.0	0.5	0.7	8.3	1.9	9.0	1.3	0.0	2.1	5.6	6.8	3.4	0.6	0.5	5.9	8.4	3.2	1.7	0.5	11.5	3.4	0.9	4.6	1.8	3.1	0.3	1.0	4.0	5.7	3.0	0.4	2.2	4.2	5.4	3.0	2.5	4.9	8.0	5.0	5.0	1.4	11.0	2.5	0.6	1.3	9.8	1.5	1.4	2.6	3.8	1.3	1.1	1.7	3.7	1.8	3.7	2.7	5.3	2.3	7.3	0.9	1.0	2.0	0.7	0.4	3.8	0.7	1.9	0.4	0.3	2.4	0.9	0.6	0.6	2.2	0.8	6.2	0.3	0.3	0.5	3.9	7.1	16.3	8.7	3.3	4.1	3.3	4.8	7.2	1.3	0.0	0.6	1.5	3.2	4.5	105.6	18.8	2.5	0.0	1.2	1.8	127.6	1.5	1.7	0.2	0.2	3.5	17.2	0.0	0.7	1.2	1.8	1.7	1.1	3.4	6.9	7.9	5.2	5.5	9.5	0.0	1.4	8.3	3.3	1.0	8.5	3.6	0.5	3.5	0.4	1.9	72.0	6.5	6.1	0.2	3.2	9.4	4.1	0.0	19.0	3.4
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731596-56752373	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	5.7	5.2	6.7	9.8	9.3	26.0	10.1	16.0	10.6	6.0	8.2	6.7	5.5	4.5	6.2	4.9	9.6	6.2	3.1	4.0	7.6	4.6	4.5	8.2	5.4	11.1	9.2	4.6	9.7	10.7	7.9	12.3	5.0	7.9	5.2	11.1	5.3	7.0	4.3	6.3	7.9	8.3	6.1	11.8	10.2	6.3	17.0	10.8	28.3	5.1	6.8	13.2	5.6	6.9	8.6	6.3	3.5	6.2	5.3	12.7	4.6	12.2	10.6	14.7	9.0	1.7	2.6	17.3	10.4	8.5	18.5	17.3	11.4	15.8	24.1	8.7	4.8	7.4	12.4	17.7	11.3	20.4	12.0	11.0	31.8	6.8	10.9	0.5	38.9	13.5	1.1	2.1	16.4	7.1	2.8	6.6	28.1	29.9	38.1	10.7	9.1	22.2	14.8	16.3	8.8	13.3	25.0	25.8	20.8	4.4	9.3	15.0	13.3	12.4	6.0	5.6	11.2	19.4	14.9	3.0	9.6	22.8	10.0	13.1	13.9	27.7	13.6	6.0	16.5	12.7	1.4	1.4	3.5	7.8	3.4	9.0	8.6	10.5	7.5	3.4	8.2	12.7	10.0	0.0	5.3	6.2	6.3	9.1	4.6	6.7	9.3	16.0	10.6	7.6	4.6	9.2	4.6	7.9	10.8	6.0	5.0	11.5	11.9	3.4	4.2	2.4	2.5	8.1	6.8	7.0	5.9	7.0	0.0	4.4	5.0	5.8	1.3	70.0	6.4	22.0	3.3	2.7	3.5	4.3	10.3	19.1	1.2	3.7	7.3	2.5	6.6	7.2	3.3	9.0	2.9	5.6	3.4	0.0	4.6	1.6	11.8	12.9	3.9	38.6	82.6	3.4	3.8	10.5	8.5	2.0
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155499-59204705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	3.2	1.4	2.8	13.8	4.2	14.9	2.0	0.9	2.8	3.1	4.2	2.2	0.7	6.9	2.0	2.1	10.3	1.7	2.1	1.4	3.1	2.3	1.7	1.1	3.4	9.6	3.2	1.6	1.7	1.0	0.2	0.6	4.8	2.0	1.2	5.5	1.2	2.2	0.5	1.3	2.9	4.8	3.2	5.1	7.3	2.5	2.5	2.1	40.8	1.3	7.7	11.7	2.8	3.2	1.4	3.0	2.5	10.6	0.7	2.0	0.8	27.6	13.3	21.0	6.1	0.6	4.9	8.6	17.2	10.8	17.9	14.3	16.4	18.7	17.9	17.6	12.6	14.6	10.2	16.1	17.7	39.3	24.8	10.3	19.7	14.7	11.0	0.2	20.8	8.3	1.1	1.3	19.7	26.2	4.4	20.2	15.0	10.7	19.5	19.1	21.5	20.4	3.7	8.7	13.0	22.5	16.4	31.5	11.5	4.8	7.5	9.1	12.6	14.2	5.2	7.5	10.6	14.0	8.0	13.7	36.8	43.0	18.5	30.6	12.6	24.2	18.0	8.2	11.6	35.9	1.0	2.3	2.5	0.8	5.1	0.3	1.4	0.6	1.0	3.0	0.9	0.6	0.8	2.3	0.7	10.6	1.6	2.0	0.8	2.8	4.2	0.9	2.8	3.1	2.3	3.2	1.6	2.0	2.1	0.0	1.7	7.0	1.9	1.6	2.0	0.8	0.0	0.0	2.3	0.0	0.0	1.8	0.0	0.3	0.5	1.1	0.4	46.7	0.4	19.2	1.6	1.0	2.3	0.0	6.5	1.6	4.7	3.7	13.3	0.2	0.9	5.1	1.7	6.4	2.2	0.8	0.6	0.0	2.1	0.3	2.8	0.0	2.1	3.0	5.1	1.1	1.7	2.5	4.3	1.4
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441605-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 190.5"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 1157.2;Enterocytes: 1047.2;Proximal tubular cells: 808.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA039396: AB_2676484, HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.55e-4)"	31.9	48.0	29.7	38.3	36.4	64.0	29.3	19.5	38.3	23.8	81.1	27.0	26.6	117.5	24.2	34.4	31.2	35.0	40.1	31.1	30.9	30.1	88.2	51.4	35.5	49.3	34.3	39.2	30.2	29.3	16.1	26.5	32.5	31.3	30.0	70.6	27.1	26.1	44.9	33.3	22.9	110.7	24.5	32.5	53.6	51.9	15.7	28.7	41.6	34.3	21.6	45.6	35.8	25.3	79.6	60.1	190.5	86.5	50.8	72.9	117.1	25.3	51.2	12.7	14.1	21.8	27.9	27.8	21.2	31.0	27.3	26.7	92.6	59.7	39.9	72.5	30.7	33.6	22.9	25.8	33.5	33.5	38.5	19.2	58.1	28.2	43.4	53.8	86.6	80.1	36.9	34.0	51.0	35.1	29.5	29.1	24.1	49.9	40.1	42.8	68.7	48.5	85.1	20.9	32.4	34.7	43.0	10.8	42.4	60.7	44.0	11.4	8.4	31.5	45.1	38.0	27.4	63.6	67.2	29.9	18.5	18.2	33.0	20.8	29.8	36.2	58.5	24.8	52.5	34.8	63.6	75.8	142.7	50.7	84.6	49.4	79.6	56.9	53.8	60.1	70.8	53.5	57.5	190.5	50.8	86.5	49.7	72.9	117.1	29.7	36.4	19.5	38.3	30.9	30.1	34.3	39.2	31.3	28.7	77.4	108.7	131.7	128.0	42.2	6.7	20.7	178.3	136.5	72.8	177.9	27.5	204.3	1157.2	205.4	8.6	70.6	1047.2	0.0	224.1	275.8	70.2	205.1	179.3	136.2	316.3	17.5	163.2	59.5	331.1	4.2	53.8	241.9	102.9	348.1	279.4	63.8	250.2	733.0	43.2	808.7	20.6	77.6	60.4	33.7	20.1	48.9	243.4	192.8	262.9	167.7
PSMC3IP	"GT198, Hop2, HUMGT198A, TBPIP"	ENSG00000131470	"PSMC3 interacting protein"	Q9P2W1	17	42572315-42577831	"Disease related genes, Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.8"	"Cell type enhanced"	"Detected in many"	14	"Spermatocytes: 109.9;Spermatogonia: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044439	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA044439: AB_10964210"	"unprognostic (2.98e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-7)"	"unprognostic (6.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (9.41e-4)"	"unprognostic (6.03e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.82e-1)"	4.0	2.0	6.6	4.2	12.1	9.2	5.2	5.0	7.7	3.4	4.3	7.0	4.1	1.7	5.2	5.5	3.9	8.6	2.4	2.1	7.4	6.3	2.8	1.2	3.1	4.7	9.7	4.1	4.8	2.7	8.5	2.1	5.4	8.7	5.5	4.3	2.4	2.5	5.7	1.9	4.1	1.9	6.9	12.7	2.3	2.8	29.8	9.9	3.1	2.5	1.5	7.1	4.2	3.3	2.4	6.2	2.2	0.5	0.2	1.9	0.3	6.4	9.7	16.2	11.8	3.8	5.4	3.6	25.2	8.0	22.1	27.4	9.6	4.2	6.9	5.6	7.4	8.8	9.8	12.5	9.6	25.5	9.5	10.5	4.1	21.8	11.4	0.5	14.6	4.7	1.8	2.2	34.9	11.7	3.0	6.4	9.1	14.0	12.6	19.2	7.5	9.8	9.1	9.9	7.2	9.2	10.4	16.5	6.2	5.0	5.3	21.6	13.7	10.1	3.7	10.2	8.4	9.0	6.4	3.0	24.0	13.7	17.9	41.6	9.9	16.8	9.9	11.2	6.9	25.9	0.0	0.2	1.8	1.9	0.3	1.9	2.4	0.9	1.7	0.2	0.8	0.3	0.9	2.2	0.2	0.5	6.2	1.2	0.3	6.6	12.1	5.0	7.7	7.4	6.3	9.7	4.1	8.7	9.9	3.0	3.0	3.0	2.5	4.7	5.8	0.8	2.5	22.7	3.4	3.5	9.8	7.6	0.0	3.4	9.2	3.2	0.0	23.3	2.8	16.4	4.3	1.3	1.1	0.9	6.3	0.0	0.0	2.5	3.8	9.4	4.9	2.4	5.0	9.0	0.7	4.6	1.6	0.0	8.1	1.9	13.3	19.4	9.2	109.9	37.9	3.6	4.3	1.9	2.6	0.7
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713541	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	Yes		610000	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	72.8	37.7	60.0	78.4	65.2	161.4	76.1	38.2	64.2	75.0	80.9	53.9	33.9	56.3	84.8	59.9	83.7	66.7	47.2	38.7	66.3	48.3	67.3	73.5	63.5	104.0	68.7	59.6	80.5	79.5	31.3	97.9	59.1	54.2	50.0	82.7	42.2	55.5	53.4	60.6	92.5	62.8	58.4	86.6	90.1	69.2	113.9	67.2	127.5	73.4	50.4	118.6	70.0	69.9	189.1	134.7	114.4	126.9	117.0	167.3	255.0	99.6	59.9	85.5	76.2	26.0	34.7	87.8	68.1	57.2	59.5	62.5	58.0	116.9	157.9	78.1	53.1	41.2	52.8	120.2	83.9	75.7	125.1	94.5	203.5	49.5	93.6	32.3	230.8	87.1	50.3	31.5	52.7	43.6	56.8	97.0	129.0	118.2	67.2	51.9	142.5	324.2	314.8	128.7	99.1	50.0	223.4	60.9	107.3	72.8	89.1	174.5	107.4	78.2	78.3	59.4	70.5	59.0	183.6	72.0	50.2	89.1	61.3	73.1	81.5	40.1	316.2	34.3	141.6	80.4	114.4	113.6	75.3	99.1	114.0	143.5	189.1	143.8	120.6	126.3	160.4	160.6	134.8	23.1	117.0	126.9	134.7	167.3	255.0	60.0	65.2	38.2	64.2	66.3	48.3	68.7	59.6	54.2	67.2	902.2	1420.8	3111.4	3331.5	6879.8	692.5	258.3	1666.3	1917.9	1803.9	2156.5	276.9	2179.3	3208.0	2815.5	89.5	3767.9	1421.2	1752.0	3609.4	4317.6	3273.0	2682.0	2759.5	1209.1	2876.6	767.5	1629.9	1539.5	3031.9	138.7	1209.6	4164.5	3499.0	2458.1	2866.2	2213.1	3219.9	1988.5	1320.3	2161.4	753.7	1895.0	6501.7	798.6	2809.8	6944.4	2286.6	2724.1	3072.9	3503.3
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"Pituitary tumor-transforming 1"	O95997	5	160421822-160428744	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.5;testis: 100.1"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.5"	"Lineage enriched"	"Detected in all"	7	"T-cells: 54.5"	"Low cell line specificity"	"Detected in all"											"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	1.5	1.7	2.1	16.2	5.5	34.1	2.9	1.4	4.6	3.8	8.2	1.0	0.7	5.8	1.3	2.6	24.1	1.0	1.9	2.3	5.1	2.7	1.7	1.4	3.8	19.2	1.5	2.2	1.1	1.2	0.2	2.0	5.0	2.2	1.6	11.3	1.5	4.5	1.1	1.2	8.7	5.8	4.5	1.4	7.5	3.4	100.1	1.0	29.8	23.9	23.2	35.1	3.3	7.2	8.1	6.1	2.4	2.1	3.3	54.5	4.7	45.7	23.8	53.8	38.5	9.1	9.0	16.8	24.3	55.7	64.6	70.8	46.0	40.3	50.0	21.7	27.6	74.3	24.0	33.4	67.6	92.7	57.1	30.3	26.4	32.2	27.7	1.8	23.9	23.2	4.2	11.3	43.8	26.6	19.8	45.5	33.5	21.1	39.0	66.3	21.5	28.6	58.8	27.1	37.7	34.6	26.7	63.3	42.9	32.9	9.3	33.5	21.3	35.1	21.4	72.2	45.5	43.7	26.2	19.4	29.2	39.1	22.8	70.9	33.6	29.9	57.2	31.5	41.4	51.7	1.9	0.7	2.4	7.0	2.1	2.5	8.1	14.4	16.2	6.1	5.5	3.6	8.9	0.8	3.3	1.4	5.8	54.5	4.7	2.1	5.5	1.4	4.6	5.1	2.7	1.5	2.2	2.2	1.0	6.0	15.5	20.5	54.1	220.3	1.3	4.9	7.6	1.4	11.4	5.2	0.0	50.4	3.3	4.0	470.4	10.3	6.3	654.1	4.5	163.8	37.7	15.3	38.0	2.9	72.7	0.0	5.8	17.8	20.0	39.3	10.3	35.9	82.7	39.7	15.4	2.7	3.5	9.1	7.4	1.2	0.7	6.5	35.3	278.1	72.8	136.5	26.7	44.5	34.5	30.7
PYURF	PreY	ENSG00000145337	"PIGY upstream reading frame"	Q96I23	4	88520985-88523813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036455	Uncertain		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA036455: AB_10673388"	"unprognostic (8.25e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	40.4	48.3	47.3	29.2	43.9	44.2	63.2	28.2	43.4	40.6	38.4	31.2	35.2	35.8	47.4	56.4	40.9	41.0	36.4	62.5	45.4	45.1	48.7	59.1	33.5	43.1	47.6	35.3	44.9	61.8	40.7	42.6	39.0	43.2	42.7	37.7	31.6	48.6	42.9	54.0	37.1	37.5	44.7	51.4	36.9	33.8	28.5	38.4	28.3	47.7	40.5	33.0	41.7	51.4	45.3	50.8	35.0	43.3	47.3	54.1	74.3	29.4	9.9	19.9	23.6	40.3	41.5	13.5	21.8	30.7	27.4	23.2	7.7	23.5	0.1	24.6	30.8	18.6	12.7	18.0	27.4	34.6	36.0	31.3	32.7	13.2	29.3	30.6	54.0	21.1	28.6	41.5	17.6	36.1	26.0	44.7	10.2	36.7	33.2	39.5	22.3	32.8	33.1	16.7	34.5	19.1	33.5	18.6	34.3	22.5	16.7	24.1	23.6	27.6	25.3	57.4	20.6	11.7	27.2	30.4	29.2	26.9	28.4	20.0	23.6	19.1	3.6	25.6	27.5	32.0	30.9	43.3	35.0	45.0	42.0	50.2	45.3	52.0	48.5	50.8	35.5	54.1	51.6	8.6	47.3	41.0	31.9	51.8	74.3	47.3	43.9	28.2	43.4	45.4	45.1	47.6	35.3	43.2	38.4	47.6	58.8	74.6	136.8	204.7	28.0	4.5	68.8	84.3	85.3	82.0	9.8	205.8	243.7	96.5	35.0	121.7	71.5	23.3	113.5	97.9	127.4	138.8	102.8	109.9	125.1	25.4	110.1	92.7	113.8	79.3	116.5	112.4	330.7	100.0	88.2	79.4	90.7	113.1	112.8	171.4	25.3	58.2	140.4	100.3	65.3	252.6	137.1	99.2	113.0	120.5
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225261-37244448	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 166.3;bone marrow: 66.3;lymphoid tissue: 169.1"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 269.8;granulocytes: 502.9;T-cells: 411.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.3;HL-60: 77.3;HMC-1: 158.6;Karpas-707: 75.3;U-87 MG: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022946, HPA047820"	Enhanced					NA	Yes		34000000			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	17.4	2.6	2.0	79.2	4.1	66.3	8.3	0.9	2.0	3.3	7.5	1.5	1.2	6.0	3.2	3.5	7.8	4.7	11.2	5.6	1.7	1.9	4.8	5.3	29.6	89.3	3.0	0.2	4.9	2.3	0.0	1.8	3.5	2.2	6.2	5.9	3.3	16.9	2.2	1.4	2.9	29.4	3.2	4.1	102.8	7.0	2.5	2.0	169.1	3.6	3.6	74.2	11.2	4.0	85.3	79.1	166.3	88.3	98.4	121.7	130.9	14.3	0.0	0.0	0.0	1.6	14.8	0.0	1.9	4.5	1.5	3.2	0.0	4.8	17.8	2.2	5.6	0.0	3.6	0.1	25.0	1.7	55.3	0.0	22.2	0.4	0.0	4.0	77.3	158.6	10.8	3.5	2.7	9.4	0.1	26.2	17.3	5.2	75.3	0.2	0.0	22.8	30.7	0.3	1.4	9.5	7.6	0.0	20.3	2.4	0.0	0.2	0.0	0.0	2.5	0.3	0.1	1.0	41.7	28.1	0.0	2.6	0.1	0.2	34.1	17.5	18.8	69.1	33.7	3.8	115.0	53.8	166.3	111.5	73.2	84.4	85.3	89.3	97.9	53.4	70.9	69.5	88.6	146.6	98.4	88.3	79.1	121.7	130.9	2.0	4.1	0.9	2.0	1.7	1.9	3.0	0.2	2.2	2.0	14.9	73.5	269.8	1.9	4.7	0.0	0.8	2.5	6.7	15.9	1.8	0.0	0.6	0.0	10.2	0.1	6.8	1.3	0.0	1.8	1.5	4.6	0.3	502.9	1.3	136.6	0.0	4.1	13.5	121.0	0.4	0.3	135.5	28.7	2.8	3.2	0.0	13.1	11.5	0.0	1.0	0.0	12.9	3.8	0.0	0.9	3.4	2.4	411.2	10.7	2.8
RAD21	"hHR21, KIAA0078, SCC1"	ENSG00000164754	"RAD21 cohesin complex component"	O60216	8	116845935-116874866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020044, CAB022065"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB022065: , HPA020044: AB_1856035"	"unprognostic (7.85e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.43e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.86e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.58e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	31.6	40.9	48.2	30.5	52.2	78.5	37.7	58.8	55.3	24.2	36.3	37.5	21.5	24.8	30.5	25.3	32.1	23.1	22.0	37.8	45.6	44.1	30.5	27.9	29.6	49.2	54.3	35.4	33.5	18.2	29.1	30.0	38.9	45.5	26.5	37.3	19.0	25.3	31.0	37.8	24.0	26.0	33.4	49.7	31.2	31.5	37.6	56.2	58.3	41.9	20.9	50.4	37.1	36.0	8.7	5.4	17.9	7.1	8.0	25.4	6.2	41.6	20.5	40.2	22.5	20.2	17.5	18.0	29.0	27.5	32.2	29.8	16.8	39.3	61.6	16.0	20.6	17.2	23.3	34.2	18.7	37.8	81.7	21.9	62.8	25.2	21.3	12.7	20.1	37.0	14.9	15.4	18.8	22.8	21.3	25.1	89.9	25.2	86.3	27.7	25.1	92.1	11.9	23.6	53.8	25.9	33.8	29.2	30.9	19.2	24.5	50.8	26.2	30.4	82.1	19.6	22.0	34.4	24.9	18.4	22.8	33.4	23.8	30.3	45.7	52.5	55.5	19.5	29.0	27.2	17.2	4.5	15.5	11.0	5.3	11.2	8.7	12.9	13.0	5.4	8.3	13.5	13.0	17.9	8.0	7.1	4.5	25.4	6.2	48.2	52.2	58.8	55.3	45.6	44.1	54.3	35.4	45.5	56.2	238.2	123.7	70.9	67.0	84.9	73.4	149.3	48.4	87.0	138.8	52.4	29.5	106.6	36.5	47.5	247.8	88.8	56.4	70.0	38.8	119.7	73.7	80.6	143.9	61.8	58.9	63.5	81.0	64.4	91.5	303.2	107.9	82.3	65.8	97.4	62.9	99.6	49.1	57.5	100.0	50.1	60.7	71.1	54.7	31.6	81.6	87.8	95.1	93.8	69.2	65.3
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.9;testis: 24.0"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 46.7;Extravillous trophoblasts: 57.9;Spermatocytes: 52.6;Spermatogonia: 26.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	1.0	0.9	0.4	6.6	0.9	5.3	1.0	0.7	0.9	1.1	5.7	0.4	0.3	1.7	0.8	2.0	4.9	0.5	1.7	1.8	0.5	0.5	1.0	1.0	1.9	7.4	0.5	0.3	0.9	0.7	0.0	0.4	6.2	0.7	0.8	7.6	0.4	1.4	0.3	1.3	2.1	2.6	1.2	1.1	5.0	1.5	24.0	0.5	27.9	0.6	3.7	9.7	1.0	1.9	3.1	1.7	2.7	2.2	2.2	8.8	1.7	12.4	5.5	13.2	5.0	1.3	3.6	12.0	22.0	6.1	19.5	19.7	13.0	8.5	7.0	10.9	7.8	7.5	26.4	24.9	10.3	19.1	14.6	8.5	17.6	10.8	9.9	0.1	14.2	12.1	0.5	1.7	13.1	5.8	3.0	10.6	19.9	23.1	19.7	16.9	10.9	20.3	13.1	15.1	29.3	6.9	23.2	18.7	11.8	7.1	16.8	5.9	11.1	9.7	17.1	3.5	16.7	10.3	11.8	4.4	14.1	9.0	19.8	11.3	5.0	24.6	23.4	6.1	29.7	12.4	2.0	0.9	2.7	4.1	2.0	0.8	3.1	4.3	5.5	1.7	1.6	1.2	2.1	1.3	2.2	2.2	1.2	8.8	1.7	0.4	0.9	0.7	0.9	0.5	0.5	0.5	0.3	0.7	0.5	0.0	0.0	0.8	1.2	3.2	0.4	0.8	0.0	0.0	1.2	0.0	0.0	16.0	0.0	0.0	2.6	0.1	0.9	46.7	0.0	57.9	0.6	0.7	0.0	0.0	10.9	0.0	0.0	1.8	2.4	4.0	0.6	0.5	0.0	0.0	3.2	0.2	0.1	3.7	0.7	0.0	0.0	0.0	0.2	52.6	26.0	1.4	21.2	1.5	5.2	1.3
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46247688-46278473	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 41.9;testis: 56.6"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	1.9	0.6	1.5	12.9	4.7	9.4	1.3	3.0	1.9	1.1	4.8	0.7	0.5	2.8	1.2	2.1	5.2	0.3	1.2	1.5	1.8	1.5	1.4	0.5	1.5	6.0	1.9	0.7	0.8	1.4	0.6	0.5	4.2	0.9	1.1	5.8	0.6	1.4	1.0	1.4	3.0	3.6	1.8	3.2	4.1	1.7	56.6	0.6	41.9	1.7	3.8	9.6	1.0	1.7	0.5	0.3	0.0	0.1	0.9	4.1	0.7	9.0	6.8	20.5	12.5	1.5	1.0	19.1	10.7	4.7	18.1	18.6	14.5	6.0	17.8	8.2	4.5	16.5	9.4	18.9	6.0	16.0	9.7	19.1	21.8	18.2	14.4	0.0	21.8	12.8	0.6	0.5	18.0	5.3	3.0	5.6	20.7	15.6	18.2	9.9	8.6	27.1	24.2	18.3	8.0	11.2	21.7	11.4	7.8	4.4	7.8	9.8	7.0	7.8	10.8	2.6	17.4	3.8	15.9	2.4	19.5	11.6	10.0	18.0	7.7	4.4	19.2	5.2	14.5	7.8	0.0	0.1	0.0	1.2	0.1	0.2	0.5	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.9	0.1	0.0	4.1	0.7	1.5	4.7	3.0	1.9	1.8	1.5	1.9	0.7	0.9	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	1.8	0.1	0.2	0.0	0.0	7.8	0.4	0.3	4.6	0.0	2.2	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.2	0.3	1.4	0.0	1.2	0.4
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	11.0	9.5	16.1	15.8	15.4	23.0	15.3	13.9	16.6	10.1	12.8	10.0	5.0	8.6	10.0	9.4	17.9	10.1	9.0	9.1	12.1	9.1	10.1	23.0	10.6	20.4	12.3	14.0	11.7	15.1	10.9	8.6	17.5	15.1	11.0	15.0	8.9	12.2	8.1	16.5	18.8	10.0	12.7	14.8	14.2	12.2	13.5	14.0	22.1	10.4	14.7	28.5	9.9	11.6	22.4	18.7	27.5	24.2	24.8	13.6	15.8	22.9	17.9	20.9	20.7	4.3	5.1	9.6	13.5	14.9	27.5	33.2	19.8	21.4	21.7	3.8	9.5	26.1	15.8	17.0	22.6	28.6	15.5	29.5	13.2	24.9	14.7	3.4	19.8	8.2	5.1	5.1	25.9	17.9	6.0	14.7	20.9	27.4	13.4	21.1	27.1	19.7	38.6	23.8	36.5	15.1	29.5	23.2	27.1	14.7	18.6	17.0	21.6	16.0	30.3	11.0	26.9	21.9	18.3	5.7	27.3	18.1	21.0	30.1	8.2	10.6	37.7	13.8	30.7	28.3	19.5	22.0	15.6	11.4	24.2	11.7	19.0	9.9	10.4	18.7	22.4	12.6	9.5	27.5	24.8	22.4	10.0	13.6	15.8	16.1	15.4	13.9	16.6	12.1	9.1	12.3	14.0	15.1	14.0	11.9	12.0	15.3	19.1	21.2	14.1	5.0	10.2	9.4	15.9	5.2	2.0	51.5	5.0	14.8	2.2	11.7	9.9	0.0	16.7	50.3	12.7	9.4	22.0	13.1	32.8	3.2	4.6	11.6	12.7	1.8	8.1	24.0	20.3	34.3	7.8	12.8	12.3	5.8	10.3	7.8	8.7	6.5	15.1	23.6	52.6	14.9	38.6	23.6	15.6	12.4
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 48.3;Spermatocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.1	6.9	11.5	14.1	16.0	26.8	10.5	28.0	13.9	8.8	11.6	5.3	5.8	8.2	11.8	7.3	13.0	10.2	7.6	8.0	8.6	6.2	8.2	9.3	6.6	22.1	14.5	9.8	12.7	11.9	6.5	9.0	11.0	12.5	7.3	16.1	5.9	8.1	5.8	8.1	8.7	11.8	13.6	8.4	15.6	9.8	20.3	12.8	28.6	6.4	11.0	25.2	8.3	8.5	11.2	7.7	7.4	10.3	7.0	16.5	6.2	34.8	12.0	28.5	18.2	4.1	4.5	22.5	16.9	10.7	27.0	29.9	17.9	16.7	25.2	39.3	8.1	25.9	18.4	25.1	16.5	33.3	38.0	22.1	25.9	18.4	18.2	3.2	27.3	17.4	3.8	6.0	18.5	14.5	6.0	9.0	39.5	20.1	35.9	18.4	16.6	34.3	25.6	25.2	31.2	16.4	27.2	24.5	34.6	9.7	13.0	27.9	13.9	21.1	23.3	19.1	22.4	39.6	26.2	4.1	16.4	20.7	27.4	50.4	20.1	44.4	83.9	14.4	30.1	21.5	0.0	2.2	7.4	9.8	3.3	9.4	10.6	9.7	10.1	3.9	11.2	9.8	8.9	0.4	7.0	10.3	7.7	16.5	6.2	11.5	16.0	28.0	13.9	8.6	6.2	14.5	9.8	12.5	12.8	0.0	2.1	20.1	13.1	5.4	17.0	6.9	10.2	9.4	7.9	10.4	0.0	26.7	5.0	9.4	18.6	4.5	2.0	23.3	14.4	48.3	5.1	4.1	8.1	2.9	20.0	7.9	1.2	6.7	2.1	7.9	9.8	5.2	1.7	15.4	4.2	12.4	7.9	3.5	7.4	6.7	14.0	6.5	10.3	67.9	38.7	2.6	9.4	8.6	11.5	3.1
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11351762	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.7;testis: 29.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.0	1.8	4.2	18.0	5.1	4.8	2.8	0.7	4.1	2.8	7.3	1.0	0.4	4.3	2.5	3.2	11.8	1.0	2.6	1.9	2.5	1.5	3.1	2.3	2.9	17.9	1.6	5.6	3.6	1.6	0.7	1.1	13.2	1.2	2.6	9.0	0.8	2.9	1.7	1.1	8.7	5.6	1.1	1.4	4.2	4.0	29.6	1.2	31.7	1.4	2.8	20.4	3.6	4.5	6.5	0.6	0.9	0.0	0.3	3.0	0.3	19.2	12.9	25.4	10.8	1.1	5.5	10.6	11.2	8.9	10.6	17.7	4.9	22.9	26.7	9.7	5.2	12.0	11.3	10.8	10.7	17.3	5.2	10.1	14.6	7.6	32.6	0.4	5.6	6.6	1.2	2.1	4.6	4.4	4.2	5.8	11.8	20.1	21.3	5.5	22.2	19.3	26.2	21.3	26.9	5.1	23.5	27.4	28.5	6.3	12.5	14.6	11.6	9.5	15.9	8.3	15.3	27.0	8.4	1.8	8.5	8.0	16.3	1.6	5.8	9.6	31.7	7.9	18.5	15.7	0.0	0.0	0.9	0.6	0.0	0.0	6.5	0.2	0.0	0.4	2.5	1.8	0.7	0.2	0.3	0.0	0.6	3.0	0.3	4.2	5.1	0.7	4.1	2.5	1.5	1.6	5.6	1.2	1.2	0.0	0.3	4.9	6.4	6.1	0.1	0.8	5.1	0.0	2.3	7.0	0.0	100.7	5.0	2.3	2.2	0.7	1.1	23.3	0.4	27.0	2.6	1.6	0.0	0.8	15.8	0.0	2.4	1.3	1.0	4.3	14.7	3.4	3.3	1.8	5.9	0.0	1.1	3.5	40.0	0.0	0.5	32.3	0.9	31.4	42.9	4.6	39.9	0.0	7.0	2.8
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337313	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	19.0	21.5	13.6	15.4	21.6	25.6	16.9	18.4	38.9	19.8	22.0	17.6	14.5	20.3	31.2	15.6	26.0	24.4	19.8	15.1	17.1	13.8	22.3	28.7	17.3	17.5	15.0	16.6	25.6	18.5	31.4	14.3	27.5	27.2	19.2	18.2	20.2	20.0	28.5	17.6	19.8	21.4	27.0	14.3	19.8	24.3	27.6	13.0	26.7	20.6	14.0	21.1	25.8	18.1	13.8	14.2	7.1	15.5	9.8	16.7	16.2	15.7	17.5	16.4	19.3	16.2	12.8	17.4	17.2	18.6	20.1	15.9	29.5	33.2	14.0	23.8	20.4	30.5	28.8	23.2	25.9	12.6	16.6	12.8	36.8	8.2	24.3	12.4	15.4	15.3	13.3	13.3	25.0	22.6	13.2	15.2	21.7	17.8	22.0	13.8	34.5	14.1	16.0	16.4	18.3	22.4	14.7	16.8	11.1	12.3	11.5	11.7	11.3	13.9	17.6	4.6	16.5	39.9	12.9	10.0	24.3	16.2	12.7	15.6	5.3	8.6	0.1	8.1	26.1	18.9	7.1	15.5	3.9	16.7	14.5	11.0	9.0	12.7	14.5	14.2	13.8	14.5	12.4	1.1	9.8	14.1	8.1	6.6	16.2	13.6	21.6	18.4	38.9	17.1	13.8	15.0	16.6	27.2	13.0	3.0	6.5	9.0	12.0	6.2	9.1	0.5	28.1	2.7	7.9	10.4	2.0	31.3	5.0	17.7	3.4	7.5	10.0	0.0	15.0	54.3	13.5	11.2	7.0	19.8	18.0	4.8	13.2	8.6	9.9	4.9	13.0	8.8	1.7	12.6	10.2	9.7	11.8	10.2	16.6	10.3	7.6	6.5	10.3	12.2	8.3	7.4	20.4	9.6	14.5	8.6
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618519-49620685	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	Yes			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.00e-1)"	60.3	55.8	45.9	46.5	40.9	68.2	66.5	35.9	37.7	69.3	74.3	29.2	56.6	52.1	54.9	102.1	61.8	45.9	31.5	48.2	38.0	34.4	69.9	139.2	54.8	63.6	45.3	34.1	105.3	131.9	35.7	62.0	56.9	40.3	62.9	50.5	30.8	85.2	68.6	82.4	40.8	99.8	71.1	48.0	78.8	61.8	36.7	41.8	65.4	72.5	67.6	71.0	87.6	63.9	105.8	112.7	119.5	66.7	84.5	132.0	139.8	73.4	55.4	40.1	23.2	57.7	79.8	23.5	60.7	67.1	56.9	64.5	57.6	50.9	96.9	57.9	50.2	40.1	53.0	34.0	51.8	66.6	33.2	39.2	60.7	58.5	74.3	73.1	96.9	52.2	81.6	79.4	43.5	58.8	67.6	72.0	43.8	38.5	86.3	43.7	94.8	57.0	87.0	22.5	52.9	57.0	36.1	63.1	51.9	86.3	111.8	35.1	21.7	53.4	42.4	60.8	39.8	91.8	53.9	55.4	35.7	56.8	46.4	46.7	52.6	53.7	97.8	25.8	43.9	33.9	119.5	66.7	99.6	98.6	63.2	132.0	105.8	129.3	123.0	68.7	79.9	120.7	112.6	74.0	84.5	55.9	112.7	118.2	139.8	45.9	40.9	35.9	37.7	38.0	34.4	45.3	34.1	40.3	41.8	285.9	358.6	508.2	1190.5	840.1	106.5	561.0	550.3	325.2	378.7	296.6	23.6	568.2	843.9	636.4	440.5	541.3	862.9	397.1	1188.0	608.8	559.0	968.4	688.3	743.7	689.7	76.3	351.4	449.9	649.0	160.8	672.0	707.1	799.7	1234.5	570.5	159.8	1112.3	813.6	502.0	790.1	95.2	478.6	799.2	285.3	135.9	733.7	431.8	698.8	483.1	1226.2
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	32.8	38.8	38.9	29.5	30.6	36.9	47.5	24.2	34.7	26.4	28.0	19.2	40.6	31.4	18.8	25.2	24.1	18.0	25.0	30.5	38.9	28.4	30.8	40.7	22.5	29.4	40.3	27.0	23.4	45.0	15.4	18.8	21.9	31.9	31.6	14.4	19.2	65.2	35.4	55.0	19.8	30.9	28.5	31.1	27.1	32.6	28.8	24.6	16.3	40.8	28.0	23.7	24.3	54.5	64.2	73.5	67.3	57.7	42.8	60.3	50.5	20.9	25.9	12.5	17.6	14.1	9.2	26.3	24.1	19.6	21.1	16.8	28.7	13.9	26.2	25.2	14.2	17.2	17.0	19.6	24.7	7.3	37.7	62.7	25.2	22.0	25.3	20.6	36.8	32.9	13.8	18.7	18.1	22.2	11.4	14.3	19.9	28.1	19.0	13.3	23.2	17.6	36.7	21.7	46.7	49.7	28.1	16.3	39.4	22.1	20.8	27.9	15.6	19.5	31.1	43.3	8.0	22.4	29.8	16.9	17.6	40.2	19.6	31.4	33.1	30.4	40.7	23.9	25.6	41.1	42.1	57.7	67.3	53.4	52.1	49.2	62.0	54.4	55.2	46.3	64.2	53.2	54.1	63.4	42.8	42.0	73.5	60.3	50.5	38.9	30.6	24.2	34.7	38.9	28.4	40.3	27.0	31.9	24.6	41.7	44.3	107.2	91.0	121.8	95.6	68.3	109.5	34.8	36.4	92.5	49.1	134.1	184.1	166.7	17.8	129.5	196.8	46.7	167.0	202.1	94.9	166.3	69.2	175.1	185.7	33.4	136.9	111.1	105.7	22.2	126.8	125.3	102.9	172.3	137.0	80.8	187.2	164.9	118.5	232.2	81.9	77.6	104.0	59.0	146.0	129.4	110.1	136.4	130.8	112.7
RPS7	S7	ENSG00000171863	"Ribosomal protein S7"	P62081	2	3575205-3580919	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056586	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	Yes		1000000	"Endoplasmic reticulum, Cytosol"		"HPA056586: AB_2683179"	"unprognostic (3.28e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-3)"	"unprognostic (7.08e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.34e-8)"	"unprognostic (3.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	54.0	42.1	41.7	57.4	47.8	91.9	112.1	35.1	52.6	57.9	54.4	22.5	35.3	38.3	49.4	70.5	75.2	60.6	80.9	42.7	35.6	28.9	88.1	184.7	40.5	73.8	35.4	49.9	128.7	94.3	19.0	42.3	56.0	46.5	49.6	61.0	27.5	61.1	46.8	96.7	74.9	53.8	46.2	35.2	74.2	55.7	120.7	30.3	59.0	49.0	129.1	89.6	54.8	62.3	124.7	91.6	22.4	53.7	83.8	117.9	145.9	62.6	61.4	94.7	101.7	94.2	206.7	155.5	76.2	133.1	126.8	74.0	106.1	99.2	209.9	127.4	88.0	88.2	69.2	107.0	123.7	112.2	65.7	144.3	76.6	45.1	152.7	227.3	132.6	79.8	173.5	186.7	78.6	171.0	137.4	148.1	194.4	118.2	106.7	128.2	84.5	146.9	296.0	139.7	189.1	95.4	117.4	96.6	186.7	143.2	77.2	108.0	162.4	40.3	155.3	231.8	83.4	85.4	192.4	69.1	76.4	50.2	52.5	122.0	119.8	218.3	205.7	80.3	159.9	85.0	22.4	53.7	19.9	74.4	47.3	109.5	124.7	107.1	94.6	91.6	107.1	117.9	103.2	11.4	83.8	44.3	87.8	90.6	145.9	41.7	47.8	35.1	52.6	35.6	28.9	35.4	49.9	46.5	30.3	461.6	611.6	3582.6	3530.2	3485.1	365.6	144.4	1480.3	812.4	1235.2	614.1	306.3	3079.2	2208.3	1634.1	1148.8	1674.5	681.7	724.2	2971.3	4852.3	1818.6	2622.1	1119.4	1214.5	2053.4	133.5	1202.6	1662.2	2169.7	372.0	2710.8	2469.9	1898.0	2610.5	1831.6	516.1	2628.7	1420.3	1643.8	3007.3	556.0	1429.3	2159.8	1061.8	775.2	4415.0	3108.3	2545.2	2502.1	3299.7
RPS9	S9	ENSG00000170889	"Ribosomal protein S9"	P46781	19	54200742-54249003	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 90.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 90.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048746	Approved					NA	Yes		1100000			"HPA048746: AB_2680510"	"prognostic favorable (9.23e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	51.9	40.6	32.5	68.3	25.6	74.8	80.3	18.2	28.1	52.1	63.8	29.5	48.3	42.3	89.9	51.1	80.4	38.9	80.4	47.4	27.5	22.2	40.4	60.5	48.3	114.8	31.8	22.9	98.2	188.8	15.2	27.1	33.1	22.4	58.7	30.2	34.0	106.3	47.5	74.5	65.1	41.6	59.4	35.5	65.5	67.0	41.5	19.4	67.3	71.4	85.0	62.9	59.5	79.4	13.1	15.7	90.3	20.0	7.4	13.9	23.9	22.1	8.6	14.2	23.1	28.5	47.0	16.9	30.4	26.9	21.8	17.4	10.5	21.6	72.3	23.7	20.4	11.8	25.1	34.3	22.8	17.4	25.7	42.2	32.5	7.9	11.4	20.2	42.3	18.0	43.1	35.8	17.7	31.2	27.5	33.0	26.9	36.7	26.8	17.2	5.1	37.5	25.1	29.2	20.3	10.0	27.2	24.1	37.8	23.8	17.3	16.7	29.0	17.8	33.7	29.4	11.4	30.2	47.7	38.2	12.1	22.6	19.7	40.5	25.4	49.1	43.7	17.8	36.5	19.6	6.2	20.0	17.1	8.8	9.3	11.7	11.9	11.7	9.2	13.1	13.1	13.9	11.1	90.3	7.4	4.6	15.7	7.5	23.9	32.5	25.6	18.2	28.1	27.5	22.2	31.8	22.9	22.4	19.4	425.8	944.9	3342.8	5052.7	5748.7	340.7	179.8	1582.2	559.4	998.6	840.9	164.9	2056.8	2108.8	1563.5	629.7	2076.8	1653.9	630.8	4888.9	3968.8	2619.1	3740.7	816.5	1809.4	2393.9	165.3	1899.5	1766.6	3230.1	1190.7	2659.9	3505.9	3114.3	2539.2	2869.7	472.8	2898.8	2433.8	1427.1	2466.8	447.6	1034.8	3377.6	475.1	482.9	6556.0	2066.0	2439.9	4056.1	4586.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062124-137070588	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	1.0	0.4	11.5	10.5	7.0	3.3	2.6	1.4	14.4	2.5	6.2	10.1	0.0	7.6	1.0	0.4	7.8	0.8	5.4	0.4	9.6	7.5	1.2	0.4	2.7	4.7	8.0	3.8	0.3	0.8	0.3	0.4	1.8	5.4	5.4	3.5	0.0	7.3	0.4	0.4	5.4	7.7	1.0	7.0	2.7	4.6	1.5	2.7	9.2	0.6	3.5	10.0	1.0	1.9	0.5	0.8	0.5	1.7	0.0	0.4	0.4	16.0	8.7	3.4	10.2	0.1	0.2	18.5	2.6	1.8	2.8	1.3	16.4	7.4	16.8	8.6	1.3	2.6	22.8	10.8	3.0	0.6	11.5	12.4	7.3	9.6	18.3	0.0	8.3	12.7	0.0	0.5	1.0	1.8	0.7	4.6	8.6	10.1	7.6	0.8	37.7	2.4	22.4	6.4	37.2	19.8	25.6	13.1	18.6	3.5	4.6	17.9	10.6	10.2	28.6	3.9	0.8	23.1	15.8	2.9	2.6	8.8	7.7	13.0	2.6	7.6	8.1	6.0	9.9	8.1	0.2	1.7	0.0	0.0	0.5	0.4	0.5	0.3	0.0	0.8	0.2	0.1	0.0	0.5	0.0	0.8	0.2	0.3	0.4	11.5	7.0	1.4	6.1	9.6	7.5	8.0	3.8	5.4	2.7	0.0	0.0	0.0	0.6	3.8	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.7	1.7	0.3	0.0	0.0	0.4	0.0	0.0	2.7	0.6	2.1	0.0	0.0	2.5	0.0	0.0	0.6	3.0	0.0	0.0	1.8	0.0	0.0	6.4	0.6	0.3	4.9	0.0	0.0	0.5	0.0	0.3	0.0	1.2	2.4	0.5	1.0	4.5	0.5
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
SCLT1	"FLJ30655, hCAP-1A"	ENSG00000151466	"Sodium channel and clathrin linker 1"	Q96NL6	4	128864921-129093607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.0"	"Group enriched"	"Detected in all"	4	"granulocytes: 31.0;monocytes: 13.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036560, HPA036561"	Approved					NA	Yes					"HPA036560: AB_2675190, HPA036561: AB_10673658"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.05e-2)"	"unprognostic (8.92e-2)"	7.4	6.5	8.5	16.5	10.5	25.0	7.1	11.8	10.6	6.9	7.1	9.7	9.8	7.8	9.5	7.2	8.3	6.8	9.1	8.1	8.9	8.0	5.5	6.7	11.6	14.9	7.8	5.2	10.8	7.5	7.6	10.3	8.9	9.3	5.5	8.6	9.7	6.0	8.8	3.6	6.5	8.3	8.4	8.9	14.5	6.8	8.9	7.9	24.3	6.8	6.0	11.9	9.2	7.6	2.0	4.5	31.0	13.3	5.0	2.2	3.1	11.7	3.4	11.9	8.4	4.1	6.7	6.6	10.2	9.0	11.1	10.1	3.5	11.0	10.4	6.6	5.7	7.8	4.7	7.7	7.4	11.6	23.2	6.2	13.7	7.0	3.9	5.7	16.0	11.0	4.2	2.8	8.8	8.9	5.5	8.6	5.7	15.1	26.1	9.5	5.5	13.0	8.0	5.4	8.7	6.4	7.5	11.9	6.5	7.0	3.4	17.8	5.3	8.0	7.2	6.7	5.6	4.2	6.7	7.9	9.4	11.5	12.2	13.5	12.5	9.3	17.8	5.1	18.0	14.3	6.5	8.1	16.1	2.2	11.2	1.4	2.0	1.4	1.7	4.5	2.0	1.5	1.8	31.0	5.0	13.3	2.3	2.1	3.1	8.5	10.5	11.8	10.6	8.9	8.0	7.8	5.2	9.3	7.9	11.9	9.8	11.7	7.9	9.8	14.3	18.9	15.3	21.4	12.5	1.8	27.5	10.1	3.3	4.8	43.1	9.5	6.4	0.0	5.5	17.2	10.6	3.1	11.5	1.5	11.6	15.9	5.2	7.4	14.9	34.6	10.0	14.5	8.5	8.2	6.2	7.7	6.6	7.2	8.5	2.7	22.2	12.9	13.1	16.6	11.1	12.2	7.8	21.5	8.3	4.8
SERF2	"4F5REL, FAM2C, H4F5rel, HsT17089"	ENSG00000140264	"Small EDRK-rich factor 2"	P84101	15	43777087-43802589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056613			Uncertain	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA056613: "	"unprognostic (3.29e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.33e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.42e-2)"	78.4	109.1	61.4	103.2	58.1	110.6	115.0	33.0	45.9	71.2	107.6	45.1	99.7	59.2	65.1	121.7	109.6	60.0	128.9	166.4	56.1	48.2	97.5	153.1	79.7	81.4	72.9	42.6	51.8	125.4	23.5	62.5	102.9	89.4	84.7	87.6	63.0	134.3	106.7	98.7	59.9	86.4	68.5	66.7	79.5	79.5	65.5	45.8	77.0	122.5	116.7	82.9	84.8	116.3	146.1	259.3	225.7	218.7	91.4	142.8	413.5	34.8	58.0	43.3	59.0	150.7	111.1	33.4	62.2	78.0	40.5	51.9	74.4	35.1	18.1	51.6	106.7	53.7	46.4	33.8	46.7	20.3	49.5	40.1	43.7	84.4	142.7	73.9	40.7	94.4	104.9	60.6	32.8	35.2	63.3	59.0	51.4	45.0	119.6	79.4	106.8	52.0	96.5	36.9	136.5	67.6	53.4	28.7	83.0	110.5	127.6	32.5	35.0	33.3	140.1	31.8	39.2	117.3	174.4	49.9	69.4	35.4	104.1	45.4	44.2	59.2	125.6	74.8	74.1	71.8	127.3	218.7	225.7	113.6	194.5	103.1	142.2	125.7	116.0	185.9	146.1	116.7	118.3	129.1	91.4	166.0	259.3	142.8	413.5	61.4	58.1	33.0	45.9	56.1	48.2	72.9	42.6	89.4	45.8	470.5	717.5	1171.8	1145.4	1022.8	54.4	1942.2	1490.4	1019.8	757.5	1647.0	51.1	2342.3	3302.5	1581.0	331.8	1228.3	2242.3	817.7	1967.3	2747.0	1831.7	2360.8	754.3	2534.0	3171.2	44.5	1122.7	1502.0	1926.7	193.3	1134.5	1999.7	1724.2	2939.6	2776.8	318.1	1792.5	2080.9	932.7	3520.7	108.9	595.0	1152.9	641.0	342.8	1360.5	2739.6	1068.3	1696.1	2044.0
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692800-1712555	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Spermatocytes: 268.0;Spermatogonia: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	19.8	18.1	26.9	30.4	28.0	60.7	27.5	23.8	30.0	19.3	19.3	14.2	20.7	16.3	20.4	21.9	25.0	19.0	15.8	17.9	25.1	26.5	23.7	21.2	18.7	43.9	19.9	24.0	23.1	17.8	13.0	19.5	27.7	16.0	20.0	21.3	17.9	24.7	21.2	15.1	24.7	17.0	20.5	17.1	26.1	18.2	50.6	12.4	52.4	24.9	17.7	42.8	23.7	26.6	24.4	24.1	45.3	29.8	19.8	36.1	30.4	29.4	12.1	17.5	18.4	15.5	17.7	18.2	25.9	22.2	31.5	31.9	25.0	34.4	38.9	15.5	21.4	37.2	18.1	35.1	23.5	37.0	15.9	19.0	48.8	15.1	25.1	19.2	45.1	23.8	12.2	18.9	23.9	15.9	18.3	17.9	26.1	34.9	38.5	38.5	10.6	69.4	41.1	21.8	31.1	21.6	52.3	28.6	24.6	30.3	22.4	19.9	15.3	22.0	14.3	15.3	24.7	23.7	29.8	15.1	26.5	15.2	27.9	40.3	22.4	40.7	93.0	24.8	38.7	26.0	9.3	29.8	21.8	23.6	22.3	21.4	24.4	30.8	33.2	24.1	18.0	26.5	25.1	45.3	19.8	19.8	19.1	36.1	30.4	26.9	28.0	23.8	30.0	25.1	26.5	19.9	24.0	16.0	12.4	14.9	16.8	53.9	86.5	93.4	17.7	7.1	25.5	8.1	7.9	34.9	23.6	121.4	91.2	43.6	64.1	31.8	21.2	23.3	27.3	39.1	59.3	64.3	23.1	26.1	70.1	23.8	34.4	29.4	34.0	32.9	40.9	44.4	62.4	61.3	27.5	27.6	30.6	23.0	41.4	37.4	11.4	12.9	49.1	268.0	323.2	92.5	37.4	59.9	37.5	71.2
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748652-74769353	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 372.3;Proximal tubular cells: 352.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 78.7;SK-BR-3: 64.2;T-47d: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		9600000	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	5.4	33.3	19.8	9.9	23.3	22.6	15.2	21.9	15.1	12.5	30.6	15.2	35.9	57.6	5.4	12.0	74.3	20.5	30.8	5.6	14.2	8.8	36.1	64.9	8.6	13.5	14.3	14.0	5.0	26.5	12.5	4.9	8.3	12.8	10.1	13.4	22.9	41.8	23.3	1.5	11.2	73.3	3.1	12.1	13.8	14.8	5.4	14.1	18.4	5.6	24.3	30.3	7.1	20.3	9.8	14.3	72.7	24.8	45.1	70.4	44.3	13.9	11.5	5.7	5.9	3.5	2.5	25.9	3.3	3.1	8.6	8.4	36.0	8.4	3.0	3.4	7.1	4.6	20.1	9.8	6.5	4.1	3.7	9.4	23.0	31.1	47.9	7.1	15.0	15.6	2.1	3.6	6.8	2.9	18.0	7.1	9.2	7.3	16.5	13.2	78.7	35.3	33.7	5.1	39.5	6.8	3.8	6.5	13.9	11.9	10.0	4.9	6.5	3.5	64.2	7.2	16.6	124.2	12.0	2.3	2.7	7.8	6.3	5.5	28.6	12.9	5.6	4.3	20.0	1.5	72.7	14.1	65.3	70.4	20.6	46.6	9.8	43.2	59.3	13.7	8.6	25.5	45.2	50.3	45.1	24.8	14.3	47.0	44.3	19.8	23.3	21.9	15.1	14.2	8.8	14.3	14.0	12.8	14.1	6.0	18.8	36.3	18.8	41.0	1.9	14.9	206.4	41.5	14.8	29.6	3.9	67.4	56.3	154.8	9.9	11.7	372.3	0.0	86.0	43.0	16.6	31.5	24.3	159.6	66.7	4.8	18.0	4.9	23.7	8.2	8.1	24.4	27.0	7.2	41.8	82.0	78.1	101.7	39.3	352.2	4.7	6.5	14.4	6.0	20.7	50.2	93.3	101.5	27.5	31.5
SMCO4	"C11orf75, FN5"	ENSG00000166002	"Single-pass membrane protein with coiled-coil domains 4"	Q9NRQ5	11	93478472-93543508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"salivary gland: 124.3"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 179.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 49.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041120	Uncertain					NA	Yes					"HPA041120: AB_2677309"	"unprognostic (7.45e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.51e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (5.81e-7)"	"unprognostic (1.61e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.01e-2)"	6.1	19.0	4.3	10.0	7.3	1.6	6.2	2.5	4.5	5.0	10.6	4.5	11.5	16.1	5.4	4.6	5.5	9.4	9.3	13.4	4.5	7.9	10.9	33.5	9.0	9.1	6.2	4.0	6.4	17.9	1.1	15.7	3.5	5.7	13.1	8.0	6.0	124.3	10.3	6.2	5.5	21.2	4.8	5.0	16.7	12.2	9.9	4.5	5.4	34.3	3.1	8.6	3.7	5.1	4.2	29.7	11.4	57.3	5.6	5.4	15.7	3.3	6.3	9.3	2.7	3.5	5.5	6.2	9.1	2.6	4.3	7.8	11.2	14.6	9.1	11.3	8.4	6.4	1.9	8.5	1.1	2.5	25.6	7.7	2.2	11.8	25.7	3.6	8.8	11.3	5.4	5.1	2.0	1.6	4.9	7.0	32.0	5.3	49.1	1.4	7.0	8.9	17.4	9.9	25.4	9.3	17.2	5.9	4.6	7.9	8.3	1.5	7.9	7.5	11.0	0.7	11.7	4.3	12.2	3.9	4.5	16.8	15.0	8.2	1.9	0.2	7.1	3.3	17.2	1.7	6.8	51.3	1.2	0.8	57.3	3.5	4.2	5.4	1.5	28.8	3.0	0.7	0.6	11.4	5.6	52.1	29.7	2.0	15.7	4.3	7.3	2.5	4.5	4.5	7.9	6.2	4.0	5.7	4.5	23.8	20.2	13.7	30.3	29.1	1.9	27.1	56.0	8.1	15.9	47.1	0.0	3.7	179.1	29.8	88.0	22.2	95.7	0.0	61.8	8.5	23.4	137.8	2.3	84.7	133.0	3.2	43.1	12.9	81.9	100.6	11.8	67.0	28.7	35.1	107.8	4.5	39.2	115.8	9.9	48.8	1.4	6.5	11.8	5.9	41.5	18.6	4.0	10.2	59.6	20.7
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes			"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.5	10.3	12.5	13.5	7.3	6.7	3.3	6.6	7.2	9.5	5.6	4.1	1.2	3.3	2.5	11.6	8.2	10.2	10.0	6.2	10.0	0.5	2.0	5.4	9.6	5.4	3.8	1.2	5.3	3.8	7.6	9.0	6.4	4.1	6.1	3.7	3.8	0.7	10.3	7.3	3.8	2.8	3.2	0.8	8.0	9.0	11.7	1.3	5.5	2.3	15.0	9.4	13.8	15.2	4.4	5.8	19.3	8.1	9.3	23.8	4.6	11.6	14.4	1.4	0.3	3.4	10.1	1.6	15.0	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7	0.0	2.6	1.4	4.8	11.2	18.8	12.1	0.0	2.7	7.9	19.2	35.3	12.5	1.7	3.4	0.4	10.5	1.7	0.0	1.3	8.6	11.0	5.2	10.4	0.2	8.5	22.3	5.8	9.8	5.3	1.5	11.2	6.0	5.0	1.0	1.3	19.4	1.8	0.0	17.7	1.2	3.7	12.9	11.3	0.7	1.0	14.1	2.7	1.0	2.5	2.5
SOX4		ENSG00000124766	"SRY-box 4"	Q06945	6	21592768-21598619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2"	"Region enriched"	"Detected in many"	4	"olfactory region: 66.5"	"Low region specificity"	"Detected in many"			HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	4.2	0.7	2.0	1.9	0.9	6.0	6.3	3.0	6.3	6.7	2.8			3.0	18.0	4.1	2.3	4.2	5.5	2.0	1.1	1.8	4.3	1.3	5.1	0.8	0.6		18.1	5.3	0.0	1.8	1.0		4.1	3.7		9.6	1.4	0.3	4.1	2.7	4.9	0.3	1.0	4.4	2.5			3.4		1.4	6.2	3.6	3.1	21.8	12.8	10.0	3.3	1.1	2.0	1.8	5.2	13.3	55.4	4.9	1.2	21.7	0.8	1.7	1.0	0.9	3.5	3.5	0.6	22.2	1.3	0.7	5.4	6.9	3.8	0.7	7.6	14.5	0.5	2.4	2.3	0.8	1.8	0.4	2.1	3.9	0.4	1.6	14.2	15.6	30.0	0.1	0.0	1.1	4.3	47.6	4.5	9.9	2.6	5.0	21.0	1.1	0.0	9.6	16.7	17.4	31.2	7.7	9.0	2.9	17.3	4.4	6.5	11.9	1.5	5.2	0.3	3.9	0.3	0.0	15.4	0.5	6.5	6.1	12.8	9.8	0.9	0.2	5.5	0.0	2.8	0.1	0.1	4.1	3.1	1.1	0.8	0.4	3.3	10.0	21.8	0.9	2.0											184.6	59.8	33.5	82.0	99.9	88.8	228.6	341.4	161.9	235.4	146.5	11.8	61.5	56.3	757.4	3.9	238.0	78.0	0.0	523.0	358.6	243.9	126.1	56.8	5.8	33.0	46.1	327.2	70.6	85.2	8.3	11.2	56.1	231.2	80.2	156.9	228.7	1059.7	155.6	10.6	77.4	25.8	6.5	198.6	3.7	175.2	81.3	25.3	23.5	265.6	178.0
SPDL1	"CCDC99, FLJ20364, hSpindly"	ENSG00000040275	"Spindle apparatus coiled-coil protein 1"	Q96EA4	5	169583634-169604778	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.7"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 97.4;Spermatogonia: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA044700, HPA048146"	Enhanced		Approved	Cytosol		NA	Yes			Cytosol		"HPA044700: AB_2679052, HPA048146: AB_2680284"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.59e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (2.63e-3)"	"unprognostic (5.70e-3)"	"unprognostic (8.27e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.93e-1)"	5.5	4.7	6.5	9.0	11.5	9.9	8.0	14.5	11.0	5.5	5.6	6.6	3.4	5.9	6.4	4.4	9.7	4.9	4.9	4.0	7.8	5.8	5.1	3.6	4.7	13.9	8.3	7.1	7.2	4.1	5.6	8.0	8.4	11.6	4.1	6.0	2.0	5.1	3.6	5.0	5.3	5.9	7.7	16.7	8.2	5.3	33.7	10.4	23.9	4.5	8.5	13.6	5.4	5.8	10.7	16.5	3.2	4.6	6.4	9.3	3.0	14.6	17.6	18.0	12.6	4.8	4.5	15.9	46.6	6.2	34.9	31.7	23.1	9.9	13.8	30.9	38.1	24.0	10.3	14.6	20.0	38.3	14.2	16.3	16.1	31.7	9.0	2.2	16.9	13.9	2.1	1.7	14.6	9.2	7.4	15.8	14.3	10.1	10.2	37.1	14.2	13.8	7.2	13.1	7.3	17.1	16.2	17.7	10.2	22.8	5.2	11.6	8.5	21.7	6.2	9.1	13.3	7.0	11.3	11.2	39.8	12.6	11.3	36.1	8.1	17.0	18.6	9.6	15.6	13.3	3.2	2.2	2.9	7.3	3.0	7.7	8.8	6.6	7.7	2.2	10.7	9.3	7.4	0.4	6.4	4.6	16.5	6.4	3.0	6.5	11.5	14.5	11.0	7.8	5.8	8.3	7.1	11.6	10.4	3.0	7.5	6.7	1.7	3.5	7.1	7.2	0.0	4.0	7.9	1.8	0.0	7.9	5.0	4.9	7.6	3.9	0.5	23.3	4.2	21.7	7.5	1.1	8.1	2.9	10.0	3.2	1.7	11.6	4.0	8.7	4.0	6.1	3.3	6.4	1.9	6.1	5.4	1.7	6.0	5.1	3.9	6.5	9.2	97.4	70.9	3.9	4.1	4.4	5.1	2.1
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	59.3	22.9	28.7	41.7	58.7	84.6	66.9	17.6	43.8	33.7	33.6	57.5	24.2	29.0	47.3	23.3	41.4	42.5	25.3	32.3	37.8	19.3	24.4	47.1	37.7	56.8	73.6	25.4	44.8	44.1	10.5	14.8	22.7	42.5	31.2	16.3	14.9	39.1	35.0	48.6	31.0	31.6	35.3	37.1	46.3	35.2	30.2	68.0	42.6	26.9	20.1	36.0	47.0	35.9	6.4	6.0	14.0	13.9	13.3	25.5	11.8	25.1	11.7	11.7	13.0	35.7	8.9	15.3	17.3	20.3	20.6	17.5	10.5	28.5	7.9	21.2	24.5	12.7	18.8	3.9	12.8	8.5	27.5	15.8	5.1	12.6	9.4	21.7	17.4	54.3	7.5	10.9	9.8	9.2	13.9	16.3	16.0	6.5	45.0	11.1	8.0	9.6	15.1	1.1	17.8	7.6	16.1	16.4	23.8	5.1	12.3	10.4	3.8	19.3	21.5	10.1	5.7	14.4	32.7	27.3	15.0	13.1	13.1	22.4	33.3	10.4	8.4	27.8	21.0	25.0	14.0	7.4	9.7	25.5	8.8	16.5	6.3	16.2	20.6	6.0	6.4	17.1	20.1	8.0	13.3	13.9	3.7	11.0	11.8	28.7	58.7	17.6	43.8	37.8	19.3	73.6	25.4	42.5	68.0	20.8	22.2	33.6	23.8	16.1	8.4	2.2	35.7	2.7	17.0	31.4	7.9	11.6	3.3	30.6	1.7	29.2	45.1	23.3	41.2	49.9	28.2	22.7	25.3	93.6	23.5	20.6	17.9	30.1	39.8	2.0	56.7	37.5	16.9	3.6	25.6	21.7	45.2	31.3	61.5	16.3	12.4	51.8	34.0	0.9	0.7	15.1	12.4	112.3	17.8	18.0
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 67.3;Peritubular cells: 39.3;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.1;HMC-1: 31.3;RT4: 20.6;TIME: 17.7"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Low region specificity"	"Detected in some"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		NA	Yes		6100000	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.5	2.5	0.0	3.9	2.5	4.2	7.5	0.3	3.9	0.0	1.0	2.7	3.6	3.5	15.1	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	31.3	0.9	0.3	3.8	0.2	1.6	10.5	0.0	1.4	0.0	1.9	1.0	0.0	0.0	0.6	10.6	0.0	0.0	1.2	0.0	3.7	20.6	7.6	0.3	1.5	5.9	0.8	1.6	3.7	0.3	17.7	2.2	4.7	10.8	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5	26.8	1.7	0.0	6.9	0.1	0.1	3.6	22.9	6.7	6.8	3.5	0.0	0.2	3.3	5.5	1.6	9.5	15.8	0.0	2.0	0.2	6.3	15.5	3.5	32.1	1.0	0.0	0.0	12.3	1.6	2.0	67.3	0.9	3.3	0.0	18.0	4.6	5.4	25.4	39.3	1.6	0.4	51.8	6.2	1.4	4.6	0.6	0.0	0.7	8.1	7.6
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11026420	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	36.1	38.1	52.3	43.3	62.9	31.7	42.8	86.2	61.8	38.7	39.8	47.6	37.5	39.8	45.8	47.2	47.8	37.9	32.4	40.8	49.5	36.7	39.3	48.3	40.2	52.8	59.0	45.2	53.0	39.1	60.2	68.1	44.2	46.5	43.3	52.9	38.4	41.7	45.3	57.1	43.0	43.4	50.5	44.7	46.1	38.1	34.5	62.6	52.2	46.7	38.0	63.5	38.1	47.9	29.4	31.7	16.5	24.8	33.6	31.1	17.0	52.6	36.2	62.1	31.8	33.7	28.4	36.7	36.2	32.0	59.6	44.6	42.7	38.9	70.2	26.6	40.2	35.0	37.8	75.2	42.1	78.6	37.6	36.3	53.2	60.1	56.7	27.6	63.7	35.4	23.1	47.9	41.8	34.3	33.5	42.2	27.7	68.3	39.6	50.4	42.5	46.6	51.7	49.5	50.5	32.4	55.3	49.8	44.6	42.9	39.0	42.4	35.0	49.3	39.1	27.9	47.4	39.1	45.0	38.5	40.0	47.0	32.9	52.0	29.6	36.5	74.3	26.2	64.1	42.4	16.3	19.6	16.5	25.4	24.8	31.1	29.4	26.0	24.6	31.7	21.2	25.9	27.7	7.9	33.6	23.6	22.2	26.8	17.0	52.3	62.9	86.2	61.8	49.5	36.7	59.0	45.2	46.5	62.6	29.8	67.3	58.2	67.5	101.8	36.2	65.0	33.1	64.3	60.3	27.9	27.5	55.0	28.2	39.9	5.6	56.1	37.9	46.7	47.0	69.3	45.5	61.8	39.5	45.1	43.8	35.0	63.7	35.6	47.5	7.8	43.7	40.0	33.7	38.7	45.1	35.8	42.4	31.6	48.4	33.2	37.8	32.3	50.6	50.2	31.1	100.1	61.4	41.7	47.8	60.0
TBKBP1	"KIAA0775, ProSAPiP2"	ENSG00000198933	"TBK1 binding protein 1"	A7MCY6	17	47694081-47712050	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 13.0;Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062347, HPA064856"	Approved		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA062347: AB_2684744, HPA064856: AB_2685371"	"unprognostic (2.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (8.14e-6)"	"unprognostic (5.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.59e-5)"	12.6	7.8	16.1	8.7	8.4	5.6	6.0	13.5	20.1	11.2	7.3	3.9	5.4	3.1	9.7	5.9	10.9	6.7	7.8	12.2	16.3	14.6	6.3	3.2	7.8	5.3	11.2	15.2	17.9	15.0	9.2	6.4	9.2	8.0	7.4	2.4	12.2	18.2	9.8	30.1	4.6	3.6	12.1	4.2	11.0	5.4	8.5	2.8	2.8	9.1	6.5	6.7	8.0	9.6	0.6	0.5	5.7	0.5	2.2	2.8	0.3	0.2	5.2	9.7	10.3	5.0	5.1	6.3	5.3	5.5	2.6	3.1	32.5	0.8	0.1	5.3	6.5	4.7	0.6	7.6	1.3	1.5	6.3	17.1	13.7	4.6	5.4	11.6	2.6	3.0	10.2	3.5	0.6	0.9	8.2	9.1	3.8	11.8	0.0	1.4	1.4	1.6	12.8	13.5	0.2	3.7	6.1	3.0	5.4	3.3	0.4	8.5	15.8	2.5	0.6	2.7	9.6	5.8	5.9	10.5	8.1	9.6	9.7	0.6	3.6	0.3	6.4	4.7	4.9	2.0	0.0	0.5	0.9	2.8	0.2	1.5	0.0	0.7	2.0	0.5	0.6	0.3	1.0	5.7	2.2	0.0	0.5	0.5	0.3	16.1	8.4	13.5	17.9	16.3	14.6	11.2	15.2	8.0	2.8	0.0	1.4	0.5	3.3	3.5	13.0	2.8	0.0	0.0	1.2	3.5	2.0	0.1	1.7	0.9	5.9	5.2	0.0	0.0	1.5	0.1	3.7	4.7	0.0	1.1	2.7	27.0	5.1	9.8	3.3	4.1	8.1	1.7	1.7	1.0	0.1	4.1	1.1	0.0	8.1	3.7	3.5	0.0	4.2	4.4	5.1	2.6	0.2	1.5	0.0	1.7
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274542-112285903	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	5.7	6.4	3.3	16.7	3.8	19.2	7.4	6.1	4.5	7.0	3.9	2.0	8.4	3.4	3.6	2.3	14.3	4.0	4.2	7.9	4.7	2.1	4.1	14.6	6.7	22.9	5.4	1.6	9.2	32.2	4.1	3.3	7.4	3.9	6.6	3.7	5.4	21.3	4.5	4.0	9.0	8.7	4.7	4.0	20.3	7.1	3.0	4.8	12.5	14.8	7.8	23.2	7.2	7.3	23.2	7.0	11.3	3.8	9.1	17.7	6.1	7.0	1.8	2.6	4.4	3.2	2.6	5.3	5.6	10.6	3.6	6.1	0.9	6.3	21.5	4.6	2.2	5.3	2.1	3.6	4.3	7.5	17.4	2.1	2.1	4.3	2.0	2.2	6.7	2.9	3.5	2.4	3.8	4.2	6.1	5.6	6.0	2.1	46.1	4.7	3.5	11.8	3.7	0.5	4.3	2.3	20.6	6.7	14.3	7.9	4.8	6.1	6.3	4.5	9.5	2.2	1.2	4.0	9.7	4.2	5.7	6.7	4.7	4.4	28.9	26.5	39.8	5.3	4.5	4.1	2.9	3.8	2.0	6.3	2.7	10.3	21.2	11.7	11.0	7.0	23.2	5.4	6.6	11.3	9.1	3.2	6.5	17.7	6.1	3.3	3.8	6.1	4.5	4.7	2.1	5.4	1.6	3.9	4.8	17.9	20.6	34.4	9.9	18.9	1.0	14.1	10.2	6.7	11.4	12.2	0.0	42.8	16.6	12.7	0.0	14.5	5.8	0.0	21.2	17.8	22.6	27.2	3.5	8.5	16.0	0.0	8.6	4.9	10.7	0.0	8.3	11.2	32.1	6.4	7.0	11.3	12.9	3.6	10.3	6.3	0.6	6.5	13.4	0.9	3.0	22.7	66.4	27.3	6.5	10.7
TIPIN	FLJ20516	ENSG00000075131	"TIMELESS interacting protein"	Q9BVW5	15	66336206-66386746	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039704, HPA058799"	Enhanced					NA	Yes					"HPA039704: AB_10795258, HPA058799: AB_2683824"	"unprognostic (3.47e-1)"	"prognostic favorable (4.15e-4)"	"unprognostic (3.49e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.18e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.91e-1)"	"unprognostic (2.89e-3)"	6.0	7.8	11.0	9.2	8.9	15.1	8.3	14.2	9.4	6.2	6.6	11.2	6.2	3.9	6.9	6.0	8.9	7.9	3.7	5.4	8.2	8.2	5.7	7.0	5.0	12.0	7.9	7.8	9.2	6.5	11.2	8.7	5.3	8.3	5.2	7.6	9.1	6.1	7.0	6.8	5.4	4.9	6.3	8.4	6.6	5.4	25.7	8.9	12.8	6.3	6.9	14.0	4.7	5.7	6.5	6.8	2.4	7.2	7.7	6.2	3.2	10.4	12.6	14.1	6.7	2.6	5.3	11.6	14.8	6.0	20.9	18.5	18.4	12.0	21.4	10.8	5.5	12.2	16.7	35.3	12.7	19.9	14.2	19.6	18.8	12.7	10.2	5.0	19.7	6.9	6.7	4.2	19.4	15.8	3.0	8.6	17.9	15.6	10.4	17.9	11.9	18.0	12.7	14.3	24.5	10.0	18.1	21.0	21.3	7.1	12.0	13.3	8.4	10.3	6.6	9.5	10.7	10.0	12.0	5.7	14.9	16.3	12.8	26.9	6.3	32.2	34.0	10.0	36.2	15.1	0.7	3.6	2.4	4.9	7.2	5.8	4.0	3.8	4.2	6.8	6.5	5.5	6.2	1.0	7.7	4.3	5.1	3.4	3.2	11.0	8.9	14.2	9.4	8.2	8.2	7.9	7.8	8.3	8.9	6.0	6.5	44.9	39.5	87.0	11.3	2.2	28.1	5.3	5.7	8.7	9.8	27.1	72.9	7.4	44.0	18.0	3.5	23.3	7.3	32.4	21.8	32.9	8.1	12.9	18.5	7.9	4.6	17.8	28.6	22.7	17.5	23.6	54.0	5.4	7.3	8.4	6.0	7.0	17.0	8.4	13.3	32.3	27.6	93.7	64.3	95.1	16.2	34.9	10.7	25.3
TMEM243	"C7orf23, MGC4175, MM-TRAG"	ENSG00000135185	"Transmembrane protein 243"	Q9BU79	7	87196160-87220587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014918	Uncertain					NA	Yes					"HPA014918: AB_2067447"	"unprognostic (5.14e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.32e-2)"	"prognostic favorable (9.13e-4)"	14.3	8.6	7.9	26.0	7.9	11.3	15.9	6.2	9.0	15.1	13.4	5.5	18.8	11.5	15.6	19.3	12.0	13.0	10.7	8.3	7.1	7.1	23.6	3.8	26.6	29.5	7.2	6.9	19.5	33.8	11.2	12.3	15.2	8.4	14.0	8.4	10.3	27.5	18.3	4.4	10.8	19.3	9.8	10.1	26.8	12.5	6.7	6.1	23.8	42.5	6.4	36.6	11.7	22.3	45.4	32.8	10.3	9.4	16.1	37.8	9.9	11.8	7.2	7.2	9.0	17.3	19.5	17.4	9.7	14.8	7.3	13.5	10.0	14.5	25.6	21.5	9.7	13.3	11.4	6.8	9.8	9.8	10.8	18.2	0.4	12.5	21.1	13.6	9.2	2.0	12.8	9.9	5.6	11.3	14.1	10.9	13.5	1.2	13.8	9.9	19.5	11.4	1.5	8.1	1.3	10.0	22.7	21.7	35.0	21.1	9.3	7.9	7.2	7.2	15.1	10.7	13.1	5.6	1.6	5.8	12.4	10.9	31.5	8.4	19.7	16.9	49.6	11.4	8.5	7.2	10.3	9.2	5.8	12.4	9.4	17.8	45.4	22.3	15.5	15.6	44.1	37.8	26.2	4.0	16.1	6.2	32.8	19.7	9.9	7.9	7.9	6.2	9.0	7.1	7.1	7.2	6.9	8.4	6.1	23.8	79.5	136.8	39.7	37.9	5.5	0.8	33.1	33.5	27.3	21.0	37.3	97.6	44.7	21.0	31.6	29.3	9.2	23.3	37.3	35.0	55.2	32.9	2.3	2.9	44.2	11.1	7.0	24.5	49.1	9.8	76.8	45.9	49.0	19.8	23.5	7.7	23.2	28.1	55.5	54.9	11.9	45.3	24.9	16.1	37.2	33.2	28.0	61.8	35.9	37.9
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 73.4;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		270000	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	21.1	2.1	1.6	49.9	3.0	17.8	18.9	1.5	1.7	11.3	8.0	1.6	4.7	4.3	9.7	9.2	15.0	4.6	9.7	8.5	1.8	1.7	8.7	8.4	22.0	71.3	2.9	1.8	4.2	12.5	5.2	1.7	36.1	12.2	11.8	5.5	4.2	13.7	5.8	2.2	14.4	21.4	6.9	3.6	37.5	13.1	4.7	2.2	83.1	9.3	8.6	41.1	12.7	12.8	50.3	25.2	73.4	19.7	19.7	54.4	36.5	7.5	5.3	2.8	4.6	6.1	5.1	26.0	4.2	11.4	3.2	6.6	2.9	8.8	14.2	1.3	4.7	5.1	10.8	2.3	12.8	4.5	15.5	4.9	22.5	11.9	4.9	2.9	27.1	25.0	5.7	12.1	9.6	4.6	6.2	4.3	28.3	8.7	44.5	4.4	2.9	23.0	35.4	4.3	4.4	2.5	7.0	12.6	20.6	12.8	15.2	1.5	2.2	15.8	3.1	1.5	9.7	2.7	31.0	2.1	5.8	2.2	4.0	4.9	21.9	24.0	28.6	6.7	29.0	3.4	73.4	18.6	55.3	22.6	19.7	43.9	50.3	45.5	33.2	25.2	44.2	54.4	34.9	10.6	19.7	14.8	12.1	34.8	36.5	1.6	3.0	1.5	1.7	1.8	1.7	2.9	1.8	12.2	2.2	8.9	16.0	115.2	57.1	142.5	0.1	8.9	15.3	48.2	25.0	17.4	0.0	133.6	14.9	46.4	1.9	18.9	1.3	0.0	87.0	135.2	42.9	45.5	208.8	0.5	45.7	0.0	1.2	6.2	52.3	1.1	2.0	76.8	35.4	266.9	7.6	3.9	105.8	2.9	1.8	11.0	0.5	45.3	34.0	0.4	14.9	104.3	244.7	119.6	3.8	58.5
TNFAIP8L1	MGC17791	ENSG00000185361	"TNF alpha induced protein 8 like 1"	Q8WVP5	19	4639518-4655568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 302.9;Late spermatids: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 23.0;HUVEC TERT2: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	Yes						"unprognostic (1.39e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (7.65e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	8.5	2.1	6.2	8.9	4.6	2.2	6.2	6.3	9.9	3.4	19.3	2.2	1.4	8.8	3.4	3.6	7.6	23.5	7.5	5.3	6.2	4.3	6.9	26.1	6.0	11.0	2.6	3.1	4.2	1.8	1.0	3.1	12.8	3.7	6.0	4.7	3.0	2.3	1.7	4.3	6.7	13.4	5.5	1.6	12.6	8.9	8.5	2.8	6.4	5.2	6.7	5.5	6.7	4.7	6.2	3.1	10.6	7.7	4.9	5.5	3.0	11.0	3.5	4.9	7.8	1.5	2.4	2.5	2.1	3.8	4.3	3.9	6.3	4.2	5.3	1.0	3.1	4.6	5.6	3.0	3.6	4.0	8.7	1.4	12.2	2.0	11.3	2.2	1.8	23.0	3.1	1.1	3.8	2.5	5.3	22.1	6.6	6.3	7.9	4.8	3.5	2.1	8.8	2.5	7.8	4.8	6.1	3.2	2.5	4.2	1.0	2.0	4.4	1.0	2.9	4.3	3.8	2.1	4.9	15.9	2.2	9.0	3.3	8.0	4.3	5.3	4.8	4.2	5.6	6.2	4.5	3.8	10.6	2.5	5.2	4.4	6.2	4.4	2.7	3.1	5.1	5.5	4.6	1.8	4.9	7.7	2.7	5.1	3.0	6.2	4.6	6.3	9.9	6.2	4.3	2.6	3.1	3.7	2.8	0.0	13.0	13.7	2.5	10.3	3.4	2.0	12.7	99.0	10.3	3.5	0.0	2.0	1.7	2.5	302.9	26.9	3.2	23.3	1.1	6.5	6.6	2.6	49.5	37.2	6.9	3.2	7.5	58.9	10.4	681.4	7.8	12.4	5.0	13.6	2.3	1.5	2.1	0.0	6.7	17.4	5.3	19.4	5.2	8.6	5.7	9.8	7.8	10.2	6.6	2.6
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064372	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 80.4;Leydig cells: 131.2;Peritubular cells: 107.1;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.2;ASC TERT1: 28.1;HHSteC: 21.7;HSkMC: 30.8;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes					"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	69.5	26.5	13.2	12.8	17.4	0.8	43.9	8.1	14.7	37.4	22.1	17.5	22.0	9.7	35.3	23.6	20.1	30.4	32.9	34.2	13.3	9.8	21.1	18.7	25.8	16.5	15.8	10.5	48.6	18.0	14.8	13.0	22.0	14.6	23.7	8.4	33.7	21.4	29.6	38.7	11.2	14.8	25.0	13.4	27.9	16.7	16.6	16.0	0.6	23.2	26.5	7.2	24.1	47.6	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.7	7.2	0.9	0.7	41.2	28.1	0.2	4.0	9.5	2.1	1.1	0.5	1.9	0.0	8.9	11.0	0.9	0.5	0.0	2.6	0.8	0.1	0.2	0.1	7.8	3.8	21.7	0.1	0.1	30.8	0.1	2.8	1.6	21.9	12.6	0.1	0.2	0.1	8.7	1.7	0.0	0.0	0.6	0.5	2.0	0.2	2.3	0.1	2.9	0.1	0.4	0.9	1.5	0.8	3.1	0.6	9.1	0.2	17.9	4.5	5.4	1.6	0.7	0.2	0.0	0.0	7.2	0.1	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	17.4	8.1	14.7	13.3	9.8	15.8	10.5	14.6	16.0	3.0	18.8	0.0	7.4	0.0	19.6	7.3	7.6	2.7	4.5	5.2	0.0	0.4	3.3	3.6	1.9	56.1	0.0	0.0	3.7	0.3	14.3	3.4	0.0	28.2	1.9	28.6	1.2	80.4	7.1	2.9	131.2	1.3	0.0	0.0	4.2	37.3	2.5	4.2	107.1	2.2	12.0	148.8	8.8	2.3	3.6	0.0	0.7	0.0	2.4	2.2
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444444	"Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 31.4;Enterocytes: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.4	2.8	1.4	11.0	1.8	11.7	1.9	6.1	2.7	1.9	5.5	1.4	3.2	5.5	2.2	1.8	5.6	1.7	1.3	1.6	1.2	1.1	2.0	2.3	2.6	3.7	1.9	1.2	2.4	2.3	1.1	1.1	2.6	2.9	2.1	1.7	0.8	3.1	2.2	1.0	4.0	6.8	1.4	1.9	5.6	3.5	4.8	2.1	10.3	3.3	3.6	5.3	3.9	5.1	0.6	0.1	0.0	0.2	1.9	0.6	0.1	6.9	6.2	4.7	7.4	0.3	0.6	11.4	5.9	1.1	3.6	2.8	5.0	6.1	6.5	6.1	0.9	1.7	4.8	4.6	3.6	0.8	6.7	9.1	15.4	8.0	5.2	0.2	4.7	9.7	0.6	0.5	3.7	0.7	0.9	1.7	9.0	17.3	4.9	1.4	14.4	11.6	8.0	6.7	6.8	9.2	14.1	3.1	6.7	2.0	7.6	7.9	4.5	6.2	4.2	2.6	1.9	6.0	4.4	2.0	4.4	18.4	5.0	7.2	1.7	3.2	3.9	4.3	10.0	5.1	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.2	0.6	0.1	0.6	0.5	0.4	0.0	1.9	0.0	0.0	0.2	0.1	1.4	1.8	6.1	2.7	1.2	1.1	1.9	1.2	2.9	2.1	6.0	31.4	5.2	3.3	7.9	2.4	2.1	10.2	6.7	5.7	1.8	2.0	2.5	0.0	1.0	0.2	2.3	32.9	0.0	0.9	4.4	4.1	3.1	2.3	8.6	3.7	1.6	2.4	4.3	1.6	0.2	0.3	5.8	13.5	1.0	8.4	0.8	0.8	5.7	1.1	3.7	2.5	6.5	3.3	2.8	8.1	9.8	1.0	3.9	9.6	3.1
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028818-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 670.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	26.6	31.0	24.6	46.3	25.3	55.3	37.4	39.6	31.1	21.3	30.0	11.1	26.7	29.7	22.9	22.5	36.0	20.5	29.2	21.0	23.0	18.3	31.8	32.7	37.9	38.6	21.9	20.9	25.5	22.5	22.2	39.9	43.9	25.2	23.3	27.2	13.6	25.3	34.3	26.2	24.6	48.4	23.1	27.4	36.9	26.7	14.2	24.2	54.2	31.5	25.1	40.6	25.2	41.7	9.0	17.2	18.4	11.1	5.8	8.2	4.6	22.0	15.4	28.9	23.7	11.7	14.0	28.7	20.0	17.6	23.2	21.2	40.5	27.8	62.9	21.4	10.3	24.8	21.5	34.7	31.9	34.1	13.6	17.7	80.2	12.4	28.7	30.6	34.5	27.6	15.8	17.0	22.6	37.2	20.8	24.2	23.0	34.7	21.9	26.2	49.0	48.8	21.9	23.3	22.1	28.8	41.7	27.2	33.4	24.8	20.5	24.1	16.7	31.3	19.4	20.3	21.8	21.6	30.9	23.7	18.8	16.0	17.4	21.4	13.9	15.6	73.3	25.3	19.4	17.8	9.1	9.2	14.3	6.5	9.2	8.2	9.0	7.2	6.8	8.6	8.7	7.7	6.9	18.4	5.8	11.1	17.2	7.9	4.6	24.6	25.3	39.6	31.1	23.0	18.3	21.9	20.9	25.2	24.2	110.2	181.3	71.6	274.4	218.4	93.3	38.9	84.1	73.6	228.6	94.2	56.9	139.0	63.0	78.8	6.3	78.8	108.1	210.2	57.1	149.4	129.3	136.7	76.2	114.3	86.4	68.3	88.0	63.8	84.7	6.5	55.3	93.8	69.2	72.1	73.8	94.4	93.7	112.2	65.4	91.4	80.4	84.1	77.1	95.2	57.3	187.2	670.2	61.2	78.0	206.2
TOR3A	"ADIR, ADIR2, FLJ22345"	ENSG00000186283	"Torsin family 3 member A"	Q9H497	1	179081377-179098023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 59.3;U-266/84: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028766	Approved				"Intracellular and membrane"	NA	Yes					"HPA028766: AB_10602251"	"unprognostic (5.55e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.82e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (4.78e-8)"	"unprognostic (4.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	12.3	13.5	8.0	22.9	11.4	20.6	14.9	4.5	15.5	11.0	15.9	12.5	9.5	13.8	14.3	13.2	12.9	13.3	21.3	9.9	7.4	8.4	12.4	17.3	13.5	28.1	8.2	11.8	13.4	26.8	14.2	14.9	10.7	8.7	13.3	15.5	11.0	22.2	14.6	20.4	12.0	18.0	13.3	8.3	31.3	16.0	6.5	6.2	18.1	17.7	13.6	25.0	14.8	11.1	31.3	29.3	6.4	23.0	9.7	13.6	16.5	11.0	13.6	3.9	10.8	7.9	6.2	12.1	8.3	9.9	9.7	7.0	5.8	17.5	17.8	14.9	8.0	5.9	14.4	10.7	6.9	5.1	13.7	10.0	19.4	8.1	8.8	12.8	21.1	16.9	6.9	6.3	7.6	6.5	4.0	7.0	7.0	23.4	34.1	6.6	23.6	13.0	11.8	7.9	13.2	7.6	10.0	6.8	17.3	6.1	15.5	7.8	10.4	12.3	19.5	5.1	6.9	14.6	15.5	4.4	7.7	5.4	12.6	10.8	59.3	64.0	15.1	5.4	15.0	5.5	1.7	23.0	6.4	10.9	17.9	13.6	31.3	10.1	12.2	26.4	21.8	7.9	9.3	4.7	9.7	17.2	29.3	13.5	16.5	8.0	11.4	4.5	15.5	7.4	8.4	8.2	11.8	8.7	6.2	3.0	9.4	42.4	12.5	15.0	3.2	9.3	15.3	10.7	3.4	10.4	9.8	27.3	3.3	27.9	0.8	16.4	11.8	0.0	39.1	50.7	19.2	15.1	10.4	8.6	51.9	0.0	13.8	11.1	22.5	0.0	15.8	26.1	15.1	72.1	16.3	15.7	18.6	14.0	17.7	7.7	9.0	6.5	14.4	0.9	5.1	13.8	9.2	23.6	24.3	10.7
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652520-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 25.7"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.2;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.5	0.3	1.1	3.4	2.3	1.0	1.1	25.7	0.4	1.5	0.7	2.4	1.3	0.3	0.4	6.2	4.8	12.8	1.4	0.3	1.9	1.2	0.2	2.1	3.8	2.0	0.5	0.0	2.6	1.5	0.3	0.7	1.7	3.2	3.6	0.4	0.4	5.5	1.4	0.4	11.9	0.5	0.3	0.9	4.2	0.8	9.8	0.3	2.5	0.4	0.8	7.1	0.6	3.9	1.4	0.1	1.2	0.1	0.0	0.6	0.1	2.0	0.1	0.2	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.5	3.2	2.0	1.6	0.0	0.7	3.4	2.1	0.7	0.0	0.6	6.9	0.1	3.2	2.0	0.0	0.0	2.3	0.0	1.4	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.6	1.5	11.4	1.5	0.4	0.0	0.1	0.0	9.3	0.1	0.2	3.0	14.6	6.8	0.3	0.0	0.6	0.0	8.7	7.1	0.0	2.3	6.2	0.0	4.5	2.7	0.5	14.6	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	1.4	0.4	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.3	25.7	0.3	1.9	1.2	0.5	0.0	3.2	0.3	0.0	1.0	0.0	3.9	2.7	0.5	1.2	0.0	17.4	7.9	0.0	0.0	0.2	0.0	0.0	18.5	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	2.4	0.0	0.0	10.0	0.6	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.2	0.0	0.0	0.1
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2, microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 92.7"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.8	1.7	1.0	13.4	2.0	21.7	1.2	2.2	1.7	2.2	5.7	0.5	0.3	4.6	1.2	2.3	13.3	0.5	1.9	1.5	0.8	0.7	1.2	2.7	2.6	12.9	0.7	1.1	0.8	0.5	0.0	0.7	6.6	0.9	0.7	7.4	0.5	2.3	0.5	2.2	5.9	4.7	3.2	0.9	5.9	3.2	22.0	0.6	92.7	0.7	11.0	16.2	2.2	3.8	1.0	1.4	4.0	0.1	4.8	10.4	1.3	70.8	23.8	28.8	22.5	2.3	4.2	27.8	29.8	16.9	43.3	32.7	50.5	30.7	33.4	17.6	16.6	32.4	37.5	32.8	27.0	49.5	14.4	12.7	65.4	22.8	34.4	0.7	25.1	16.8	1.4	1.5	27.1	19.8	6.2	23.3	25.3	48.3	30.5	33.9	29.1	41.9	19.5	32.1	27.4	25.8	23.9	77.8	20.2	11.6	11.6	20.9	14.1	45.6	17.3	13.5	20.7	30.0	15.3	15.7	48.6	29.9	22.2	45.7	12.2	21.1	29.9	15.2	89.5	31.6	4.0	0.0	0.5	0.6	0.0	0.3	1.0	1.9	2.3	0.6	0.4	0.4	0.7	0.4	4.8	0.1	1.4	10.4	1.3	1.0	2.0	2.2	1.7	0.8	0.7	0.7	1.1	0.9	0.6	0.0	6.2	16.2	0.8	6.2	0.8	0.8	7.6	0.0	5.7	0.0	0.0	4.4	0.0	1.0	6.4	0.3	0.6	70.0	0.4	57.2	2.9	0.6	0.0	2.5	15.9	1.6	1.2	9.8	5.3	10.6	0.9	5.1	0.0	3.6	2.6	0.3	1.2	0.6	0.0	0.0	0.3	0.0	2.1	121.8	68.8	5.4	3.9	6.9	7.3	1.4
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	Q13748	13	19173770-19181852	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	415	"testis: 161.0"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 509.9;Late spermatids: 171.1;Spermatocytes: 798.7;Spermatogonia: 313.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	50	"HDLM-2: 28.0;U-2 OS: 71.3;U-266/70: 23.1;U-266/84: 28.0"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes			Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	71.3	0.0	0.0	23.1	28.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	509.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	12.9	0.0	798.7	313.9	0.3	0.0	0.0	0.0	0.0
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241213-137243707	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 207.7"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 1754.5;Late spermatids: 2132.3;Spermatocytes: 1761.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	31.1	22.1	33.0	22.1	32.7	87.5	24.4	22.3	67.2	23.0	44.0	35.9	25.2	33.4	22.7	52.7	65.7	122.5	32.1	66.4	35.2	55.5	46.6	49.7	28.4	21.0	33.8	46.6	33.7	33.0	13.4	25.3	31.9	48.4	29.8	27.3	40.9	41.8	31.8	37.1	55.9	38.9	28.4	21.5	21.0	30.5	207.7	12.2	61.1	40.1	56.7	40.1	21.8	25.7	17.2	18.3	37.0	14.6	11.2	21.7	14.4	59.3	89.0	38.1	27.4	19.2	20.3	53.1	55.8	47.0	77.2	53.4	94.0	73.1	36.4	42.7	54.1	75.3	113.0	47.1	89.8	29.4	25.9	39.8	26.4	70.9	73.8	12.1	31.0	29.4	13.0	25.5	58.9	16.2	19.2	55.1	26.1	36.8	21.0	63.6	163.2	28.1	42.3	40.2	105.3	155.3	35.8	72.7	33.7	58.0	55.6	26.7	28.7	73.9	42.6	14.8	22.6	61.3	33.8	42.7	55.2	61.5	62.5	73.3	8.1	22.5	40.2	45.0	24.3	47.8	37.0	14.1	20.5	21.4	14.6	20.6	17.2	16.7	18.2	17.5	14.1	10.7	14.3	28.6	11.2	14.6	18.3	21.7	14.4	33.0	32.7	22.3	67.2	35.2	55.5	33.8	46.6	48.4	12.2	205.4	139.7	150.7	842.9	289.7	457.2	82.3	132.5	1026.5	175.1	136.1	282.7	235.6	187.3	348.8	1754.5	152.3	547.1	490.6	391.5	458.3	161.8	365.4	188.9	114.3	228.8	230.4	375.8	129.5	67.2	2132.3	235.3	111.2	131.6	359.7	292.5	271.2	343.5	375.2	143.9	259.6	647.3	109.9	245.2	1761.9	564.6	260.1	268.5	97.8	359.3	575.4
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	19.8	13.1	10.9	6.2	12.2	3.6	13.8	9.9	17.4	15.3	13.2	10.7	9.7	11.3	17.6	14.0	9.3	15.0	11.0	11.0	10.4	10.5	13.8	12.2	9.3	4.3	12.3	11.3	16.5	10.3	9.6	9.1	17.9	10.4	15.8	8.4	10.2	14.9	14.2	15.6	14.8	11.9	12.1	8.6	7.5	11.8	32.0	11.9	2.9	20.0	11.4	6.7	11.0	14.9	0.6	1.8	0.0	0.8	0.0	0.1	0.0	6.6	1.4	1.5	0.0	4.9	4.1	0.0	5.1	0.0	2.0	2.4	0.1	2.4	0.0	1.6	6.0	5.3	0.0	3.6	6.4	1.2	0.0	7.1	25.9	7.7	0.0	2.4	0.0	0.0	5.0	9.0	2.2	5.1	0.0	2.1	0.0	0.0	0.0	2.3	3.3	0.0	0.1	1.3	5.3	6.6	0.0	1.0	0.1	2.7	3.1	0.5	11.7	6.3	5.3	5.2	3.0	4.6	7.3	4.5	0.0	9.5	0.1	0.0	0.0	0.0	0.0	6.2	1.7	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.8	1.8	0.0	0.0	10.9	12.2	9.9	17.4	10.4	10.5	12.3	11.3	10.4	11.9	11.9	5.4	0.0	35.5	54.0	25.2	9.7	17.8	2.7	5.7	15.7	3.9	24.7	56.3	6.4	50.7	21.8	8.0	0.0	10.7	12.0	22.0	30.2	0.0	16.4	8.1	20.6	12.6	15.4	2.2	5.0	28.4	5.3	27.0	1.0	12.7	29.9	6.4	10.5	20.5	18.1	13.4	32.3	39.6	89.6	11.5	33.1	24.3	0.0	12.8	15.6
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597208-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1500000	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	20.5	31.9	27.9	17.8	30.0	34.0	24.4	20.6	34.5	22.5	20.1	21.5	17.3	20.1	22.1	33.8	29.6	18.0	19.8	37.2	27.7	28.5	28.0	38.5	16.4	21.7	27.7	22.8	26.1	34.3	21.5	23.3	26.8	32.1	23.1	21.6	17.6	22.4	20.9	64.4	17.6	21.1	26.5	23.4	20.4	24.0	19.3	21.1	22.3	96.0	27.7	23.3	27.7	18.9	22.2	29.9	39.0	35.3	23.4	23.0	30.9	24.8	24.6	33.3	34.3	29.0	42.5	23.7	29.7	30.6	38.4	32.6	21.8	24.6	27.1	26.5	32.3	27.8	31.0	31.5	26.9	39.8	27.6	14.4	37.1	20.6	40.8	34.0	54.0	24.2	32.2	27.9	36.1	33.2	40.6	30.8	20.8	27.1	45.5	38.8	23.9	31.2	35.3	24.1	17.3	26.5	25.5	22.5	47.0	44.8	38.9	27.7	25.3	16.9	23.7	28.1	27.7	25.9	29.0	24.4	40.4	21.3	14.0	28.9	44.2	47.3	42.3	26.3	41.4	29.5	39.0	35.3	25.3	15.9	29.6	21.7	22.2	19.7	20.8	29.9	19.3	19.4	19.6	26.5	23.4	27.9	25.5	23.0	30.9	27.9	30.0	20.6	34.5	27.7	28.5	27.7	22.8	32.1	21.1	53.6	38.7	77.2	102.3	119.4	77.4	92.0	48.4	57.6	61.4	27.9	131.6	212.5	92.9	122.4	165.3	62.6	79.4	46.7	112.7	104.6	91.2	91.6	51.9	68.4	133.8	54.0	72.8	56.4	76.0	218.7	71.9	78.2	62.4	131.7	97.3	59.0	117.2	83.1	78.8	104.9	82.7	64.7	97.8	196.1	99.4	110.2	299.9	68.2	101.2	105.2
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 109.0;Spermatocytes: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	"CAB002784, HPA074922"	Enhanced					NA	Yes					"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.9	21.5	44.9	21.7	5.0	8.4	22.8	32.9	19.7	35.6	42.7	18.1	11.2	21.7	12.9	17.7	20.2	6.3	31.3	12.4	30.8	20.4	34.8	36.8	20.2	31.1	1.1	75.6	40.4	7.4	2.9	22.4	7.0	6.8	29.7	46.2	29.5	34.9	44.8	16.0	91.0	41.9	16.2	17.0	16.1	60.2	40.4	26.1	13.3	12.4	15.3	24.9	27.8	12.9	8.3	29.1	8.8	34.5	11.7	41.2	81.4	37.7	64.2	43.3	53.3	49.6	10.9	32.7	47.0	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3	0.0	2.9	3.0	11.2	12.8	0.4	2.1	5.1	0.0	7.9	0.0	0.0	36.1	1.7	2.4	18.3	1.5	8.4	23.3	0.7	109.0	7.2	4.0	6.9	1.7	57.9	0.0	1.2	6.2	15.9	22.3	5.8	9.2	10.1	6.4	13.0	42.9	1.4	3.5	3.5	19.4	1.9	12.9	4.1	197.1	30.9	6.4	22.5	7.5	39.0	3.5
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 226.9;Spermatocytes: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	60.3	32.7	28.8	22.9	1.8	2.6	5.1	49.2	14.9	30.4	27.7	22.1	21.6	58.8	20.4	12.3	36.6	17.8	28.8	12.8	13.5	46.0	95.7	35.1	18.8	7.1	5.5	42.0	34.2	2.9	3.6	22.3	21.6	6.6	11.9	32.1	34.9	41.2	19.0	16.0	56.8	21.8	72.2	16.9	55.5	50.1	22.2	21.1	8.1	12.9	73.1	39.6	62.7	15.6	27.9	9.1	11.1	22.8	18.2	18.3	52.1	15.6	116.9	33.2	79.7	69.0	19.2	29.7	66.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2	0.0	4.3	37.3	136.4	144.5	56.5	2.4	7.6	0.0	0.0	19.2	51.1	34.3	13.3	44.4	86.7	31.2	25.8	70.0	26.4	226.9	94.9	63.2	18.4	9.6	55.5	30.2	88.9	22.7	24.7	27.7	16.1	39.9	70.9	55.1	28.4	76.7	57.6	28.1	11.7	14.8	59.0	12.9	96.6	216.2	140.8	101.4	50.0	44.7	30.4	121.0
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.6	13.9	14.0	16.3	32.2	20.6	8.8	15.1	18.0	11.4	12.6	7.8	8.8	14.3	16.6	17.8	17.8	11.0	26.6	16.9	13.8	22.1	16.0	5.8	19.2	8.2	16.9	11.3	12.8	19.1	21.4	15.3	13.4	16.5	9.9	9.3	6.7	15.8	17.9	8.7	14.5	9.9	11.6	6.0	16.6	13.0	18.1	13.5	23.0	14.6	17.3	16.2	21.8	9.7	8.8	25.6	16.2	8.4	11.1	12.1	12.4	17.4	9.1	6.0	7.4	9.9	13.6	12.0	10.2	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7	20.8	12.1	13.7	34.3	27.7	41.9	31.1	12.7	13.4	9.1	17.4	17.7	23.0	14.9	17.9	0.0	17.1	14.4	0.0	14.5	22.2	23.5	24.0	12.7	19.2	21.1	39.7	32.8	18.4	34.3	0.4	23.0	18.9	16.9	27.9	18.1	22.1	15.8	14.0	34.3	10.9	31.2	12.9	32.5	0.3	0.2	26.6	33.4	17.5	18.8	32.1
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498868-97571209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5;neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	16.0	5.6	7.7	7.3	7.1	10.2	20.5	5.1	9.0	11.5	4.6	5.8	9.7	2.9	6.6	13.9	8.1	8.3	9.0	23.8	6.8	6.5	15.6	11.2	26.0	8.3	9.1	4.8	8.9	12.9	3.1	7.8	5.3	6.4	6.5	1.5	8.9	10.7	10.8	24.2	22.7	2.5	7.0	6.7	5.3	4.1	30.3	5.7	1.0	12.9	10.9	4.4	10.3	8.6	0.3	1.7	8.5	3.4	0.0	0.4	0.5	9.0	9.0	2.4	11.9	10.1	9.5	2.8	10.4	15.3	11.2	8.6	6.0	7.9	1.1	12.7	7.0	7.0	10.9	2.4	13.9	1.5	2.7	4.7	1.1	2.8	7.5	14.6	1.0	3.1	13.1	4.7	12.1	3.0	17.2	17.8	2.4	0.6	1.7	7.1	4.3	0.4	9.2	3.9	1.7	16.6	0.9	4.2	1.0	8.6	3.4	0.8	2.5	4.7	2.9	13.4	2.2	10.8	6.8	19.1	14.2	8.7	14.8	13.5	2.2	2.5	0.4	11.9	6.1	7.3	1.3	3.4	7.5	0.2	0.8	0.2	0.3	0.1	0.0	1.7	0.0	0.1	0.0	8.5	0.0	0.9	1.2	0.4	0.5	7.7	7.1	5.1	8.1	6.8	6.5	9.1	4.8	6.4	5.7	38.7	19.9	0.0	7.7	23.1	2.2	14.1	7.6	9.4	13.6	7.0	3.9	2.8	10.0	16.1	52.6	20.4	0.3	0.0	11.2	9.4	17.5	12.5	0.0	5.8	24.5	6.4	0.0	4.9	7.3	20.2	11.8	8.5	10.1	9.0	0.1	10.1	16.8	0.0	8.9	8.1	15.9	12.9	9.0	5.9	5.7	26.0	2.4	0.9	0.2	6.2
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 63.9;REH: 145.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.9	11.6	17.5	12.4	0.5	2.0	2.8	13.0	6.2	13.6	13.2	13.8	8.1	9.1	3.2	5.7	4.9	8.0	12.0	7.0	9.6	14.7	13.7	7.8	10.8	14.7	0.2	19.3	11.9	1.0	0.5	7.3	1.9	2.1	4.0	14.4	11.2	10.5	8.1	12.5	63.9	11.8	7.8	5.8	12.5	145.0	39.1	6.6	3.7	11.7	13.0	10.3	10.2	5.6	1.8	2.9	10.1	18.4	5.0	14.4	11.7	18.6	15.7	4.5	4.6	26.8	8.3	18.8	18.3	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9											0.0	0.0	1.5	0.6	0.0	2.6	1.6	2.5	1.4	1.2	0.0	0.0	1.7	0.0	1.7	2.5	0.0	0.9	0.0	0.3	5.8	0.5	0.5	0.0	0.6	7.5	3.2	0.0	0.0	2.1	0.9	0.6	0.7	0.0	2.8	1.5	0.5	2.6	1.9	0.4	0.0	0.8	0.0	1.5	4.2	6.9	0.0	1.1	0.0	4.7	0.7
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097574-109110992	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	16.3	44.1	17.0	19.4	17.0	10.0	22.8	10.5	14.4	13.5	20.3	10.2	21.4	12.6	11.8	10.8	22.5	11.8	11.0	15.4	13.5	13.1	20.4	23.3	7.1	12.1	19.6	12.2	12.3	12.7	17.3	8.9	18.6	12.0	12.9	22.1	10.7	16.6	19.7	29.1	22.5	13.5	11.0	19.7	13.2	12.3	35.6	9.8	35.1	25.1	19.8	19.0	11.5	14.4	9.8	3.9	5.8	3.0	8.7	19.5	7.9	20.1	20.7	20.0	18.1	33.3	9.6	19.1	11.9	8.2	18.9	14.5	16.4	13.9	26.5	18.0	10.7	9.9	12.8	22.0	12.4	18.4	22.4	40.9	25.9	12.0	27.7	5.0	38.4	16.0	8.6	11.4	9.0	5.0	15.1	13.6	31.9	20.9	8.9	12.7	25.2	35.3	45.4	35.5	32.9	32.0	32.6	30.1	22.6	11.8	25.5	28.5	15.8	21.5	18.5	10.4	27.2	34.5	18.0	7.0	16.4	14.7	10.8	16.5	17.3	37.2	50.3	12.5	25.9	20.0	5.8	1.5	2.7	13.4	3.0	19.5	9.8	15.9	15.5	3.9	9.2	10.3	11.5	0.0	8.7	3.0	2.8	14.0	7.9	17.0	17.0	10.5	14.4	13.5	13.1	19.6	12.2	12.0	9.8	0.0	4.5	6.7	10.0	16.0	2.6	10.6	7.6	2.7	2.3	40.1	3.9	41.8	16.6	11.9	3.2	11.6	7.3	0.0	5.5	24.6	10.3	5.9	7.0	20.3	15.7	4.8	8.1	14.7	2.9	3.4	13.0	4.5	13.5	5.4	18.2	11.8	5.9	7.0	13.8	14.6	3.0	6.5	9.0	18.6	64.3	18.2	17.0	17.8	34.2	7.6
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"U-2197: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.8	3.2	1.2	5.3	5.2	1.6	2.7	0.3	0.6	0.0	1.9	3.5	0.2	0.0	0.0	0.1	0.2	1.2	0.1	0.1	1.5	1.6	10.2	0.0	0.0	3.3	0.0	4.0	0.1	2.7	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	2.5	4.2	0.0	0.2	0.9	0.2	0.0	4.9	1.3	126.7	0.6	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5	6.0	12.5	0.9	6.0	8.5	0.0	12.9	35.7	1.4	3.4	22.7	0.0	3.0	6.6	10.3	1.0	3.3	0.2	0.0	2.6	6.4	108.9	7.4	3.5	12.9	2.8	0.0	0.0	4.9	0.3	1.8	46.3	1.2	13.5	0.0	0.4	16.3	17.4	0.0	57.3	12.5	0.7	97.0	96.8	0.5	5.1	6.6	8.4	1.8	0.2	3.3
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826963-43868419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 37.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	Yes			"Nuclear bodies"	"Nucleoli fibrillar center"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (6.98e-4)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	5.4	1.8	2.4	21.9	3.0	17.5	4.8	12.9	6.0	5.3	6.3	1.5	1.6	3.6	4.9	3.6	8.2	3.3	2.1	2.5	2.4	2.0	2.8	2.5	5.1	19.8	2.4	2.1	4.2	4.8	3.9	3.3	4.3	3.3	4.2	6.8	4.5	4.6	2.4	1.4	6.3	5.8	7.0	3.9	6.5	4.8	6.7	2.1	37.2	2.9	7.1	21.9	5.3	5.5	3.2	1.6	0.4	0.8	5.7	8.3	2.6	11.1	5.7	13.6	10.4	1.5	3.7	3.7	18.8	11.2	20.6	26.0	7.2	5.9	16.5	8.3	8.7	10.4	16.2	14.0	6.7	18.0	25.6	8.3	20.3	18.2	2.3	0.8	20.6	9.1	1.1	1.1	11.3	2.6	3.0	6.5	17.9	15.3	28.9	14.1	3.9	19.9	4.8	4.8	3.5	5.9	21.4	23.4	10.4	3.8	11.6	10.5	10.4	11.8	7.5	2.3	4.4	11.6	10.0	2.9	19.0	9.0	21.2	19.0	14.3	35.6	42.1	13.6	18.3	10.4	0.0	0.8	0.4	5.1	0.5	5.4	2.5	6.4	4.4	1.3	3.2	5.2	4.1	0.0	5.7	0.2	1.6	8.3	2.6	2.4	3.0	12.9	6.0	2.4	2.0	2.4	2.1	3.3	2.1	3.0	2.2	6.0	3.1	6.5	2.0	1.2	0.0	0.0	3.4	1.8	9.8	5.5	1.7	2.0	1.5	3.5	0.8	0.0	3.5	11.4	2.5	1.6	5.7	0.4	7.5	1.6	0.0	3.1	3.3	0.6	1.7	3.1	3.3	3.6	2.2	7.3	0.9	1.5	2.1	0.6	15.7	6.5	5.3	8.7	44.7	5.1	3.0	10.9	5.6	1.3
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486156-186509363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	25.2	31.1	35.7	25.2	40.1	67.3	38.0	32.9	52.6	24.7	24.7	10.5	30.2	29.0	25.1	30.7	28.2	19.8	22.6	25.2	60.0	35.4	32.8	40.3	20.3	29.5	32.3	33.5	24.5	32.7	26.9	35.3	29.4	51.6	24.3	28.9	10.7	25.8	26.2	58.0	27.0	29.9	27.4	43.4	28.5	23.3	23.7	21.7	28.3	30.5	19.0	30.1	30.0	38.8	32.8	31.1	28.3	39.1	32.5	36.9	22.4	27.2	18.5	22.9	29.4	26.1	26.5	34.4	30.4	20.8	28.2	25.5	53.9	22.1	37.2	27.9	21.5	36.2	19.9	42.1	37.1	40.0	33.8	32.2	53.4	28.6	59.6	35.3	54.3	32.8	21.6	41.2	30.6	43.6	24.9	30.2	23.2	51.0	29.2	29.4	24.5	34.6	38.8	43.2	36.0	46.9	27.7	31.0	34.6	35.7	33.3	27.7	20.4	19.2	26.3	43.9	36.0	18.5	39.6	25.9	31.9	27.6	19.5	36.2	25.5	42.7	53.2	28.3	38.6	27.8	28.3	27.5	26.9	27.2	34.0	33.7	32.8	33.8	34.5	31.1	24.7	31.5	33.2	16.8	32.5	39.1	27.5	36.9	22.4	35.7	40.1	32.9	52.6	60.0	35.4	32.3	33.5	51.6	21.7	68.5	78.9	141.2	127.1	188.5	73.2	87.6	66.2	78.9	102.4	109.9	56.9	114.7	217.2	91.2	123.7	87.8	121.8	46.7	90.4	141.8	94.0	129.7	109.7	114.6	109.7	54.0	97.5	65.7	86.1	224.0	72.8	100.6	60.8	118.2	99.1	80.5	96.4	97.7	82.0	189.8	120.6	32.3	103.2	184.4	186.8	182.8	148.5	83.7	117.5	153.1
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418329	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.8;lymphoid tissue: 21.5"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 8.9;Sertoli cells: 6.5;Spermatocytes: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	7	"T-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	2.7	1.2	2.1	8.9	4.6	23.8	4.4	2.9	3.9	2.2	4.9	2.9	1.7	3.2	1.3	2.1	4.5	1.3	3.0	4.6	2.5	2.1	3.3	12.0	2.6	4.7	4.4	2.0	2.2	1.8	3.9	0.6	3.7	3.8	1.4	3.8	2.1	3.2	0.6	3.9	3.9	3.2	2.6	4.3	3.4	2.4	9.6	4.3	21.5	1.3	6.5	5.0	2.1	2.5	0.1	0.2	0.1	0.2	0.1	1.8	0.7	13.3	5.5	5.4	4.9	2.1	3.0	7.4	18.7	11.1	9.3	11.2	3.4	9.5	10.2	8.0	8.9	7.0	16.5	6.3	6.8	11.1	11.1	5.5	7.4	10.6	2.8	0.0	10.3	9.1	0.5	0.4	7.5	3.8	2.0	3.4	7.2	6.7	24.9	11.9	8.9	15.8	8.5	3.7	14.8	9.1	8.0	27.6	6.2	2.7	9.0	9.6	6.7	8.2	9.9	5.7	4.6	5.2	9.2	3.0	15.4	8.8	14.1	14.1	9.7	16.4	4.2	9.3	9.1	12.9	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.8	1.2	0.2	0.1	1.1	1.3	0.0	0.1	0.2	0.1	1.8	0.7	2.1	4.6	2.9	3.9	2.5	2.1	4.4	2.0	3.8	4.3	0.0	0.0	2.2	1.0	8.9	0.6	2.2	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.4	0.6	0.6	0.6	0.0	1.0	3.5	1.7	0.4	0.0	3.9	1.7	0.0	0.0	1.3	2.5	0.6	0.6	1.5	3.3	0.0	1.9	0.5	0.5	0.0	0.7	2.2	1.5	6.5	2.5	7.2	1.4	5.6	0.7	2.5	2.5	0.1
ZNF718	FLJ90036	ENSG00000250312	"Zinc finger protein 718"		4	124480-202303	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 17.0"															NA	Yes						"unprognostic (1.96e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.39e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-1)"	3.1	6.0	5.9	5.7	7.7	4.7	4.6	16.0	7.5	6.9	4.7	7.7	4.5	3.0	6.5	4.3	2.8	5.9	3.6	2.9	6.5		4.8	2.7	3.5	6.5	9.7	5.8	7.2	4.6	8.8	17.8	5.4	7.2	5.9	4.4	7.8	3.1	4.2	1.4	5.3	3.3	5.0	9.1	5.0	3.4	3.9	10.5	11.0	9.1	1.7	6.2	5.4	3.0	4.3	4.4	9.6	3.2	9.0	4.2	2.1	0.0	0.9	5.1	0.1	3.2	5.9	1.2	6.3	0.9	4.1	3.4	5.3	7.1	7.6	3.8	2.2	7.2	1.9	4.0	2.9	5.5	0.0	1.5	0.0	1.3	0.0	3.9	0.0	0.2	3.1	2.6	4.1	0.5	3.6	2.7	2.2	3.5	0.0	7.0	3.9	0.7	4.8	6.3	0.0	2.4	17.0	2.0	4.3	3.3	1.9	6.8	1.6	3.2	1.1	3.8	4.2	11.7	1.9	1.9	3.0	3.8	3.8	4.6	0.0	0.0	12.1	0.0	0.0	3.7	4.7	2.5	9.6	4.2	3.2	4.1	3.9	3.6	2.6	4.3	4.3	4.2	4.0	3.1	9.0	1.9	4.4	2.7	2.1											3.0	2.2	0.5	1.7	1.8	8.3	1.6	0.0	4.0	7.9	0.0	2.0	1.6	0.0	2.8	0.3	2.9	0.5	0.0	1.2	1.2	1.5	1.5	5.7	0.4	1.2	7.9	1.2	8.0	2.1	0.4	3.4	2.5	3.3	1.0	0.7	2.4	1.2	0.0	4.2	1.8	4.6	0.0	2.8	1.7	2.3	0.6	1.1	2.9	0.6	0.6
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081297	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	26.4	27.4	39.8	31.1	42.2	35.1	34.4	54.1	48.6	39.3	28.8	19.6	33.3	23.4	48.3	45.6	20.2	30.6	20.3	27.5	33.5	30.6	20.1	19.5	26.7	37.8	34.1	40.5	39.5	23.9	23.1	77.5	24.6	32.0	30.5	29.3	17.5	25.1	33.2	54.4	27.9	24.9	35.1	42.2	26.2	23.6	31.6	38.0	40.0	32.8	24.3	30.9	32.8	25.6	31.4	34.0	32.1	16.3	20.9	30.8	13.8	23.7	8.6	35.6	20.5	13.9	24.0	20.3	29.1	16.0	25.6	32.7	16.1	15.4	49.3	25.8	17.9	24.1	15.0	30.1	18.1	38.4	34.8	21.7	42.8	33.8	13.4	20.7	46.6	17.5	18.2	22.7	24.9	21.5	29.0	21.5	25.5	44.7	26.4	19.5	8.1	38.1	15.1	36.3	14.2	16.9	43.4	26.6	28.9	16.5	20.3	26.5	16.8	24.8	16.7	24.8	19.4	20.5	20.5	28.8	18.9	18.1	14.8	28.7	21.8	27.0	54.2	27.9	43.5	26.5	32.1	16.3	14.2	22.2	15.0	25.1	30.6	23.6	21.3	12.4	31.4	30.8	24.2	14.6	20.9	14.8	34.0	22.0	13.8	39.8	42.2	54.1	48.6	33.5	30.6	34.1	40.5	32.0	38.0	92.3	128.7	70.6	66.5	45.0	171.8	89.9	58.6	91.0	72.8	47.1	121.7	45.9	41.4	45.1	111.6	51.1	53.4	23.3	58.7	46.6	56.3	44.1	84.4	36.4	38.8	201.8	70.2	51.0	27.2	20.7	171.7	52.0	45.5	50.5	41.0	144.1	55.6	45.6	108.5	30.6	205.0	116.4	59.5	149.3	96.0	40.7	53.1	60.9	36.0	49.3
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 13.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.2	4.0	11.3	2.2	12.1	3.5	11.2	36.4	27.6	8.0	9.9	3.6	5.9	3.2	16.3	8.4	9.9	6.8	15.5	6.4	8.0	3.8	5.2	4.5	8.7	1.9	16.7	5.6	17.7	8.1	4.8	8.3	2.3	14.9	7.1	5.1	3.5	6.5	8.3	7.0	11.0	3.5	10.7	21.9	2.1	13.3	18.4	11.8	0.6	21.0	5.6	3.1	7.3	6.9	1.5	2.0	13.4	0.3	1.4	1.5	0.3	1.0	1.4	2.2	10.3	0.3	0.5	3.3	0.5	0.6	0.5	0.4	1.3	15.7	0.2	21.8	0.7	3.2	3.3	1.1	0.9	0.3	1.8	0.9	3.6	8.1	2.4	0.9	7.3	4.5	0.3	8.7	0.6	0.9	1.0	14.9	2.8	3.9	2.8	2.3	1.5	1.2	1.7	0.7	0.7	6.4	3.2	2.0	1.9	1.5	1.3	7.3	2.0	13.9	9.0	2.0	1.7	4.5	2.5	16.3	3.3	26.6	0.7	1.2	1.1	1.6	0.2	0.4	3.5	0.7	13.4	0.3	0.6	1.5	0.2	1.3	1.5	1.2	1.2	0.3	1.3	1.0	1.5	0.3	1.4	0.3	2.0	0.2	0.3	11.3	12.1	36.4	27.6	8.0	3.8	16.7	5.6	14.9	11.8	26.8	3.5	0.0	2.2	0.7	6.5	6.1	5.1	2.7	12.5	3.5	0.0	1.8	6.6	2.4	114.2	4.5	1.6	0.0	7.1	0.8	1.5	1.7	2.3	3.9	0.6	1.6	5.8	2.5	0.3	52.0	3.4	1.1	1.7	1.0	2.2	7.3	4.0	3.5	4.9	4.2	4.9	6.5	1.7	2.3	2.5	1.9	0.7	1.5	2.3	1.3
